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Summary
The innate immune system provides our body with a first set of rapid defense mechanisms against
invading pathogens. Microbial or eukaryotic invaders are sensed by specialized, germline-encoded
innate immune receptors that induce the activation of a systemic response in order to fight off the
infection. The innate immune system also triggers the activation of the adaptive immune system
and modulates the phenotype and function of the adaptive response.
Constitutive activation of innate immune sensors, however, or loss of specificity and thereforemisfir-
ing by detection of endogenous molecules can lead to serious autoimmune disorders. Indeed, more
and more diseases have been linked to different innate immune pathways. The molecular basis for
incorrect signaling, nevertheless, often remains to be determined.
The RIG-I-like receptors (RLRs) RIG-I, MDA5 and LGP2 are cytosolic distributed proteins, that detect
foreign double-stranded (ds) RNA. RLRs consist of several domains specialized in dsRNA-recognition
as well as in transmitting the recognition event to other proteins in order to start the defense.
Despite the availability of several RLR protein structures accompanied with various in vitro and in
vivo experiments, the exact role of their central Superfamily 2 (SF2) helicase domain, that displays
an RNA-dependent ATP hydrolysis function, is still not understood. Furthermore, whereas from in
vitro experiments it is known that RIG-I favors the recognition of short dsRNA ends containing 5′ tri-
or diphosphates andMDA5 cooperatively binds within long dsRNA, so far only limited knowledge of
in vivo ligands and their origin in infected cells is available.
In order to identify physiological ligands of RLRs, in the first part of this thesis, RIG-I and MDA5 pro-
tein:RNA complexes from measles virus (MeV)-infected cells were purified and analyzed via deep
sequencing. The results were validated by qPCR and are supported by several in vitro and in silico
analyses. Specifically, RIG-I and MDA5 were found to recognize distinct but partly overlapping MeV
RNA species: MDA5 preferentially interacted with mRNA species of the MeV polymerase gene. RIG-
I additionally bound positive and negative-sense RNA near the genomic and antigenomic 5′ ends.
Both RIG-I and MDA5 interacted with 5′-copyback defective interfering (DI) sequences as detected
by PCR. Further, in vitro transcripts covering different regions of the MeV antigenome were used
to verify the correlation between actual immunostimulatory potential of RNA and deep sequencing
results. Bioinformatics analysis in addition revealed a preference of MDA5 for AU-rich RNA but an
anti-correlation of MDA5 ATP hydrolysis rate and RNA AU-content.
Based on this study, a model of how MDA5 preferentially senses AU-rich dsRNA species can be es-
tablished: In this regard a reduced ATPase function of MDA5 when bound to AU-rich RNA helps to
generate stable protein filaments and therefore leads to increased type I interferon signaling.
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In the second and major part of this thesis the RIG-I SF2 helicase domain as well as RIG-I variants
identified in the multi-system disorder Singleton-Merten syndrome (SMS) were functionally ana-
lyzed. RIG-I SF2 mutants deficient in ATP binding severely lost their signaling capabilities in both
infected and uninfected cells. In contrast to that, ATP hydrolysis-impaired RIG-I that can still bind
ATP, a phenotype that is found in SMS patients as well, constitutively signaled on endogenous RNA.
Furthermore, the recognition of a ribosomal expansion segment by ATP hydrolysis-impaired RIG-I
could be determined through co-immunopurification from uninfected cells and was visualized by
cryo-electron microscopy. Interactions with the ribosome were also found for the respective MDA5
mutant as well as in infected cells. Subsequent biochemical analyses validated reduced binding of
wild type RIG-I in presence of ATP, whereas ATP hydrolysis-deficient RIG-I was found to stably inter-
act with this RNA.
The presence of ATP therefore seems to be a prerequisite for RIG-I immune signaling and probably
helps to release the CARD domains. ATP hydrolysis by RIG-I, in contrast, weakens the affinity of the
protein towards endogenous RNA lacking the 5′ triphosphate signature. This renders the ATPase
domain of RIG-I to be an essential feature for the discrimination between self and non-self RNA.
Importantly, both studies combined provide the basis for an updated view on ATP-dependent RIG-I-
like receptor signaling that is presented and discussed.
2
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1 Basic principles of the immune system
All organisms need to continuously protect themselves against invading pathogens. Because of that
all domains of life evolved sophisticated defense strategies, including both inherited as well as adap-
tive mechanisms, known as immune system1. Immunity is provided if an organism is able to detect
and eliminate foreign molecules or pathogens while tolerating non-harmful self molecules or com-
mensal organisms.
The human body is prepared with two distinct kinds of immune systems: an inherited, rather unspe-
cific system, as well as an adaptive one, that is able to specifically react to changing environmental
conditions2.
Inherited or innate immune systems are passed from one generation to the next and often provide
more general detection mechanisms for several classes of molecules. The innate immune system
of multicelluar organisms is fairly conserved across evolution and mediated by a limited number of
germline-encoded receptors. Similar receptors are found in plants and animals3. Innate systems,
however, only have a short term memory and need to start from the beginning every time they
encounter foreign molecules.
Adaptive immune systems, on the other hand, are typically more specialized and can be acquired in
a relatively short period of time1. Adaptive immunity of jawed vertebrates is facilitated by antigen
specific receptors that are not germ-line encoded, but generated by randomgenomic recombination
of gene segments resulting in many different but individual receptor specificities. Those adaptive
systems are characterized by a greater number or reacting receptors, an extended life span and
memory, while providing a more rapid response to molecules they might not have seen before. The
adaptive response, however, is also more prone for the development of allergy and autoimmunity4.
The importance of an intact immune system is frequently emphasized, for instance by the recent
Ebola or Zika virus pandemics or by the recurring influenza virus outbreaks. The molecular basis for
pathogen recognition and defense of the human body as well as the tricks of pathogens to evade
immune recognition and to successfully reproduce, however, are still fairly unknown and subject of
recent research.
A precise knowledge about these mechanisms will help to develop better vaccines or therapeutics,
but also contributes to our understanding of autoimmune diseases where immune receptors are
directed against self.
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2 Pattern recognition receptors of the innate immune system
If pathogens successfully overcome the physical and chemical barriers of the human body and try
to establish an infection, they immediately face different innate immune sensors called pathogen
recognition receptors (PRRs). PRRs survey both the intra- and extracellular space, and are activated
by unique, so-called pathogen-associated molecular patterns (PAMPs) that are conserved and spe-
cific to a wide range of microorganisms5.
PAMPs are often to some extent invariable since they represent molecular structures that are es-
sential for the pathogen survival and therefore are not subject to a rapid adaptive evolution of the
pathogen5. Further, PAMPs are typically either not expressed ormodifiedby themammalian host, or
only occur in certain compartments. Nevertheless, somePRRs also recognize endogenousmolecules
released from damaged cellular compartments or cells, so-called damage-associated molecular
patterns (DAMPs)6. Recognition of PAMPs and DAMPs by different PRRs is considerably redundant
ensuring that a microbe that evades one mechanism can still be detected by another.
Upon sensing of PAMPs or DAMPs, PRRs activate signaling cascades that start the expression of in-
terferons, cytokines and chemokines, that in turn promote the synthesis of many antiviral proteins7.
These proteins shut down translation, promote growth arrest or even cell death. Cytokines and che-
mokines further recruit immune cells to the site of infection in order to control pathogen spread and
to initiate an adaptive immune response7. Collectively, both innate and adaptive immune response
subsequently provide the mechanisms to fight off the infection and to restore homeostasis.
Problems occur, however, if there is no clear cut-off criterion for the distinction between self and
non-self. Viruses for example, express only a very limited number of specific molecules and on top
exploit the host cell machinery for their reproduction. In order to detect viruses, the immune system
thus often relies on the recognition of viral nucleic acids that flood the cell upon an infection, and
thereby risks to evolve autoimmunity against very similar self molecules8.
The major families of human PRRs are: Toll-like receptors (TLRs), C-type lectin receptors (CLRs),
retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs), nucleotide binding oligomerization do-
main (NOD)-like receptors (NLRs), absent in melanoma 2 (AIM2)-like receptors (ALRs) and the cyclic
GMP-AMP synthase (cGAS)/ stimulator of interferon genes (STING) system.
TLRs are membrane bound receptors recognizing a variety of different bacterial, fungal and viral
PAMPs ranging from cell wall parts such as lipopolysaccharides and lipopeptides over parts of the
bacterial flagellum to different kinds of nucleic acids9. CLRs are a large family of soluble and mem-
brane bound receptors recognizing specific carbohydrate structures10. RLRs, ALRs and cGAS bind
foreign or mislocated cytosolic double-stranded (ds) nucleic acids11. NLRs are located within the
cytosol as well and provide a back-up defense by recognizing bacterial cell wall components similar
to TLRs, but also toxins or host-derived ligands, e.g. uric acids or damaged membranes. Many NLRs
assemble into large inflammasome complexes12.
This thesis focuses on RIG-I-like receptors and the detection of cytosolic viral RNA. For that pur-
pose, first other nucleic acid-sensing PRRs in general, including TLRs and the cGAS/STING system,
are briefly introduced. Afterwards the main attention is drawn towards RLRs signaling.
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2.1 Nucleic acid-sensing by Toll-like receptors
Toll-like receptors are membrane-bound proteins mostly expressed on immune cells, endothelial
and epithelial cells with each cell type expressing a different set of TLRs13,14. They reside both on
the cell surface as well as on intracellular membranes. 10 human TLRs are known: TLR1, TLR2, TLR4,
TLR5, TLR6 and TLR10 are expressed largely on the surface of cells and recognize molecules found
outside of pathogens, like e.g. components of the bacterial cell wall. TLR3, TLR7, TLR8 and TLR9 are
locatedwithin themembrane of the endosomal compartment and generally bind structures that are
only available after uptake and destruction of potential pathogens15. TLRs all have a characteristic
extracellular horseshoe-like shaped leucine-rich repeat (LRP) domain, a transmembrane domain and
a cytosolic Toll/interleukin-1 receptor (TIR) domain16.
TLRs are activated by simultaneous PAMP binding to two TLRs which leads to homo- or heterodimer-
ization and to the recruitment of several intracellular signaling adapters and kinases. Activated and
dimerized TLRs further form higher order clusters in the cell membrane. Specifically, TLRs recognize
PAMPs via their extracellular domains. Except for TLR3, which uses TRIF as adapter molecule, all
TLRs then directly or indirectly interact through their cytosolic TIR domains with the adapter protein
MyD88 for downstream signal transmission (Figure 1). MyD88 in turn promotes the formation of the
so-calledMyddosome, a large helical assembly of several TLRs andMyD88s, via their death domains
that enables the interaction with signal transmitting kinases18.
TLR2 forms a heterodimer with either TLR1 or TLR6 in order to bind different kinds of bacterial
lipoproteins19,20. TLR10 seems to have regulatory roles by competing for ligands with TLR221. TLR4
recognizes lipopolysaccharides (LPS) which is a major component of the outer membrane of Gram-
Figure 1: Simplified signaling cascade of the en-
dosomal Toll-like receptor pathway. All
nucleic acid-sensing TLRs reside in endo-
somes, dimerize upon ligand binding and
signal either via the adapter protein TRIF
or MyD88. These in turn activate the
NF-κB- and IRF3-dependent expression of
proinflammatory cytokines and type I in-
terferons.
Figure adopted from Junt and Barchet 17 .
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negative bacteria22–24 and TLR5 can be activated by a depolymerized form of bacterial flagellin25.
Nucleic acid-binding TLRs, however, only reside within the endosomal compartment. Guanosine-
and uridine-rich single-stranded (ss) RNA as well as synthetic polyuridines and siRNAs are recog-
nized by TLR7 and TLR826–29. TLR3 responds to dsRNA30. TLR9 was originally described to recognize
double-stranded, unmethylated CpG-rich DNA31 but was later shown to only depend on the 2′de-
oxyribose backbone of nucleic acids and therefore to respond to all kinds of dsDNA regardless of
specific sequences32,33.
2.2 Recognition of cytosolic DNA
Since the occurrence of DNA within eukaryotic cells is restricted to the nucleus and mitochondria,
the appearance of cytosolic DNA in non-dividing cells provides a clear danger signal for potentially
invaded pathogens or cellular damage. DNA-sensing TLRs are, however, restricted to plasma mem-
branes, thereby facing the extracellular space or endosomes. Thus several cytosolic DNA sensors,
including DNA-dependent activator of IFN-regulatory factors (DAI), DDX41, interferon gamma in-
ducible protein 16 (IFI16), AIM2 and cGAS, exist11,34–38. With the exception of cGAS and IFI16, how-
ever, they play redundant roles or may be cell type specific.
cGAS is ubiquitously expressed and belongs to the nucleotidyltransferase (NT) family. It consists
of a C-terminal NTase and Mab21 domain which is highly conserved in vertebrates, and of a less
conserved, long unstructured N-terminal sequence37. cGAS is activated by a variety of DNA stim-
uli, including transfected plasmid DNA, mislocated mitochondrial DNA, and viral DNA generated by
infection with DNA viruses as well as retroviruses. For HIV-1 especially, it was shown that cGAS rec-
ognizes short Y-shaped cDNA structures with unpaired, flanking guanosines39. cGAS was also found
to indirectly contribute to the recognition of some RNA viruses, perhaps by inducing a very low basal
autoimmune response triggered by endogenousDNA,which ensures the availability of other sensors
needed for the primary response to viruses40.
When activated by dsDNA, cGAS catalyzes the production of cyclic AMP-GAMP (cGAMP) from ATP
and GTP, which in turn functions as an endogenous second messenger for the activation of the en-
doplasmic reticulum (ER)-bound adapter protein STING41 (Figure 2). dsDNA-binding by cGAS is facil-
itated by a highly positive charged platform as well as a conserved zinc thumb which is furthermore
important for DNA-induceddimerizationof cGAS42–45. Interestingly, the cGAMPproducedby cGAS is
Gp(2′– 5′)Ap(3′– 5′) and contains a mixed phosphodiester linkage between the two ring-forming nu-
cleotides46–48. STING, however, responds to various cyclic dinucleotides (CDNs) and is, even though
to a lesser extent, activated by bacterial CDNs like c-di-GMP or c-di-AMP as well, thereby providing
an additional direct immune response to bacterial second messengers49.
Upon binding to CDNs, STING in turn triggers the induction of type I interferons in order to start an
immune response. Thereby STING was found to dimerize and to relocate from the ER to perinuclear
vesicles50.
Two other DNA sensors, AIM2 and IFI16, are shown to trigger an immune response through the
6
2 Pattern recognition receptors of the innate immune system
Figure 2: Simplified signaling cascade of the
cGAS/STING pathway. Upon detection
of cytosolic dsDNA, cGAS dimerizes and
produces the eukaryotic second messen-
ger cGAMP, which activates the adapter
protein STING. STING in turn induces the
NF-κB- and IRF3-dependent expression
of proinflammatory cytokines and type I
interferons.
Figure adopted from Junt and Barchet 17 .
dsDNA
TBK1
NF-κB
proinflammatory cytokines type I interferons
cytosol
nucleus
IRF3
cGAS
cGAS cGAMP
GTP
ATP
STI
NG
ST
IN
G
ER
activation of the inflammasome51–53, which is an intracellular multiprotein complex that mediates
the activation of caspase-1 and thereby triggers pyroptotic cell death through an inflammatory re-
sponse54. Both proteins contain a positively charged DNA-binding HIN-200 domain55 as well as a
pyrin domain (PYD) that allows homotypic PYD:PYD interactionswith the adapter protein ASC56. ASC
further possesses a caspase activation and recruitment domain (CARD) and, through CARD-CARD
interactions, links the PYD-containing sensor proteins to caspase-1 recruitment, dimerization, and
autoproteolytic activation. Caspase-1 in turn processes the inactive precursors of IL-1β and IL-18
into mature cytokines57.
In addition IFI16 was reported to detect foreign DNA within the nucleus58 and might thereby even
interact with cGAS59.
2.3 RNA-sensing by RIG-I-like receptors
In contrast to cytosolic DNA, cytosolic RNA as such is no unusual condition, since translation is facil-
itated outside the nucleus. Thus several types of endogenous RNAs, including small RNAs, mRNAs,
rRNAs and tRNAs are localized in the cytosol and need to be discriminated from foreign, often viral,
RNA.
Non-self cytosolic RNA is detected by the RIG-I-like receptors including the eponymous RIG-I, mela-
noma differentiation-associated gene 5 (MDA5) and laboratory of genetics and physiology 2 (LGP2).
RLRs are ubiquitously expressed and thereby ensure that every cell can respond to viral infections. All
RLRs specifically recognize foreign dsRNA with slightly different substrate specificities which broad-
ens the spectrum of detected viruses.
RIG-I andMDA5 are composed of three major domains: two N-terminal CARDs necessary for signal-
ing, a central Superfamily 2 (SF2) helicase domain and a C-terminal domain (CTD). Both SF2 helicase
domain and CTD are involved in RNA binding60–62. Furthermore, an alternative splicing form for
each RIG-I and MDA5 exist63: RIG-I isoform 2 lacks the amino acids (aa) 36 – 80 within the CARDs,
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while MDA5 isoform 2 contains only the CARDs aa 1 – 207 as well as an additional 14 aa tail.
LGP2 misses the CARDs entirely but has otherwise a similar domain architecture.
Detection of dsRNA by RIG-I and MDA5 releases the otherwise shielded CARDs61, rendering them
free to bind to the mitochondrial antiviral signaling protein (MAVS) through CARD-CARD interac-
tions64–69. This interaction can further be stabilized by binding of K48-linked ubiquitin chains69,70.
Translocation of activated cytosolic RIG-I to the membrane bound MAVS is facilitated by 14-3-3ε
chaperons71. Activation of MAVS by RIG-I or MDA5 in turn starts an innate immune response that
aims to clear the cell of the invading virus, to attract specialized immune cells, and to alert and pro-
tect uninfected neighboring cells.
LGP2 is thought to have regulatory functions within this process, since it lacks the signal promoting
CARDs72,73.
2.3.1 RIG-I and MDA5 signaling cascade via the adapter protein MAVS
Similar to MyD88 within the TLR pathway or STING within the cGAS axis, MAVS integrates the RLR
immune response signal, and promotes the activation of several transcription factors. These include
nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) and various interferon regulatory
factors (IRFs), all of which together act to create an antiviral state of the cell (Figure 3).
MAVS itself contains a C-terminal transmembrane domain anchoring it to mitochondria, peroxi-
somes and mitochondrion-associated membranes74, a long unstructured region and an N-terminal
CARD domain. Binding of the RIG-I or MDA5 CARDs to the MAVS CARD, leads to conformational
changes within MAVS and to multimerization into prion-like functional aggregates. Thereby MAVS
polymers recruit more MAVS molecules and that in turn activate downstream proteins75.
MAVS is, depending on its localization, able to induce a sequential antiviral response. Peroxisome-
bound MAVS triggers an immediate interferon-independent antiviral response that provides short-
term protection by inducing type III interferons and the rapid expression of antiviral genes76. Mito-
chondrion-located MAVS, apart from that, triggers type I interferon (IFN) gene expression ensuring
a long-term containment of the infection74. In the latter case, MAVS polymers recruit several re-
dundantly acting tumor necrosis factor (TNF) receptor-associated factors (TRAF) ubiquitin E3 ligases
through proline-rich repeats within the unstructured region to synthesize linear K63-linked polyu-
biquitin chains77. These polyubiquitin chains in turn bind the regulatory subunits of IκB kinase (IKK)
and TANK-binding kinase 1 (TBK1) complexes thereby activating them78–81. Active IKK phosphory-
lates the inhibitor ofNF-κB (IκB) resulting in its degradative K48-linked polyubiquitination and subse-
quent proteasome-mediated digestion. Active TBK1, in contrast, phosphorylates theMAVS polymer,
which is then able to recruit IRF3 that harbors a positively charged phospho-binding domain82. This
recruitment enables TBK1 to phosphorylate IRF3 as well, thereby resulting in its dimerization and
activation. Finally, activated NF-κB and IRF3 translocate into the nucleus and activate the expression
of interferons and multiple cytokines or chemokines.
Cytokines and chemokines help to recruit immune cells to the site of viral infection in order to control
8
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Figure 3: Signaling cascade initiated by RIG-I-like receptors. RIG-I and MDA5 recognize different foreign cy-
tosolic dsRNA species or RNA polymerase III transcripts. LGP2 is thought to have regulatory func-
tions. Activation and tetramerization of RIG-I and MDA5, followed by subsequent K63-linked ubiq-
uitination or ubiquitin binding (see section 3.4), induces to MAVS polymerization. MAVS polymers
recruit several TRAF proteins that synthesize K63-linked ubiquitin chains and thereby activate IKK and
TBK1 complexes. IKK and TBK1 phosphorylate different IRFs or IκB and thus induce their transloca-
tion into the nucleus in order to activate the expression of type I interferons and proinflammatory
cytokines.
Released interferons in turn initiate the expression of hundreds of interferon stimulated genes via
the STAT pathway.
virus spread and to initiate the adaptive immune response. IFNs activate the janus kinase/signal
transducers and activators of transcription (JAK/STAT) pathway and lead in turn to the expression of
several hundreds interferon regulated genes (ISGs) in both the infected and surrounding uninfected
cells83 (Figure 3). ISGs encode additional cytokines and chemokines, antibacterial effectors, pro-
and anti-apoptotic molecules, as well as molecules involved in metabolic processes, that amplify
and stabilize the antiviral response. In addition, all RLRs are ISGs themselves and are upregulated in
order to boost or control the immune response84.
Other ISGs comprise the RIG-I splice variant lacking aa 36-80 within the first CARD domain85. This
variant competes with full-length RIG-I for RNA substrates, but potentially suppresses the CARD-
CARD interactionswithMAVS and therefore interferon signaling. Further, an N-terminally shortened
isoform of MAVS that entirely misses the CARD domain is upregulated during infections and might
interfere with the immune response by competing with downstream signaling factors of MAVS86.
Both shortened molecules thus provide a negative feed-back loops and help to modulate the im-
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mune response.
RLRs were further shown to co-localize to virus-induced stress granules (SGs) upon phosphorylation
of eukaryotic translation initiation factor 2α (eIF2α) by dsRNA-dependent protein kinase (PKR) or
general control non-derepressible-2 (GCN2) during some viral infections87–89. Phosphorylation of
eIF2α terminates the initiation of translation, stalls mRNAs and thereby inhibits mRNA translation
until eIF2α is dephosphorylated again. Several viruses are implicated in inducing SG formation or
even shown to exploit them for replicating their own RNAs90,91. Other viruses however, like measles
virus, are shown to inhibit SGs by promoting RNA editing thereby decreasing the amount of PKR
substrates92. SGs could thus represent a platform for viral RNA recognition and immune response
activation by RLRs.
2.3.2 LGP2 has regulatory functions in RIG-I or MDA5-mediated signaling
In contrast to RIG-I andMDA5, there is still relatively little knownabout LGP2. LGP2was originally dis-
covered as highly expressed gene in a mammary tissue93 and later shown to be involved in anti-viral
signaling94. Since thenmostly controversial literature regarding LGP2’s function has been published.
Even though, of all RLRs, LGP2 has the highest affinity for RNA and it might bind to the same RNA
substrates as RIG-I or MDA5 or both95, the role of LGP2 within the RLR signaling pathway is contra-
dictory. Since LGP2 lacks CARDs it might function as a negative feedback regulator by competitive
binding of stimulatory RNA68,72. Later studies, however, suggested that LGP2 might have different
regulatory roles depending on the virus and the RLR it might interact with96.
In that regard, limited levels of LGP2 are reported to have a positive regulatory role forMDA5 by pro-
moting cooperative dsRNA binding97–99. Higher levels of LGP2, however, negatively regulate RIG-I-
and to a lesser extentMDA5-mediated signaling99. Furthermore, LGP2was shown to be required for
T cell survival during virus infection by blocking death-receptor-mediated cell death100. This might
be related to the inhibition of RIG-I-mediated signaling at high protein concentrations in order to
terminate the immune response and to prevent cell death.
2.3.3 RNA structures recognized by RIG-I-like receptors in vitro and in vivo
Despite their structural similarities, RLRs recognize distinct dsRNA species in vitro. At the same time,
they have overlapping functions in virus recognition. Many negative-sense RNA viruses including
orthomyxoviruses, rhabdoviruses and bunyaviruses are predominantly recognized by RIG-I. MDA5,
in contrast, detects picornaviruses and caliciviruses. Several flaviviruses, paramyxoviruses and re-
oviruses are sensed by both RIG-I and MDA5101.
In order to allow a distinction of both RNA strands within the duplex, this thesis will refer to the
strand that is mainly recognized by the SF2 helicase domain as “bottom strand”. The complementary
strand, that might harbor the phosphorylation mark, will be referred to as “top strand” of the RNA
duplex (compare to Figure 4).
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RNA 5’ endtriphosphate7-methylguanosine
RNA
RNA
RNA 3’ end
top RNA strand                 bottom RNA strand
Figure 4: The first two base pairs of a potential RIG-I dsRNA substrate. RIG-I preferentially recognizes short
dsRNA ends. Methylation of the cap structure as well as of the first 5′ ribose (depicted in pink)
reduces recognition.
The top and bottom RNA strand of the duplex, as used in this thesis, are indicated. Figure adopted
from Leung and Amarasinghe 112 .
Numerous in vitro experiments defined the optimal RIG-I ligand as short 5′ tri- or diphosphory-
lated dsRNA with at least 10 base pairs length and the phosphate-carrying nucleoside being part
of a Watson-Crick base pairing102–106. Binding affinities of RIG-I towards 5′ phosphorylated dsRNA
are in the low nanomolar range107,108. However, with only slightly lower affinities RIG-I recognizes
blunt-endeddsRNAwithout phosphates108 and also tolerates unmethylated 5′ cap-structures105,109.
Methylation at N7 of the capping guanosine or the top strand first ribose, however, drastically de-
creases signaling105 (comparewith Figure 4). Further, RIG-I accepts RNA:DNA hydrides as well, while
only tracking the OH-groups of the bottom RNA strand110,111. 3′ overhangs at the phosphorylated
end are better tolerated by RIG-I than 5′ overhangs102.
Despite the variety of RNAs that RIG-I is able to recognize in vitro, in vivo ligands are still controver-
sial. Several transfection assays validated the preference for tri- or diphosphorylated dsRNA102–104.
The minimal RNA duplex length, however, varies and might depend on the stage of infection or the
amount of available RIG-I or RNA substrates, respectively111,113. In that regard, even unphosphory-
lated dsRNAs like ribonuclease L (RNase L) cleavage products of endogenous or viral RNAs amplify
RIG-I signaling114–116.
Likewise, different infection assays confirm RIG-I activation by 5′ tri- or diphosphorylated dsRNA
structures, as these are present on viral genomes102,104 or incoming viral nucleocapsids that are de-
tected by RIG-I117,118. RIG-I also recognizes viral replicating RNA products as for instance stem-loop
structures in defective interfering (DI) RNA genomes, short internal deletion defective interfering
particles119,120 or abortive replication products. Further, viral or even endogenous mRNAs might
represent RIG-I agonists and thereby especially their 3′ untranslated regions (UTR)114,121–123.
In addition, RIG-I indirectly senses cytosolic DNA through RNA polymerase III that transcribes AT-rich
DNA as for instance present in Epstein-Barr virus, adenoviruses and Herpes simplex virus-1, or in
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intracellular bacteria like Legionella pneumophila, promoter-independently into dsRNA containing
a 5′ triphosphate124–126. RIG-I is further implicated to be involved in the recognition of cytosolic
uncapped and unphosphorylated bacterial mRNA127.
In contrast to RIG-I, MDA5 has a lower affinity to dsRNA in general, but cooperatively recognizes
long dsRNA stems and branched or higher-order structured RNAs128–130. Similar to RIG-I, MDA5 is
described to discriminate self from non-self based on ribose 2′-OH methylation marks as well131.
Further, MDA5 is like RIG-I implicated to take part in the recognition of intracellular bacteria, like
Plasmodium species, probably by detecting double-stranded non-coding RNAs132.
In addition, both RIG-I and MDA5 might prefer U- and AU-rich RNA respectively114,119,133–135.
Furthermore, RIG-I and MDA5 might respond to viral infections in a temporal manner136. For in-
stance, early occurring triphosphate-containing replication intermediates of West Nile Virus are rec-
ognized by RIG-I, whereas MDA5 responded to later produced dsRNA species137.
Ligands of LGP2 are not well described. Similar to RIG-I, LGP2 preferentially recognizes RNA ends
but does not discriminate the phosphorylation state138. Furthermore, in infected cells, LGP2 was
shown to have overlapping binding sites with MDA5 since LGP2 co-immunopurified RNA was found
to stimulate in a MDA5-dependent manner95.
3 Structural basis for antiviral signaling of RIG-I and MDA5
RIG-I-like receptors are a subfamily of SF2 helicases owing to their central DECH box RNA helicase
domain that consists of two structurally almost identical RecA-like domains (domain 1a and domain
2a, Figure 5). Both domains 1a and 2a form an active site for ATP binding and hydrolysis between
their interfaces, which defines SF1 and SF2 helicases and distinguishes them from SF3 – SF6 helicases
that form hexameric toroids. Compared to other SF2 helicases, the RLR helicase domain further
harbors an unusual helical insertion domain (domain 2b) within domain 2a as well as an elbow-like
helical pincer domain that also emerges from 2a. The helicase domain is structurally related to the
archaeal Hef helicase/nuclease139.
Functional specificity of RLRs comes from their accessory domains that augment the SF2 helicase
domain (Figure 5): All RLRs possess a CTD that supports the helicase domain in RNA binding and that
confers RNA substrate specificity. The CTD further contains a conserved zinc-binding site essential
for the structural integrity of the domain85,140. Structurally, the CTD resembles GDP/GTP exchange
factors of Rab-like GTPases140. Furthermore, except for LGP2, RLRs harbor two N-terminal CARDs
belonging to the death domain (DD)-fold superfamily141 that elicit the downstream signal. Similar
DD-fold domains can be found in various other immune signaling pathways.
Other RLR homologue proteins include Dicer as well as the DNA-binding protein Fanconi anemia,
complementation group M (FANCM)142.
Upon RNA and ATP binding large conformational changes are induced with all subdomains moving
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CARD1     CARD2                 1a          2a         2b           2a    Pincer    CTD
MDA5
RIG-I
LGP2
SF2 domain
1 925
10251
1 678
C-RecAinsertion 
domain
N-RecA
Figure 5: Domain organization of the RIG-I-like receptors RIG-I, MDA5 and LGP2. Individual domains are de-
picted as cylinders, long linkers are shown as lines. SF2 helicase domain notations are according to
Singleton et al. 143 .
relative to each other (Figure 6). RIG-I, MDA5 and LGP2 completely encircle the RNA double-strand
within a large network of interactions between RNA, SF2 helicase domain and CTD60–62,144,145. The
dsRNA itself, maintains an A-form conformation without any structural evidence of RNA destabiliza-
tion or partial unwinding60–62. In addition, RLRs miss a characteristic phenylalanine-loop motif, that
is conserved in other SF2 helicases with nucleic acid unwinding activity62. In in vitro experiments,
nevertheless, RNA unwinding was reported and thereby preferentially takes place on 3′ overhangs
and independently whether the bottom strand consists of RNA or DNA146.
RNA + 
ATP binding
CARDs 
shielded
CTD 
released 2b
pincer
2a
1a
CARD2
CARD1
CARDs 
released
CTD bound
2b
pincer
2a
1a
CARD1
CARD2
inactive conformation             active conformation
Figure 6: RIG-I three-dimensional reorganization upon RNA and ATP binding. In the ligand-free state RIG-I
adopts an inactive conformation with CARD2 bound to the insertion domain 2b, whereas the CTD
is flexibly linked and free to survey the cytoplasm. Upon RNA binding, the CTD presents bound
dsRNA to the helicase domain and subsequent ATP binding establishes the active conformation with
released CARDs that are able to transmit the signal. Colors of individual domains are according to
Figure 5. Flexible linkers are shown as dashed lines.
RCSB PDB codes for the depicted structures are: 2qfb (CTD released, human), 4a2q (CARDs bound
to SF2 helicase, duck), 3tmi (RIG-I∆CARDs bound to dsRNA and ADP·BeF3, human).
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3.1 The ligand-free state of RIG-I and MDA5
In the ligand-free state the SF2 helicase domain of RIG-I is shown to be in an extended flexible con-
formation with only domains 2a and 2b rigidly attached to each other60,61,147,148. Domain 1a is
stabilized by the pincer arm, but otherwise only in lose contact to domain 2a. Without RNA, ATP can
bind to domain 1a, but cannot be hydrolyzed because domain 2a is rotated and too far away147. In
addition, several interstrand loops for ATP binding or hydrolysis, particularly within domain 2a, are
disordered. The CTD is flexibly linked to the rest of protein and is thus available for RNA-sensing and
capturing61,106. The CARDs, in contrast, form a rigid head-to tail unit and are bound via CARD2 to
domain 2b61,106.
The insertion domain 2b, hence, has a very pivotal role in maintaining the non-signaling state: while
attached to domain 2b, CARD2 is shielded from interactions with other cytosolic proteins and thus
unable to interact with theMAVS CARD. In addition, the binding site of CARD2 to domain 2b partially
overlaps with an RNA binding site of domain 2b and would sterically clash with both CTD and RNA in
the ligand-bound state61. The domain 2b:CARD2 interface is thus thought to provide a checkpoint
for RNA selection, which only tightly CTD-bound 5′ tri- or diphosphorylated dsRNAs can disrupt108.
The helicase domain of ligand-free MDA5 adopts an open conformation similar to RIG-I and the
CTD is flexibly linked as well. Domain 1a is, as in RIG-I, stabilized by the pincer arm. In contrast to
RIG-I, however, a longer linker between CARD2 and domain 1a, as well as several variations within
domain 2b lead to reduced intramolecular autoinhibitory interactions and partially released CARDs
even in absence of ligands. To that effect, the length of several domain 2b helices is reduced and a
critical phenylalanine within 2b, which is responsible for CARD2 binding in RIG-I, is not conserved in
MDA5149. The MDA5 CARDs thus do not as tightly associate with domain 2b106,130. In contrast to
RIG-I, MDA5 is therefore thought to alternate in a conformational equilibrium between bound- and
extended-CARDs with the bound state being favored149. This in turn results in a higher background
activity of MDA5 compared to RIG-I.
The crucial role of the CARDs in triggering an antiviral response is emphasized by the fact that over-
expression of the isolated RIG-I or MDA5 CARDs is sufficient for immune response activation70,72.
Release of the CARDs as well as the establishment of CARD-CARD interactions withMAVS, therefore,
need to be carefully controlled.
3.2 RIG-I signaling requires a conformational switch that releases the CARDs
RIG-I binds dsRNA as a monomer without forming protein-protein mediated oligomers113. RNA
binding to RIG-I induces a closure of the SF2 domain and creates the mature ATP binding pocket.
Yet, RNA binding alone is not sufficient to entirely free the CARDs, but rather slowly destabilizes the
CARD2:domain 2b interface and leads to a partial release106. RNA-induced ATP binding, however,
induces further conformational changes within the protein resulting in a switchlike compaction of
the SF2 helicase domain that brings domains 1a and 2a into very close proximity61,62. ATP hydrolysis
was further suggested to induce an intramolecular domain repositioning that is needed to release
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Figure 7: RIG-I∆CARDs bound to dsRNA and the ATP analogue ADP·BeF3 (RCSB PDB code 3tmi, human). RIG-I
completely encircles the dsRNA and especially caps one RNA end via the CTD. Coloring according to
Figure 5.
the CARDs, since ATP binding-deficient RIG-I is unable to induce signaling, even though the protein
has no altered RNA binding properties73. Nevertheless, the exact activation mechanism remained
elusive until recently and will be discussed in detail later.
An overview of dsRNA encircled by RIG-I∆CARDs is shown in Figure 7.
Most of the dsRNA contacts are provided by domains 1a and 2a of the helicase domain (Figure 8A-1),
whichmainly track the bottomRNA strand. Thereby, almost every helix from RIG-I’s SF2 domain that
reaches into the RNA-binding tunnel provides potential binding partners to the RNA phosphodiester
backbone thus creating an extensive network of protein:RNA interactions. The insertion domain 2b
also participates in RNA binding with an α-helix that runs perpendicular to the minor RNA groove
and contacts both RNA strands (Figure 8A-2). ATP is coordinated within a pocket between domain
1a and 2a distant from the RNA binding sites (Figure 8A-3).
The pincer domain further establishes comprehensive contacts between domains 1a, 2a and CTD,
thereby providing amechanical connection that might transmit information between different parts
of the molecule60–62 (Figure 6, 7). Thus, the pincer domain might allosterically control the ATPase
core and probably plays an important role by mediating the enzymatic and signaling activities of
RIG-I150. In accordance with this, disruption of the domain 1a:pincer interface results in loss of
immune signaling because of defects in RNA dissociation and ATP hydrolysis while ATP and RNA
binding are still intact150.
The RIG-I CTD mainly captures the very 5′ dsRNA end via a positively charged end-capping loop
(Figure 8B-4/5). This loop contains several lysines that either contact the phosphate backbone or
the 5′ phosphate groups of RNA107,140,151. Thereby, specific contacts to the phosphates are varying
between different crystallized RIG-I CTD:RNA constructs and even capped RNA ends can be flexi-
bly accommodated109(Figure 8B-4). F853 within the end-capping loop stacks to the terminal base
pair explaining the preferred nucleic acid end recognition of RIG-I60,62,107. S854 (also part of the
end-capping loop) and H830 contribute to preference for RNA over DNA by hydrogen bonding with
the ribose hydroxyl groups of the first base pair62. H830 further sterically hinders binding of 2′-OH-
methylated RNA105,107,109.
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Figure 8: Contacts of RIG-I’s helicase domain (A) and CTD (B) to dsRNA as well as to ADP·AlF3. (1) Potential
contacts of domains 1a and 2a to the dsRNA backbone. (2) Potential contacts of domain 2b to the
dsRNA backbone. (3) Coordination of the ATP analogue ADP·AlF3 by several residues of the ATP
binding pocket. (4) Several residues of the RNA end-capping loop coordinate the first nucleotide
base pair including the phosphates. The cap itself, however, is not coordinated and therefore found
in different conformations (green and black). (5) RIG-I CTD contacts to the dsRNA backbone via a
second positively charged loop. Domain coloring according to Figure 5.
RCSB PDB codes for the depicted structures are: 4a36 (RIG-I helicase, duck), 5f98 (RIG-I ∆CARDs,
human, only CTD is shown).
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Figure 9: Helical assembly of RIG-I CARDs bound to ubiquitin (1, RCSB PDB code 4nqk, human) and building
the scaffold for the MAVS CARD assembly into large filaments (model of RCSB PDB code 2ms7, hu-
man, docked onto 4nqk using pymol). Structural stability of the RIG-I CARDs tetramer is provided
by several ubiquitin chains wrapping around the complex. (2) Model of RIG-I and MDA5 nucleating
signaling competent MAVS filaments. Whereas MDA5 cooperatively assembles onto long dsRNA,
RIG-I preferentially recognizes shorter dsRNAs or RNA ends and therefore requires stabilization by
ubiquitin chains.
Due to the disruption of the CARD2:domain 2b interface, the CARDs are released and accessible
for the interaction with the MAVS CARD or other proteins69 (Figure 9). Thereby, each four RIG-I
molecules oligomerize via their CARD domains to build a tetrameric complex70. In particular, left-
handed helical CARDs tetramers with a 5Å rise per CARDs module and a total rise of one CARD per
turn are formed152. In addition, covalently or transiently-linked ubiquitin chains can wrap around
the CARDs tetramer and thus further stabilize the complex152 (Figure 9). The CARDs tetramer in
turn constitutes the scaffold for the assembly of large MAVS-CARD filaments starting at the surface
of the second RIG-I CARD and extending the helix in a counter-clockwise manner153. Similar large
assemblies have as well been shown to arise from other death domain-fold proteins including the
death domains of the Myddosome and inflammasome154,155.
3.3 Cooperative binding of MDA5 on dsRNA stems induces signaling
In contrast to RIG-I’s preference for RNA ends, MDA5 nucleates within the RNA duplex and coopera-
tively assembles into long filaments on dsRNA130,149,156. Protein:protein contacts are induced upon
RNA binding106 and are dynamically regulated via the ATPase activity of MDA5.
Similar to RIG-I, MDA5 interacts with dsRNA using the helicase domain as well as the CTD. RNA con-
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Figure 10:MDA5∆CARDs bound to dsRNA and the non-hydrolyzable ATP analogue AMPPNP (RCSB PDB code
4gl2, human). MDA5 completely encircles the dsRNA similar to RIG-I, but instead of binding to the
RNA end, it rather recognizes the dsRNA stem. Coloring according to Figure 5.
tacts to the RNA backbone and 2′ hydroxyl groups are, except for the CTD:RNA contacts, conserved
in MDA5 and RIG-I144 (Figure 10).
The orientation of the MDA5 CTD, however, is 20◦ rotated compared with the RIG-I CTD and runs
parallel to the dsRNA stem thus leaving a gap of approximately 30◦ (Figure 10). This results in an
open, C-shaped structure of MDA5 and preferential binding to the dsRNA stem through recognition
of internal duplexes130,144. In NMR experiments, the isolated MDA5 CTD was shown to have a sim-
ilar fold compared to the RIG-I CTD and seemed also be able to bind RNA ends via its end-capping
loop157. MDA5∆CARDs co-crystallized with dsRNA, however, was found to recognize the RNA stem
via a flat surface with the end-capping loop being unfolded144. The intrinsic flexibility of the MDA5
CTD might thus allow alternative binding modes.
MDA5 filaments build up by stacking of individualmonomers in a head to tail arrangement144 (Figure
11). In the current model, each monomer is rotated by 70◦ and each helicase domain is in close
contact with the adjacent helicase domain resulting in extensive protein:protein interactions. These
interactions explain the cooperativity of MDA5 upon dsRNA binding and lead to higher affinity for
long dsRNA144.
Filament formation brings several MDA5 CARDs into close spatial proximity in order start immune
signaling (Figure 9). As detailed earlier, release of the MDA5 CARDs, however, seems not as strictly
coupled to ATP as the RIG-I CARDs106,149 (see Discussion as well).
3.4 RIG-I and MDA5 are regulated by post-translational modifications
As aberrant or premature immune signaling as well as sustained activation maybe harmful to the
host, control mechanisms are required that prevent RLR activation in uninfected cells or that shut
down signaling in infected cell once the infection is cleared. Therefore, signal-transducing activities
of RIG-I and MDA5 are tightly regulated by various post-translational modifications (PTMs) that act
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Figure 11: Structural basis for filament formation of MDA5. (A) and (B) Surface representation of RIG-I
∆CARDs bound to dsRNA (A, RCSB PDB code 3tmi, human) and MDA5 ∆CARDs bound to dsRNA
(B, RCSB PDB code 4gl2, human). (A) The RNA end-capping mode of RIG-I does not allow filament
formation on dsRNAs. (B) MDA5’s O-shaped structure that recognizes dsRNA stems is compatible
with filament formation. (C) Model of a head-to-tail MDA5 filament with a 70◦ turn per molecule
based on the monomer crystal structure in B and built with pymol. Bridging RNA (gray) was added
to assemble monomers while preserving the dsRNA continuity. Coloring according to Figure 5.
on protein activation and degradation. Regulation occurs by phosphorylation, acetylation, ISGyla-
tion, SUMOylation and polyubiquitination or binding of free ubiquitin chains respectively. The latter
can be distinguished into eight different linkage types of ubiquitin chains158, of which K48-linked,
i.e. degradative, and K63-linked, i.e. signal-transducing, ubiquitination are reported for RLRs.
Most post-translational modifications are identified within the CARDs or the CTD of RLRs and are
again best studied for RIG-I (Figure 12).
In uninfected cells RIG-I is constitutively phosphorylated at serine 8 of the first CARD and threonines
170 and 197 of the second CARD by protein kinases C -α (PKC-α) and PKC-β 159,160. Threonine 770
within the RIG-I pincer kink as well as serines 854 and 855 within the CTD RNA end-capping loop
are shown to be phosphorylated by casein kinase II (CK2) or IKK subunit ε161–163. Furthermore,
lysines 858 and 909 are acetylated by a so far unknown acetyl transferase162,164. All modifications
are thought to help keeping RIG-I in an inactive state by either stabilizing the RNA unbound state,
interfering with RNA binding, or by suppressing other modifications that help to activate RIG-I.
Besides these experimentally validated post-translationalmodification sites, several other sides have
been found in mass spectrometry-based assays: serine 468 and tyrosine 473 have been found to be
phosphorylated, and lysines 99, 169, 181, 190, 193, 644 and 796 might be ubiquitinated69,162,165.
The in vivo relevance, however, is not determined.
In infected cells and upon RNA and ATP binding, conformational changes of RIG-I allow access of
phosphoprotein phosphatase (PP) 1α and PP1γ to the CARDs, which dephosphorylate serine 8
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Figure 12: Knownpost-translationalmodifications of RIG-I. (putative) phosphorylation sites: (light) green; (pu-
tative) ubiquitination sites: (light) red; acetylation sites: orange. (A) Left: RIG-I PTMs within the
CARDs (RIG-I ligand-free state). Estimated localization of PTMs within the unstructured linker are
marked as red circles. Right: Localization of PTMs on a CARDs tetramer (RIG-I ligand-bound state).
(B) RIG-I PTMs within the helicase domain as well as within the CTD. Domain coloring according to
Figure 5 and residue labeling according to the human RIG-I sequence. Flexible linkers are shown as
dashed lines.
RCSB PDB codes for the depicted structures are: 4a2q (CARDs bound to SF2 helicase, duck), 4nqk
(CARDs tetramer, human), 3tmi (RIG-I∆CARDs bound to dsRNA and ADP·BeF3, human).
and threonine 170166. This in turn renders the CARDs free to interact with K63-linked polyubiq-
uitin chains159,167. Several kinds of RIG-I:ubiquitin or ubiquitin-like protein interactions have been
described, emphasizing the apparent importance of this process during RLR signaling: RIG-I was
found to be either polyubiquitinated by tripartite motif 25 (TRIM25) at lysine 17269,85, to bind short
unanchored cytosolic polyubiquitin chains70,168 or to interact with the tandemubiquitin-like domain
(UBL) of the human IFN-inducible oligoadenylate synthetases-like (OASL) protein that mimics polyu-
biquitin chains169–171. RIG-I was further shown to be modified by small ubiquitin-like modifier-1
(SUMO-1), which promotes ubiquitination and the interaction with MAVS as well172.
Ubiquitination or ubiquitin binding is thought to be critical for efficient interactions with MAVS69
and a prerequisite for stable antiviral signal transduction since it prevents rebinding of the CARDs
to domain 2b due to steric reasons61. Polyubiquitin binding further induces RIG-I oligomerization
and stabilizes the CARDs cluster which in turn interact with the MAVS CARD, thereby activating the
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immune response70,75.
Other ubiquitin ligases, that have been described to promote K63-linked ubiquitination of the RIG-I
CARDs and that might complement TRIM25 in cells where it is not present, are RING finger protein
leading to RIG-I activation (Riplet, also called RIG-I E3 ubiquitin ligase/ REUL or Ring Finger Protein
135/ RNF135, ubiquitination of lysines 154, 164)173, TRIM4174 and the stress granule associated
ligase MEX3C175. In addition to ubiquitination of the CARDs, Riplet was shown to attach K63-linked
ubiquitin chains to lysine 788within the pincer region of RIG-I, which like ubiquitination of the CARDs
promotes RIG-I signaling176,177.
Furthermore, during an infection, lysine 909 of the RIG-I CTD is deacetylated by histone deacetylase
6 (HDAC6), which was shown to promote recognition of viral RNA178. The phosphatase that is re-
sponsible for pincer and CTD dephosphorylation as well as the biological significance still need to be
investigated.
Proteasomal degradation of RIG-I and thus negative regulation, on the other hand, is facilitated by
the interferon inducible ubiquitin ligase Ring Finger Protein 125 (RNF125) and guided by the p97
chaperon complex179,180. RNF125 conjugates K48-linked ubiquitin to RIG-I lysine 181179. This can be
reversed byUSP4 that removes K48-linkedpoly- ubiquitination chains and thereby stabilizes RIG-I181.
RIG-I is further shown to be ISGylated with ISG15182, which is as well an ubiquitin-like protein nega-
tively regulating antiviral signaling183. Another suppressor is the linear ubiquitin assembly complex
(LUBAC) that targets both TRIM25 and RIG-I. LUBAC induces proteasomal degradation of TRIM25
and competes with TRIM25 for RIG-I leading to inhibition of RIG-I ubiquitination and suppression
antiviral signaling184. In addition cylindromatosis (CYLD)185,186, USP3187, USP15188 and USP21189
remove K63-linked polyubiquitin chains from RIG-I and therefore constitute a negative regulatory
mechanism as well.
Post-translational modifications of MDA5 are less well investigated, even though alsoMDA5 is heav-
ily modified a. For instance, in uninfected cells, the MDA5 CARDs are similar to the RIG-I CARDs
phosphorylated at serines 88 and 104 in order to inhibit downstream signaling166. Dephosphory-
lation upon infection is accomplished by PP1α and PP1γ as well166. The MDA5 CARDs were, as
RIG-I, found to bind K63-linked polyubiquitin chains 70,168 as well as SUMO-1191. In addition, also
proteasomal degradation of MDA5 due to K48-linked ubiquitination was shown to be mediated by
RNF125179.
4 The ATPase domain of RIG-I-like receptors
RIG-I-like receptors are often termed ”RIG-I-like helicases” due to their classification as SF2 helicases.
RNAor DNAhelicases are usually found to unwind duplex nucleic acids by translocation on one of the
product single strands in an ATP-dependentmanner110. Their ATPase activity is therefore stimulated
in presence of single-stranded nucleic acids. RLRs, in contrast, hydrolyze ATP upon detection of
afor an overview see also http://www.phosphosite.org 190
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Figure 13: RIG-I-like receptor helicase motifs and their three-dimensional arrangement. (A) Motif localization
within the primary amino acid sequence and their respective function. (B) Left: Mapping of motifs
onto the ligand-free, inactive conformation of RIG-I. Right: Mapping of motifs onto the RNA- and
ADP·AlF3-bound active conformation of RIG-I.
RCSB PDB codes for the depicted structures are: 4a2q (RIG-I CARDs bound to helicase domain,
duck), 4a36 (RIG-I ∆CARDs bound to dsRNA and ADP·AlF3, duck), only domains 1a and 2a are
shown.
double-stranded RNA102,103 and their helicase activity is controversial62,146.
ATP hydrolysis occurs within an ATP binding pocket between both RecA-like domains in presence of
RNA. RLRs are thus as well termed dsRNA-dependent ATPases (DRAs)192. Sequence and structure
analysis of different SF2 helicases including RLRs revealed a common arrangement of several con-
served motifs for ATP hydrolysis and RNA binding which are distributed between the domains 1a
and 2a of the helicase core193 (Figure 13). Motifs for ATP binding and hydrolysis include the Qmotif,
motif I (”Walker A motif”) and motif II (”Walker B motif”) within domain 1a, and motif VI (”argi-
nine finger”) within domain 2a. Residues of the Q and Walker A motifs primarily coordinate the
nucleotide-triphosphate for hydrolysis and provide specificity for the adenine base. Furthermore,
Walker A motif residues, but mainly the Walker B motif bind a magnesium ion, that in turn coordi-
nates the β and γ-phosphate of the nucleotide and thereby helps stabilizing the ATP conformation
needed for hydrolysis. In addition, a residue of the Walker B motif usually serves as a catalytic base
by activating the water residue that participates in hydrolysis of ATP. The arginine finger of domain
2a of the opposing side of the ATP binding pocket stabilizes the ATP hydrolysis transition state.
Conserved SF2motifs involved in binding of the bottomRNA strand are themotifs Ia, Ib and Ic within
domain 1a as well as motifs IV, IVa and V of domain 2a. Motifs III within domain 1a and Va within
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domain 2a help to couple RNA binding and ATP hydrolysis143,193,194. Furthermore, in contrast to
other SF2 helicases, two other possible RNA binding motifs, motif IIa within domain 1a and motif Vc
within domain 2a, were suggested192. Both of them help to recognize the complementary top RNA
strand and thus explain the double-stranded RNA binding mode of RLRs.
ATP hydrolysis, however, does not occur on the isolated SF2 domain, but requires besides RNA also
the C-terminal domain62,195. Presence of the CARDs, on the other hand, decreases the ATPase func-
tion and emphasizes a negative regulatory role for the CARDs.
The role of ATP hydrolysis in RNA binding and signaling, however, is still controversial. Already early
studies found a strict dependence of in vivo signaling on the presence of ATP, since RIG-I and MDA5
Walker A mutants, that are defect in ATP binding are impaired in immune signaling as well68,72,73.
Later on, both protein gain-of-function, i.e. increased signaling, as well as loss-of-function, i.e. re-
duced signaling, have been described for different ATPase motif mutants196,197. ATPase activity of
RLR was further reported to lead to either unwinding of RNA duplexes146, translocation on dsRNA,
oligomerization110,198–200 or dissociation from RNA149.
4.1 ATPase activity of RIG-I correlates with its binding affinity towards RNA
In order to infer a possible in vivo relevance, several studies addressed the in vitro biochemical prop-
erties of RIG-I in presence or absence of ATP, RNA or both.
In vitro ATP turnover rates of RIG-I under saturating ATP and RNA conditions are shown to be mostly
independent of RNA length, the presence of a 5′ triphosphate motif or even an RNA end108,113. ATP
binding under dsRNA saturating conditions, however, decreases with increasing RNA length but is
still independent of RNA-end phosphorylation113. Whereas the maximal ATP hydrolysis rate, thus,
seems to be independent of the RNA substrate, only ATP binding conditions, i.e. RNA-dependent
formation of the ATP binding pocket, impact hydrolysis.
In vitro RNA binding, on the other hand, is dependent on the availability of ATP108. The only ex-
ception are short triphosphorylated RNA with a very high affinity at nanomolar range, that is not
significantly changed in presence of ATP108. The affinity towards short blunt-ended dsRNA is slightly
weaker and was shown to further decrease under ATP saturating conditions108. Therefore, ATP, as
present in cells, might help decreasing the affinity of RIG-I towards RNA without phosphorylated
ends.
In addition, ATPase activity of RIG-I under saturating ATP conditions was shown to correlate with
the RNA binding affinity. Blunt-ended or triphosphorylated dsRNAs induce the highest ATPase rates,
whereas hairpin RNAs have a reduced potential108. Nevertheless, ATPase activity and RNA binding
do not correlate with immune signaling106. Blunt ended dsRNAs, for instance, show very tight bind-
ing affinities to RIG-I and stimulate ATP hydrolysis rates comparable to triphosphorylated RNA, but
do not induce an immune response in vivo102,103,106. The presence of a 5′ triphosphate on dsRNA
might therefore be important at the initial steps of RNA- and ATP-binding as well as for release of
CARDs. The lack of immune system stimulation by blunt-ended dsRNAs, also excludes the possibility
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that ATP hydrolysis of RIG-I would provide the energy to directly liberate the CARDs.
4.2 MDA5 forms ATP-sensitive filaments
For MDA5 comparably little biochemical data concerning the ATPase activity is available so far. Nev-
ertheless, several in vitro studies showed that filament formation of MDA5 on long double-stranded
RNA becomes instable upon addition of ATP. ATP hydrolysis by MDA5 is thus found to weaken the
protein:RNA interaction similar to RIG-I. This is thought to confer MDA5 filament disassembly on
RNA ends and thus mainly effects the stability on short dsRNA130. By that, MDA5 improves length
discrimination of dsRNA and it explains the preference for long double-stranded RNAs201. Repeated
cycles of ATP hydrolysis and hence filament assembly and disassembly, however, can fill gaps within
filaments and promote a more efficient coating of the dsRNA (Figure 14).
Since MDA5 immune signaling requires filament formation and subsequent CARDs oligomerization,
ATP thereby controls the MDA5 antiviral immune response to different types of RNAs130,149. The
non-hydrolyzable ATP analogue AMPPNP or the reaction product ADP have no effect on filament
formation149. This emphasizes the importance of a functional ATPase activity, rather than the need
to bind ATP.
ATP hydrolysis-dependent 
end disassembly
ATP hydrolysis-dependent 
cooperative filament propagation
autorepressed
MDA5
dsRNA internal nucleation
Figure 14:Model of MDA5 ATP-dependent filament formation. MDA5 cooperatively assembles on dsRNA
stems. ATP hydrolysis helps to efficiently coat the dsRNA stems and leads to disassembly on dsRNA
ends. The longer an RNA is, the more stable MDA5 can bind. Figure adopted from Peisley et al. 199 .
4.3 RIG-I forms signaling competent filaments in presence of ATP
Similar to MDA5, RIG-I was recently found to form filaments on dsRNA as well. RIG-I filament
formation is ATP-dependent and correlates with immune signaling198,199. Mechanistically, mono-
meric RIG-I binds to the RNA end, translocates inward thereby hydrolyzing ATP, and stacks along the
translocation track (Figure 15). During that process, the RIG-I CTD needs to adopt a different orien-
tation towards the dsRNA stem and the RNA capping loop is most likely not involved in RNA binding,
resulting in loss of affinity106. In addition, RIG-I filaments propagate with only very limited coop-
erativity leading to inefficient coating and poor recognition of longer dsRNA198,199. Nevertheless,
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Figure 15:Model of RIG-I ATP-dependent filament formation. RIG-I preferentially binds to dsRNA ends, but
is able to translocate into the dsRNA interior by hydrolyzing ATP irrespective of a triphosphate
PAMP. RIG-I filaments propagate only with very limited cooperativity. Figure adopted from Peisley
et al. 199 .
the 50 aa linker between the RIG-I’s CARDs and the SF2 helicase domain is in theory long enough to
allow direct contacts between CARDs that are six molecules apart.
The RIG-I filaments have been shown to be signaling competent without further binding of ubiquitin
chains199. Ubiquitination, however, could help stabilizing CARD-oligomers that do not arise from
one long double-stranded RNA and are therefore more prone to dissociate again (compare with
Figure 9).
4.4 RIG-I and MDA5 show ATP-dependent effector-like functions in virus-infected cells
The translocation function of RLRs might provide a direct, interferon-independent mechanism by
remodeling of protein:nucleic acid complexes and by displacing viral proteins bound to dsRNA200.
In accordance to this RIG-I and MDA5 CARD-less proteins, that are impaired in downstream signal-
ing and induction if ISG expression, were shown to have an antiviral activity against several RNA
viruses200. This was not true for their respective ATP binding-deficient Walker A mutants, which
again illustrates the relevance of an intact RLR SF2 helicase domain.
Further effector functions of RIG-I and MDA5 where found in hepatitis B virus (HBV) infected cells,
where RIG-I might counteract the HBV polymerase by binding to the 5′ ε region of the pregenomic
RNA and suppresses replication202. Similar results have been reported for influenza A virus-infected
cells, where RIG-I was shown to recognize the incoming fully encapsidated, 5′ triphosphate-contain-
ing genome and inhibits infection probably by competing with the nucleocapsid proteins203.
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5 Immune evasion strategies of viruses to avoid RIG-I-like
receptor-signaling
In order to avoid detection and subsequent signaling of RLRs, viruses evolved an immense arsenal
of counteracting strategies. These include modification of their own RNA in order to decrease RLR
binding and the prevention of RLR immune response activation.
The simplest case of viral RNA modifications is probably processing of 5′ termini of genomes and
replication intermediates in order to avoid RIG-I detection. This can include either processing to a
monophosphate, trimming of the 5′ end in order to produce 3′ overhangs or usage of a more so-
phisticated ”prime and realign”mechanism during genome and antigenome synthesis that produces
a 5′ G overhang117,204–207. Furthermore some viruses modify their 5′ RNA termini by capping and
2′-O-methylation in order to appear like host mRNA, or by protecting the end with covalently linked
viral proteins131,208,209. Another strategy is to coat the viral dsRNA with proteins that out-compete
binding by RIG-I and MDA5210, or to degrade dsRNA replication intermediates and thus to remove
potential PAMPs211.
Some viruses reduce activation of RLRs by manipulating post-translational modifications of RIG-I or
MDA5. Examples are the viral blockage of TRIM25-mediated ubiquitination of RIG-I or the expres-
sion of deubiquitination enzymes that remove covalently-linked K63-linked ubiquitin residues of the
CARDs212–214. Also PP1-α/γ is a viral target and blockage of MDA5 dephosphorylation was shown
to impedes its signaling activation215. Other viruses were shown to attack MDA5 by inserting into
the three-dimensional structure and unfolding the protein216,217, or to cleave RIG-I or MDA5 either
by exploiting cellular caspases and the proteasome or by expressing viral proteinases218–220.
6 Mutations within the RIG-I-like receptor SF2 domain can cause
autoimmune diseases
A comparably new field within RLR research are RIG-I- and MDA5-related autoimmune diseases.
Due to the growing field of genome-wide association studies (GWAS) of human diseases, an increas-
ing number of genetic variants become available. GWAS usually compare genetic data of healthy
people to those of people carrying a certain disease phenotype and look for single-nucleotide poly-
morphisms (SNPs) that are more frequent within the disease genomes. Thereby more and more
attention is also drawn to RLRs.
Examples for RLR-related diseases are the Aicardi-Gutières syndrome, diabetes mellitus type 1, mul-
tiple sclerosis, systemic lupus erythematosus, the Singleton-Merten syndrome, psoriatic arthritis or
cutaneous psoriasis, dermatomyositis, selective IgA deficiency and dilated cardiomyopathy221,222.
In most cases the involved RLR is MDA5, with only a few known disease-correlated SNPs for RIG-I
and so far non for LGP2. Interestingly, almost all of the so far identified pathogenic SNPs are either
non-coding or are located within the RLR helicase domain (Table 1 and Figure 16).
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Table 1: DDX58 (encodes RIG-I) and IFIH1 (encodes MDA5) single nucleotide polymorphisms associated with
autoimmune diseases.
SMS: Singleton-Merten syndrome, AGS: Aicardi-Gutières syndrome, SLE: Systemic lupus erythemato-
sus, T1D: type 1 diabetes, NA: not available
protein SNP nucleotide
change
amino acid
change
SNP location disease
RIG-I rs786204848 G to T C268F domain 1a SMS
rs786204847 A to C E373A domain 1a SMS
MDA5 rs587777447 A to G R337G domain 1a AGS
rs587777576 C to T L372F domain 1a AGS
rs587777449 A to T D393V domain 1a AGS
rs587777575 G to A A452T domain 1a AGS
rs10930046 G to A R460H domain 1a SLE
rs672601336 G to A G495R domain 1a AGS
rs35744605 G to T E627X domain 2b T1D1
rs587777445 G to A R720Q domain 2a AGS
rs587777446 G to A R779H domain 2a AGS, SLE
rs587777448 C to T R779C domain 2a AGS
rs376048533 G to A R822Q domain 2a SMS
NA G to A R824K domain 2a AGS
rs3747517 A to G R843H pincer, AP-1 binding site T1D
rs35667974 A to G I923V CTD T1D1
rs1990760 G to A A946T CTD, HNF-3bFOXA2 binding site T1D, SLE
rs13023380 G to A intronic intron SLE
rs2111485 T to C intergenic 13 kb 3′ of IFIH1 gene T1D
rs13422767 C to T intergenic 23 kb 3′ of IFIH1 gene T1D
rs35337543 G to A intronic intron 8+1 T1D1
rs35732034 G to A intronic intron 14+1 T1D1
1 The indicated SNPs confer protection against T1D.
6.1 Type I interferonopathies – the Aicardi-Gutières syndrome and systemic lupus
erythematosus
The term ”type I interferonopathies” is only recently emerging in literature and is used to describe a
group of (mono)genetic diseases in which a constitutive upregulation of type I IFN production is con-
sidered to be directly relevant to pathogenesis223. As detailed earlier, type I interferon production
and the expression of ISGs controls virus replication and spread in infected cell. Aberrant stimula-
tion, however, or unregulated control of the type I interferon system can lead to inappropriate or
sustained IFN production and might thus result in autoimmune diseases.
Known RLR-related diseases that are associated with the activation of type I interferon production
include the Aicardi-Gutières syndrome and systemic lupus erythematosus.
Aicardi-Gutières syndrome:
The Aicardi-Gutières syndrome (AGS) is a rare monogenetic, inflammatory disease affecting the skin
and brain, and is manifested by the degeneration of white matter due to the deterioration of myeli-
nated nerve fibers224. The majority of affected patients are profoundly disabled with significant
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Figure 16:Mapping of known RLR disease-related susceptibility loci to the three-dimensional protein struc-
ture. Amino acids connected to a disease-promoting prognosis are depicted in green, potential
disease-protecting sites are shown in orange. Dashed lines: invisible linkers containing susceptibil-
ity loci. (A) Overview ofMDA5 susceptibility loci. (B) and (C) Susceptibility loci that map to residues
within the ATP binding pocket between domains 1a and 2a of MDA5 or RIG-I respectively.
RCSB PDB codes for the structures depicted are: 4gl2 (MDA5∆CARDs) and 3tmi (RIG-I∆CARDs).
intellectual and physical problems225. Other symptoms that are consistently associated with AGS
include skin lesions referred to as chilblains and raised intraocular pressure (glaucoma). All patients
show a constitutive upregulation of type I IFN production that is considered to cause pathogene-
sis226.
So far, AGS is known to be induced by mutations in one or several of the genes encoding the fol-
lowing seven proteins: the DNA 3′ repair exonuclease 1 (TREX1)227, the subunits H2A, H2B and H2C
of the ribonuclease H2 (RNase H2) endonuclease complex228, the deoxynucleoside triphosphate
triphosphohydrolase and ribonuclease SAM domain and HD domain 1 (SAMHD1)229, the adenosine
deaminase acting on RNA 1 (ADAR1)230 and the gene encoding MDA5197. A deficiency in these
genes may result in the accumulation of immune stimulatory RNA or DNA, leading to the chronic
production of IFN via nucleic acid sensors like TLRs, RLRs or cGAS221.
In total 8 susceptibility loci within domains 1a and 2a of MDA5 have been related to AGS197,225,231
(see Figure 16 and Table 1). All SNPs are described as gain-of-functionmutations due to increased IFN
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signaling197. In contrast to all other so far identified AGS-related SNPs, mutations in MDA5 display
an autosomal dominant pattern of inheritance and occur exclusively heterozygous225. Nevertheless,
some of the patients inherited themutation from their parents or grandparents that were symptom-
free despite also having elevated IFN levels197. A monogenetic background, therefore, seems not
necessarily be sufficient to develop AGS.
Interestingly, increased IFN signaling of ADAR1 mutations within AGS patients is also dependent
on MDA5. ADAR1 converts adenosine to inosine within endogenous RNAs and is essential for the
maintenance of both fetal and adult hematopoietic stem cells by protecting against IFN-mediated
apoptosis232. ADAR1-edited RNA has immunosuppressive properties233 and altered binding affini-
ties to RLRs234. Specifically, ADAR1 was shown to deaminate adenosine to inosine preferentially at
the 3′ UTR of mRNA thereby remodeling RNA secondary structure and preventing the formation of
long dsRNA regions which are potential MDA5 binding sites235.
Systemic lupus erythematosus:
Systemic lupus erythematosus (SLE) is a chronic systemic inflammatory disease characterized by
multi-organ damage caused by hyperactive T and B cells and autoantibody production against self
nucleic acids and small nuclear RNA-binding proteins223,236. Affected organs are for instance the
skin, kidney, joints, lungs, various blood elements, heart and the central and peripheral nervous
system237. Like AGS, SLE is characterized by high IFN levels and dysregulated expression of genes of
the IFN pathway with both the innate and the adaptive immune system being activated238. 90% of
the SLE incidences affect women of child-bearing age between 20 and 30 years239.
For SLE there are so far more than 40 genetic susceptibility loci identified240. Many of these loci are
shared with other autoimmune diseases like type 1 diabetes or AGS. The most prominent loci are
HLA genes, especially class II genes, and the Fcγ receptor. MDA5 is also shown to be a risk factor
and especially the SNP that results in the MDA5 A946T mismatch241,242 as well as MDA5 R779H243,
R460H and an intronic SNP244 have been linked to SLE (see Figure 16 and Table 1).
6.2 Other RIG-I-like receptor-related autoimmune diseases: the Singleton-Merten
syndrome and type 1 diabetes
So far, not all RLR-related immune diseases are connected to elevated levels of type I IFN in patients.
Examples, were no interferon signature is described are the Singleton-Merten syndrome as well as
Type I diabetes.
Singleton-Merten syndrome:
The Singleton-Merten syndrome (SMS) is a multi-system disorder mainly characterized by dental
dysplasia, thoratic aortic calcification, osteoporosis, psoriasis, glaucoma and skeletal abnormali-
ties245,246. SMS has an autosomal dominant pattern of inheritance246.
Recently, two mutations of RIG-I and one of MDA5 were found to be associated with SMS247,248. All
mutations are located within the ATP binding pocket (Figure 12 and Table 1) and led to enhanced
IFN signaling in cells, even without stimulus247,248. Clinical features of SMS patients harboring the
identified mutations, however, are very diverse with for instance RIG-I-associated SNPs resulting in
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atypical SMS which lacks the dental dysplasia phenotype.
The RIG-I SMS variant C268F and E373A affect key aa residues within the ATPase motifs I (Walker A)
and II (Walker B) of domain 1a, respectively (see Figure 16). MDA5 R822 is located in motif VI (the
”arginine finger”) of domain 2a. The molecular basis for increased IFN production of SMS mutants
was so far not understood, but is addressed in the second part of thesis and will be discussed later.
Type 1 diabetes:
Type 1 diabetes (T1D) is a type of the metabolic disorder diabetes mellitus that is developed dur-
ing childhood or adolescence. It is characterized by chronic hyperglycaemia with disturbances of
carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action,
or both. During T1D the body develops amongst others autoantibodies against insulin-producing
β-cells in pancreatic islets and insulin itself249. The trigger for the occurrence of those autoanti-
bodies is still highly controversial and might, amongst others, be connected to enterovirus infec-
tions249–251. Statistically, the development of T1D has a seasonal pattern, being more common
during the cold season, and has a higher incidence in industrialized countries where the sanitary
conditions are better and, paradoxically, the prevalence of enteroviral infections is lower249,252.
The enteroviruses mainly implicated with T1D are Coxsackie type B viruses253 and are sensed by
MDA5254. It is speculated that the appearance of autoantibodies is connected to either an enhanced
production of type I IFNs and subsequent inflammation induced tissue damage, or to a weak re-
sponse that might favor viral replication and spread and therefore tissue damage255. In any case,
the upregulation of type I IFNs helps to activate the adaptive immune response by enhancing the
expression of major histocompatibility complex (MHC) molecules. By that cells become highly sus-
ceptible to recognition and destruction by adaptive immune cells256. Infections with enteroviruses
might therefore contribute either to the initiation of autoimmunity or to the progression from islet
autoimmunity to T1D or both255.
So far, more then 50 susceptibility loci for T1D have been identified257. Implicated genetic factors are
mainlymutationswithin human leukocyte antigen (HLA) geneswith class II genes being the strongest
genetic contributors. Less prominent associations have been found for example for MDA5, which
could therefore provide a link between genetic susceptibility, viral infections and the innate immune
response, all being believed to contribute to T1D pathogenesis250.
In case of MDA5 the A946T and R843H substitutions as well as two intergenic SNPs were implicated
in being a risk factor for T1D258,259 (Figure 16 and Table 1). These fourmutations, however, are found
in a strong linkage disequilibrium and are reported to have cumulative effects259,260. Furthermore,
MDA5 gene expression in unstimulated cells is increased260. Opposed to that, the mutations I923V,
E627X and two variants with SNPs at an intron first nucleotide position are suspected to confer lower
risk for T1D261 (Figure 16 and Table 1). In vitro I923V and E627X show decreased IFN production
after poly(I:C) stimulation262,263 and except for I923V all protective MDA5 SNPs have lower mRNA
levels264. A decrease in MDA5 driven production of type I IFNs might thus have protective effects
on T1D development.
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7 Objectives
RIG-I and MDA5 are the key immune receptors for defending many viral infections. Over the last
decade, an immense number of studies focused on the molecular characterization of RIG-I-like re-
ceptors and their respective agonists in vitro. Several crystal structures of RIG-I and MDA5 suc-
cessfully explain different binding preferences of both proteins towards distinct kinds of dsRNA,
and build together with biochemical and cellular assays the foundation for their particular mode
of action. The optimal RIG-I agonist, as defined in vitro, is short 5′ di- or triphosphorylated, but
unmethylated, dsRNA. MDA5 ligands, however, are less well understood and only characterized as
long unmethylated dsRNAwithout any further particular discriminating element. In contrast to their
distinct binding partners in vitro, RLRs show nevertheless overlapping functions when it comes to
virus detection in vivo. The precise nature and origin of viral RLR agonists are thus still enigmatic.
In addition, the function of the central SF2 helicase domain of RLRs remained mysterious. This be-
came even more important, since recently several autoimmune disease variants, including single
nucleotide polymorphisms causing Singleton-Merton syndrome (SMS), have been identified within
the RLR helicase domain and particular within ATP binding or hydrolysis motifs of RIG-I and MDA5.
The aim of the first part of this thesis was the isolation and characterization of in vivo occurring
ligands of RIG-I and MDA5 in measles virus-infected cells. Because of the comparably low affinity of
MDA5 towards dsRNA a protein:RNA crosslinking approach with subsequent co-immunopurification
from infected cells was established. In order to elucidate the nature of physiological RLR agonists,
the recovered RNAwas analyzed via Next Generation Sequencing. In addition, different biochemical
assays were used to validate the sequencing results.
The second, and major, aim of this thesis was the functional characterization of the SF2 domain
of RIG-I. For that purpose designed Walker A and Walker B mutants as well as RIG-I SMS variants
were used. The impact of these mutations onto the RLR signaling pathway was analyzed in cellu-
lar assays with both infected and uninfected RIG-I KO cells. In addition, physiological ligands of the
RIG-I Walker B mutant, that shows constitutive activity, and of SMS variants were investigated by
co-immunopurification. The interaction of one putative endogenous ligand, that was found to be
recognized by the RIG-I Walker B mutant, was visualized by cryo-electron microscopy. Again, bio-
chemical experiments with purified proteins were used to independently validate the results.
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1 In vivo ligands of MDA5 and RIG-I in measles virus-infected cells
Runge S∗, Sparrer KMJ∗, Lässig C∗, Hembach K, Baum A, García-Sastre A, Söding J, Conzelmann K-K,
Hopfner K-P (2014) In vivo ligands ofMDA5 and RIG-I inmeasles virus-infected cells. PLOS Pathogens
10(4):e1004081.
∗ These authors contributed equally.
DOI: 10.1371/journal.ppat.1004081
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Summary
In this publication we report the purification and characterization of physiological ligands of MDA5
and RIG-I in measles virus-infected cells. Since MDA5 shows only comparably poor affinity towards
RNA ligands, we established a protein:RNA crosslinking approach aiming at improving the nucleic
acid yield. Thereby incorporation of photoactivatable nucleosides into newly-synthesized RNA al-
lows a subsequent selective UV light linkage to interacting proteins. Afterwards, we analyzed MDA5
and RIG-I co-immunopurified RNAs by next generation deep sequencing and compared the obtained
reads to the measles virus genome.
In accordance with previous literature, RIG-I mainly interacted with measles virus genomic (i.e.
negative-sense) RNA or antigenomic (i.e. positive-sense) RNA close to the 5′ end. These RNA species
most likely represent leader read-through transcripts or abortive replication products. For MDA5 on
the other hand, we were for the first time able to purify in vivo relevant RNA and show that it solely
interacted with antigenomic RNA/ mRNA excluding the end, but otherwise similar regions as RIG-I.
For both proteins most interactions were found to occur within the measles virus L gene encoding
the viral polymerase. We confirmed the sequencing results by quantitative PCR. Furthermore, by
PCR, in both sequencing libraries measles virus copyback DI sequences could be detected. By bioin-
formatics evaluation of the sequencing data we found a direct connection between sequencing read
number and AUbase composition forMDA5. With subsequent cellular analysis of dephosphorylated
in vitro transcribed (IVT) RNA spanning different regions of the measles virus antigenome, we could
recapitulate this finding: IVTs with higher AU content exhibited also higher immunostimulatory po-
tential. We further confirmed this correlation with Mengo virus IVTs. Finally, using in vitro ATP hy-
drolysis assays of purified MDA5 interacting with measles virus IVTs we show a negative correlation
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of MDA5’s ATPase function with AU base composition, indicating that ATP hydrolysis might disturb
immunopurification of MDA5 associated RNA.
Based on our results we conclude that MDA5 preferentially senses AU-rich RNA species because
they are poorer activators of its ATPase domain and therefore result in more stableMDA5 filaments,
which in turn are better activators of type I interferon signaling.
Author contributions
I generated measles and Mengo virus in vitro transcripts together with Konstantin M. J. Sparrer and
analyzed their ATP hydrolysis potential together with Simon Runge. I generated RIG-I andMDA5mu-
tants and performed luciferase reporter gene assays. Together with Katharina Hembach I analyzed
the sequencing data and calculated correlation coefficients for different biochemical RNA parame-
ters or assay results. I revised the manuscript together with Simon Runge, Konstantin M. J. Sparrer
and Karl-Peter Hopfner.
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Infected Cells
Simon Runge1., Konstantin M. J. Sparrer2., Charlotte Lässig1., Katharina Hembach1, Alina Baum3,
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Abstract
RIG-I-like receptors (RLRs: RIG-I, MDA5 and LGP2) play a major role in the innate immune response against viral infections
and detect patterns on viral RNA molecules that are typically absent from host RNA. Upon RNA binding, RLRs trigger a
complex downstream signaling cascade resulting in the expression of type I interferons and proinflammatory cytokines. In
the past decade extensive efforts were made to elucidate the nature of putative RLR ligands. In vitro and transfection studies
identified 59-triphosphate containing blunt-ended double-strand RNAs as potent RIG-I inducers and these findings were
confirmed by next-generation sequencing of RIG-I associated RNAs from virus-infected cells. The nature of RNA ligands of
MDA5 is less clear. Several studies suggest that double-stranded RNAs are the preferred agonists for the protein. However,
the exact nature of physiological MDA5 ligands from virus-infected cells needs to be elucidated. In this work, we combine a
crosslinking technique with next-generation sequencing in order to shed light on MDA5-associated RNAs from human cells
infected with measles virus. Our findings suggest that RIG-I and MDA5 associate with AU-rich RNA species originating from
the mRNA of the measles virus L gene. Corresponding sequences are poorer activators of ATP-hydrolysis by MDA5 in vitro,
suggesting that they result in more stable MDA5 filaments. These data provide a possible model of how AU-rich sequences
could activate type I interferon signaling.
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Introduction
The retinoic acid inducible gene I (RIG-I)-like receptor (RLR)
proteins are key players in innate immunity and act by recognizing
viral RNA (vRNA) in the cytosol. The RLR family consists of
the members retinoic acid inducible gene I (RIG-I), melanoma
differentiation associated protein 5 (MDA5), and laboratory of
genetics and physiology 2 (LGP2) [1–3]. In vitro studies have shown
that RIG-I and MDA5 recognize the majority of viruses in a
complementary manner. While many negative-strand RNA
viruses like rabies and influenza viruses are predominantly sensed
by RIG-I, picornaviruses are predominantly recognized by
MDA5. The observed preferences are, however, unlikely to be
exclusive and the exact role of LGP2 still needs to be investigated
[4–9]. In case of MDA5, a minor contribution to recognition of
measles, rabies, vesicular stomatitis and Sendai virus has been
reported [10–13].
The RLR proteins belong to the DExD/H-box ATPases
sharing a central ATP-dependent helicase domain and a C-
terminal regulatory domain (RD) that is responsible for initial
RNA binding. In addition, RIG-I and MDA5 possess N-terminal
tandem caspase activation and recruitment domains (CARDs) that
are responsible for downstream signaling transduction [2,14,15].
Several crystal structures of RIG-I have shown that, in the absence
of virus, the protein exists in an auto-inhibited state where the RD
domain folds back to the CARDs, thereby shielding them from the
cytosol. Upon viral infection and initial vRNA binding, the protein
undergoes large conformational changes leading to the interaction
with the mitochondrial associated signaling protein (MAVS) [16–
19]. This leads to the activation of a downstream signaling cascade
and finally to the induction of type I interferon (IFN) expression
and the establishment of an anti-viral state. Although the exact
nature of RLR ligands is not yet fully understood, several studies
report that RIG-I preferentially binds to relatively short (between
25 to 1000–2000 bp) 59-triphosphate double-stranded RNAs
(59-triphosphate dsRNA) like those of Sendai virus (SeV) defective
interfering (DI) particles [20–23]. In contrast, MDA5 seems to
have a preference for long (more than 1000–2000 bp) dsRNA
stretches [24,25]. Upon binding to dsRNA, MDA5 is thought to
cooperatively form polar helical filaments leading to association
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with MAVS and activation of the downstream signaling cascade
[26–28].
Viruses have developed numerous strategies to evade the
immune system. For instance, viruses of the paramyxovirus family
(e.g. measles, parainfluenza, Sendai and Nipah viruses) encode
V inhibitor proteins that specifically bind to MDA5 and LGP2,
but not always to RIG-I [29–31]. By determining the structure
of MDA5 in complex with parainfluenza virus V-protein, we
previously showed that the viral protein unfolds the ATPase
domain of MDA5. This leads to the disruption of the MDA5
ATP-hydrolysis site and prevents RNA bound MDA5 filament
formation [32].
One of the remaining key questions in this field is how RLR
proteins are able to distinguish between self and non-self RNA in
the cytosol. Recently, several studies showed that 59-triphosphate
RNA is not the only RNA ligand for RIG-I. Specific poly U/C-
rich regions within certain viral genomes seem to contribute to
efficient recognition by the protein [33,34]. In case of MDA5, it is
not known which features of vRNA are required in order to induce
an immune response. Expression of subgenomic and subgenic
RNA from parainfluenza virus 5 (PIV5) indicated that MDA5
recognizes a specific region within the L mRNA [35]. For
picornaviruses, it is speculated that MDA5 binds to long dsRNA
that represents replicative intermediates composed of the positive
genome and the negative antigenome [36]. These studies were,
however, based on in vitro transfection experiments and it has so far
not been possible to isolate a natural RNA ligand for MDA5
directly from virus-infected cells.
In this study we combined different methods, including RNA-
protein crosslinking and deep sequencing, to investigate in vivo
RNA ligands for RLR proteins from virus-infected cells. Based on
the crosslinking we were able to co-purify immunostimulatory
RNA in a RIG-I and MDA5 dependent manner from measles
virus (MeV)-infected cells. Deep sequencing and bioinformatics
analysis revealed that RIG-I and MDA5 bind RNA of positive
polarity originating from the L gene of the MeV genome. In
addition, RIG-I binds to the 59 ends of genomic and antigenomic
RNAs, which probably represent 59-triphosphate RNA, and are
therefore not recognized by MDA5. Furthermore, we showed that
RIG-I, but not MDA5, binds RNA of negative polarity, indicating
that MDA5 does not efficiently recognize the MeV genome. Based
on bioinformatics analysis, we observed a correlation between
MDA5-enriched RNA sequences and the AU content and this was
confirmed by in vitro transcription assays. In summary, we report
the isolation of MDA5-associated RNA from virus-infected cells
and the discovery of in vivo occurring activating viral RNA ligands
for MDA5.
Results
4-thiouridine treatment and 365 nm UV light exposure
lead to improved RLR-associated RNA recovery from
virus-infected cells
Several in vitro studies showed that MDA5 preferably recognizes
long dsRNA stretches [24,25]. However, it is still unclear if the
protein has a preference for specific RNA sequences. The main
reason for this may lie in the weak interaction between the protein
and its ligand resulting in very poor RNA levels that co-purify
from MDA5 immunoprecipitates. In order to address this
problem, we established an RNA-protein crosslinking approach
adapted from the PAR-CLIP (Photoactivatable-Ribonucleoside-
Enhanced Crosslinking and Immunoprecipitation) methodology
[37]. With this approach, we intended to improve RNA recovery
from RLR immunoprecipitates in the context of a viral infection.
For validation of the method, we compared the crosslinking
approach with a conventional pull-down technique previously
used for the identification of SeV DI particles as potent RIG-I
inducers [20]. We infected A549 human lung carcinoma cells with
SeV at a high multiplicity of infection (MOI) in the presence of 4-
thiouridine (4SU) and allowed infection to occur over 24 h. A part
of the cells was then exposed to 365 nm UV light and endogenous
RIG-I was immunopurified (Figure 1a). The recovered RNA was
isolated and subjected to quantitative PCR (qPCR) analysis and
immunoactivity experiments. The data indicate that treatment
of cells with 4SU and exposure to 365 nm UV light lead to a
reduction of immunostimulatory activity of RIG-I-associated
RNA to 50% (Figure 1b). However, the results of qPCR analysis
showed that the crosslinking approach yields a quantitatively
improved RNA recovery, with an increase of 50% in SeV DI
particles in comparison to the non-crosslinking approach
(Figure 1c and d). Furthermore, we confirmed that treatment
of cells with the photoreactive nucleoside does not affect cell
viability or virus replication (data not shown). Taken together, our
data indicate that the crosslinking technique is a promising tool to
study in vivo occurring RNA ligands for RLR proteins.
Next, we validated the crosslinking approach on cells that were
infected with a variety of viruses, including negative-stranded (2)
RNA viruses (MeV [38] and rabies [39]) and positive-stranded (+)
RNA viruses (Encephalomyocarditis virus (EMCV [40]) and
Mengo virus [41]). In all cases, we infected A549 cells at an
MOI of 1.0 in the presence of 4SU. Cells were crosslinked 24 h
post infection (hpi) and RIG-I and MDA5 were immunopurified.
The recovered RNA was subjected to immunoactivity experi-
ments. Based on the data, we concluded that immunoactive RNA
was co-purified in a RIG-I- and MDA5-dependent manner from
MeV-infected cells. This induction was significant in comparison
to the negative control (Figure 2). In the case of RIG-I-associated
RNA, we obtained an immunostimulatory effect that was 2600-
fold higher in comparison to the control. For MDA5, we observed
an 800-fold induction. The data show that the approach yields
RIG-I- and MDA5-specific immunoactive RNA from MeV-
infected cells in a RIG-I- and MDA5-dependent manner.
Author Summary
RIG-I-like receptors (RLRs) are helicase-like molecules that
detect cytosolic RNAs that are absent in the non-infected
host. Upon binding to specific RNA patterns, RLRs elicit a
signaling cascade that leads to host defense via the
production of antiviral molecules. To understand how RLRs
sense RNA, it is important to characterize the nature and
origin of RLR-associated RNA from virus-infected cells.
While it is well established that RIG-I binds 59-triphosphate
containing double-stranded RNA, the in vivo occurring
ligand for MDA5 is poorly characterized. A major challenge
in examining MDA5 agonists is the apparently transient
interaction between the protein and its ligand. To improve
the stability of interaction, we have used an approach to
crosslink MDA5 to RNA in measles virus-infected cells. The
virus-infected cells were treated with the photoactivatable
nucleoside analog 4-thiouridine, which is incorporated in
newly synthesized RNA. Upon 365 nm UV light exposure
of living cells, a covalent linkage between the labeled RNA
and the receptor protein is induced, resulting in a higher
RNA recovery from RLR immunoprecipitates. Based on
next generation sequencing, bioinformatics and in vitro
approaches, we observed a correlation between the AU-
composition of viral RNA and its ability to induce an
MDA5-dependent immune response.
In Vivo Ligands of MDA5 and RIG-I
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Although we detected significant immunostimulatory activity for
RLR-associated RNAs from MeV-infected cells, the experimental
set up is currently unsuitable for the isolation of RLR RNA ligands
from the other viruses (Figure S1). The reason for this may lie
in the heterogeneity and the need for precise timing of viral
replication cycles or in the efficiency of 4SU incorporation and
crosslinking. Utilization of this technique for other viruses may
require adjustment of parameters, such as the time points of 4SU
addition, crosslinking and harvesting after infection.
Deep sequencing reveals regions within the measles
virus genome recognized by RIG-I and MDA5
Based on the above-mentioned results, we focused our studies
on MeV, which belongs to the order of Paramyxoviridae. MeV has a
single-stranded RNA genome of negative polarity consisting of
15,894 nucleotides. It comprises six non-overlapping genes,
which are flanked by small terminal non-coding regions known
as leader (le) and trailer (tr) sequences. These sequences serve as
promoter regions during viral replication and transcription
[42,43]. While the replication of the genome and antigenome is
performed in a continuous process, viral transcription is carried
out in a sequential manner, giving rise to an mRNA gradient
declining in the 39 to 59 direction (Figure S2), as previously
published [44]. Since (2) RNA virus polymerases eventually fail in
transcription termination, they generate, in addition to mono-
cistronic mRNAs, numerous alternative RNA species including
read-through transcripts, such as leader-N, bi- or tricistronic
mRNAs [45]. Furthermore, replication can give rise to abortive
replication products and DI RNA with large internal deletions or
copy-back genomes [46]. Due to the complex RNA composition of
Figure 1. Validation of crosslinking and immunoprecipitation of RLR/RNA complexes from 24 h virus-infected cells. A: Schematic
representation of the experimental procedure for characterization of RLR-associated RNA molecules. B: Immunostimulatory activity of RNA from RIG-I
and control (GFP) crosslinking samples in comparison to non-crosslinking immunoprecipitates. C: Western blot analysis of crosslinked and non-
crosslinked RIG-I and control (GFP) pull-down experiments. D: Comparison of RNA recovery levels by quantitative PCR analysis of RIG-I-associated
RNA from SeV-infected cells (n = 3). n.d. = not detectable.
doi:10.1371/journal.ppat.1004081.g001
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a virus-infected cell, the analysis of specific RNA ligands for RLR
proteins is challenging.
In order to shed light on the exact nature of RIG-I and MDA5-
associated RNAs derived from MeV-infected cells, we performed
a deep sequencing analysis on isolated RNA species from co-
immunopurifications with antibodies against endogenous RIG-I
and MDA5. As a control, we used an antibody against GFP (GFP
protein was not present). The MeV strain used for the studies
presented here was a recombinant measles virus rescued from
cDNA with the exact sequence of the Schwarz vaccine strain
(Genbank AF266291.1) [38].
Obtained sequences were mapped to the MeV antigenome and
the relative abundances of these sequences between RIG-I pull-
down, MDA5 pull-down, and GFP pull-down were compared.
Analysis of the reads showed that RIG-I and MDA5 bind to similar
regions within the L gene-derived RNAs. In addition, RIG-I,
but not MDA5, binds to RNAs derived from the 39 and the 59 ends
of the MeV genome (Figure 3a and b). These regions probably
represent le or trRNA generated in the course of replication or
transcription. Additionally, internal genomic and antigenomic
sequences found in the pull-downs could potentially originate from
MeV DI particles [46–51]. To address this question, we performed
a PCR analysis of RLR libraries in which we specifically amplified
copyback DI RNA of MeV [47–49]. Indeed, we detected copyback
DI particles not only in the RIG-I pull-down but also within RNA
recovered from MDA5 immunoprecipitates (Figure S3). We did
not find DIs in the GFP control pull-downs.
Consistent with previous work, the higher copy numbers of
reads indicate that RIG-I binds MeV RNA with higher affinity
than MDA5 [11]. This observation is in good agreement with
the increased immunostimulatory activity of isolated RNA from
RIG-I pull-down samples in comparison to MDA5. Regarding
the immunostimulatory activity, RIG-I-associated RNA gives a
4-fold higher induction in comparison to MDA5-associated RNA
(Figure 3d and e).
Analysis of deep sequencing data reveals remarkable
differences in the strand-specificity of RIG-I and MDA5
Based on the protocol used for cDNA library preparation,
sequencing reads could be separated according to their strand
orientation. During cDNA synthesis, adaptors were specifically
ligated to the 39 or 59 ends, thereby keeping the information of
strand specificity during the deep sequencing run. Separation of
sequences revealed remarkable differences between both protein
immunoprecipitations. RIG-I associated RNA sequences of
positive polarity, which represent either antigenomic RNA or
mRNA transcripts, are enriched in regions close to the 59 end of
the viral antigenome (leader) but also in distinct regions within the
L gene. In contrast, sequences of negative polarity, representing
the viral genome, are exclusively enriched in the 59 end of the
genome (trailer region) and in regions of the L gene (Figure 4a).
Analysis of MDA5-associated RNA revealed that sequences of
positive polarity were enriched within the L gene originating from
similar regions as (+) RNA from the RIG-I library (Figure 4b).
In contrast to RIG-I, however, MDA5 did not bind to RNA
sequences comprising the 59 end of the antigenome or leader
RNA. Comparison of (2) RNA from RIG-I and MDA5 libraries
further revealed that, in contrast to RIG-I, MDA5 did not enrich
sequences of negative polarity, including trailer sequences.
According to the analysis of strand specific enrichment, it
appears that MDA5 does not bind vRNA of negative polarity that
represents the MeV genome. Furthermore, the data evidently rule
out the possibility that MDA5 recognizes RNA duplexes of (+)
and (2) RNA that might represent replication intermediates, as
previously suggested for a positive-strand RNA virus [36]. In fact,
the result suggests that MDA5 binds (+) RNA that could either
represent mRNA or the MeV antigenome.
To further validate the specificity of the accumulation of RIG-I
and MDA5-associated RNA, we calculated specific read enrich-
ments [52] of the RLR libraries compared to the control library
(Figure S4). Enrichment (greater than 26 compared to the
control library) of RIG-I-associated RNA of positive polarity can
be found across the whole genome, whereas only few reads of
negative polarity are enriched within the N and L segment. In
contrast, enriched sequences of MDA5-associated RNA are
exclusively present within the L segment of positive polarity,
whereas no specific enrichment was observed for (2) RNA.
Based on the data, we observed a good correlation between the
deep sequencing analysis and enrichment calculations, indicating
that distinct regions within the MeV genome are indeed
specifically enriched in a RIG-I- and MDA5-dependent manner
in comparison to the control.
Confirmation of deep sequencing data with quantitative
PCR
To independently validate the relative amount of RLR-
associated RNA, qPCR amplification was performed. The
obtained copy read numbers were normalized to the GFP negative
control in order to compare the genomic segments in the RIG-I
and MDA5 samples (Figure 5a). Analysis of relative abundances
confirmed that RIG-I specifically enriches sequences from the
39 and 59 regions of the MeV genome, representing either
antigenome or viral mRNA. Interestingly, the analysis showed
that RIG-I-associated RNA from the genomic 39 end most likely
represents leader read-through transcripts or abortive replication
products and not N mRNA. In MDA5 pull-downs, RNA was
enriched in the case of the L mRNAs and partly in the case of H
mRNAs, while no relevant copy numbers were obtained at other
genomic positions. This is in good agreement with the results of
Figure 2. Immunoprecipitation of RLR-associated RNA from
24 h MeV infections. Validation of immunostimulatory activity of
RNA from RIG-I, MDA5, and GFP immunoprecipitates upon transfection
into 293T ISRE-FF reporter cells (n = 3, ** P,0.01).
doi:10.1371/journal.ppat.1004081.g002
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Figure 3. Deep sequencing analysis of RLR-associated RNA from MeV-infected cells. A–C: RNA from RIG-I pull-down (red), MDA5 pull-
down (blue), and control (GFP) pull-down (black) from MeV-infected cells were subjected to Illumina deep sequencing analysis. Obtained sequencing
reads are mapped to their position on the viral antigenome. The x-axis corresponds to all possible 15,894 positions in the MeV antigenome and the y-
axis shows the number of reads at the respective position. (A) RIG-I-associated sequences in comparison to the control mapped to the viral
antigenome. (B) MDA5-associated sequences in comparison to the control mapped to the viral antigenome. (C) Overlay of RIG-I associated and
MDA5-associated sequences. D: Western blot analysis of RIG-I and MDA5 immunopurification in comparison to the GFP pull-down. E: Validation of
immunostimulatory activity of RNA from RIG-I, MDA5, and GFP immunoprecipitates upon transfection into 293T ISRE-FF reporter cells.
doi:10.1371/journal.ppat.1004081.g003
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the deep sequencing analysis, indicating that MDA5 indeed
recognizes RNA originating from the L gene of the MeV genome.
Furthermore, comparison of the relative copy numbers between
RIG-I and MDA5 revealed remarkable differences between both
proteins. The relative abundances in the RIG-I sample were up to
40-fold higher in comparison to MDA5. This observation again
indicates that RIG-I has a higher affinity for MeV RNA sequences
in comparison to MDA5. Our conclusion is further supported by
immunoactivity experiments, where the relative immunostimula-
tory activity of RIG-I-associated RNA was 20-fold higher in
comparison to MDA5 (Figure 5b and c).
Bioinformatics analysis reveals a preferred binding of
RIG-I and MDA5 to RNA species with a higher AU
composition
To elucidate the exact nature of sequences enriched by RIG-I
and MDA5 immunoprecipitations, we conducted a bioinformatics
analysis. For this, the complete genome was divided into fragments
of size 201 nt with a shifting window of 5 nt. Each sequence was
folded in silico (RNAfold [53]) and several RNA primary and
secondary structure features were analyzed. The analyzed para-
meters were set in relation to the mean coverage of sequencing
reads from RIG-I and MDA5 pull-down experiments. Heat scatter
plots indicate that sequences rich in AU correlate with a high
mean coverage of sequencing reads in both the RIG-I (cor =
0.273, cor = 0.334) and MDA5 (cor = 0.358, cor = 0.348) libraries
(Figure 6a and b). These data suggest that RIG-I and MDA5
preferably bind to AU-rich sequences originating from the viral
genome. Although we further analyzed a variety of secondary
structure parameters, including paired nucleotides and bulges, we
did not see any other relevant correlation with the mean coverage
of sequencing reads (Figure S5 and Figure S6).
Confirmation of deep sequencing analysis by
immunoactive experiments on in vitro transcripts
To further confirm the obtained sequencing data, we generated
17 single-stranded, 200 nucleotide long in vitro transcripts (IVTs)
covering different regions of the MeV antigenome (Table S1).
RNAs were double-dephosphorylated in order to ensure that
59-triphosphate groups were removed. For immunoactivity
Figure 4. Strand separation of sequencing libraries into (+) and (2) MeV RNA. RNA deep sequencing libraries were generated based on the
strand-specific mRNA sample preparation protocol from Epicentre. The Epicentre protocol encompasses sequential ligation of 59 and 39 adapters to
RNA molecules, thus preserving strandness information. A: RIG-I-associated sequences in comparison to the control mapped to the viral antigenome.
(+) RNA is shown in red; (2) RNA is shown in magenta; the control library is shown in black and grey. B: MDA5-associated sequences in comparison to
the control mapped to the viral antigenome. (+) RNA is shown in blue, (2) RNA is shown in cyan; the control library is shown in black and grey.
doi:10.1371/journal.ppat.1004081.g004
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Figure 5. Quantitative PCR analysis of RLR-associated RNA from MeV-infected cells. A: Comparison of RNA levels between RIG-I and
MDA5 immunoprecipitates for each genomic segment at 24 hpi. Relative RNA ratios were normalized against the control (GFP) library (mean values, n = 2).
B: Western blot analysis of RLR pull-down experiments in comparison to the GFP pull-down. C: Immunostimulatory activity of RLR-associated RNA at 24 hpi.
doi:10.1371/journal.ppat.1004081.g005
Figure 6. Heatscatter plots of AU content of 201 nucleotide MeV RNA fragments and the fragment’s mean coverage. The linear
correlation is expressed via the Pearson coefficient. Every dot corresponds to one fragment with its respective AU content and mean coverage within
an RLR library. The more yellow the plot, the more data points overlap. A: Correlation between AU composition and coverage of RIG-I-associated RNA
of positive and negative RNA respectively. B: Correlation between AU composition and coverage of MDA5-associated RNA of positive and negative
RNA respectively.
doi:10.1371/journal.ppat.1004081.g006
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experiments IVTs were transfected into 293T ISRE-FF reporter
cells. The stimulatory effect revealed a correlation of high read
numbers from deep sequencing analysis and high stimulatory
activity of the IVT sequences (Figure 7). According to the
immunostimulatory experiment, we observed increased immunos-
timulatory activities for transcripts 8, 9, and 12 (Figure 7a). These
transcripts correspond to regions at the 59 end of the L gene,
which is also the region with the highest copy numbers of reads
(Figure 3). In general, IVTs representing regions within the L
gene have higher immunostimulatory activity in comparison to
the upstream genomic segments. This is in good agreement to
the deep sequencing analysis. Furthermore, calculated Pearson
correlations showed that the best correlation between maximal
numbers of sequencing reads and the immunostimulatory activity
of RNA transcripts can be found in the MDA5 sequencing data
(cor = 0.526), while RIG-I and GFP samples showed less
correlation (cor = 0.369 and cor = 0.217) (Figure 7b). In order
to find a possible explanation for the different immunostimulatory
potentials of IVTs, several characteristics of the transcripts were
analyzed in silico. The obtained data revealed that the immu-
nostimulatory potential correlates with the AU content of IVTs
(cor = 0.599) (Figure 7d), which is consistent with the results
from the deep sequencing analysis. Visualization of transcripts on
an Agilent bioanalyzer RNA chip indicates that no higher-order
structures due to the sequence composition were formed that
might explain differences in immunostimulatory activity (data not
shown).
In order to get a more general conclusion about the
contribution of the AU content to the immunostimulatory
potential of RNAs, in vitro transcripts from Mengo virus (Table
S3) were tested for their immunostimulatory activity. The
transcripts were generated according to the protocol for MeV
RNA sequences. We again observed a correlation (cor = 0.583) of
the AU content of the tested sequences and their immunostimu-
latory potential (Figure S 7a and b). These data are consistent
with the in vitro analysis of MeV RNA sequences indicating that the
AU composition of RNA might play a general role in activating
RLR signaling.
In vitro transcripts with a low proportion of AU strongly
stimulate ATP hydrolysis by MDA5
Finally, we asked whether the ATP hydrolysis activity of MDA5
correlates with the immunostimulatory potential of the tested
IVTs. We measured the ATP hydrolysis rate of recombinant
mouse MDA5 in the presence of RNA transcripts (Figure 7 and
Figure S8) and observed a negative correlation between the
maximum number of sequencing reads in the MDA5 library and
the ATP hydrolysis rate (cor = 20.414, Figure 7c). Analysis of the
in vitro data revealed that AU-rich sequences lead to a decrease in
ATP hydrolysis activity of MDA5 (cor = 20.445). Furthermore,
the ATP hydrolysis rate negatively correlates with the immu-
nostimulatory potential of RNA transcripts (cor = 20.426)
(Figure 7d). This result suggests that the ATPase hydrolysis
activity of MDA5 is not correlated to the binding and the
immunostimulatory potential of the RNA transcripts and could
therefore provide a model of RNA recognition by the protein.
The data are consistent with previous work on MDA5 filament
formation upon dsRNA binding [26,27]. In structural and
biophysical studies, Berke et al showed that ATP hydrolysis by
MDA5 causes filaments to disassemble, perhaps by inducing
translocation along the RNA or triggering a conformational
change in the protein. According to our data, this may explain
the observed inverse correlation between the immunostimulatory
activity of IVTs and their potential to induce the ATPase activity
of MDA5.
Discussion
Until now, in vivo RLR ligands were poorly understood and
a naturally occurring MDA5 ligand could only be purified
indirectly by immunoprecipitation of LGP2:RNA complexes from
virus-infected cells overexpressing LGP2 [54]. By applying a
combination of RNA-protein crosslinking, immunoprecipitation of
endogenous proteins and RNA deep sequencing analysis, we were
able to investigate RLR-associated RNA from MeV infected cells.
We compared our results to the empty GFP antibody control
resembling a previously published immunoprecipitation strategy
[20].
Our approach reveals that MDA5 preferentially binds measles
virus RNA of positive polarity, whereas RIG-I additionally binds to
(2) sense RNA within the trailer region as well as in the adjacent L
gene. We propose that enriched RNA of positive polarity most
likely represents mRNA species, since antigenomic RNA is only
generated during replication and is immediately packed into
nucleocapsids [55–57]. For Mononegavirales, these RNA-protein
complexes are considered inaccessible for cytoplasmic proteins
[55,58] and might not be ligands for RLR proteins unless they
become released. We show that, unlike MDA5, RIG-I binds (+)
sense RNA originating from not only the L genomic segment,
but also from the 39 end of the MeV genome, which could be
either le-N read-through transcripts or abortive replication
products comprising 59-triphosphate ends [45,46]. Furthermore,
we hypothesize that RIG-I specific enriched RNA of negative
polarity represents abortive replication products also having
59-triphosphate ends [20–23]. Additionally, 59-copyback DI
sequences combining vRNA of positive and negative polarity
were found both in RIG-I and MDA5 immunoprecipitates and
may contribute to recognition [49].
Bioinformatics analysis and in vitro transcription experiments
revealed a correlation between AU content and read coverage of
the obtained sequences or IVTs, respectively. As shown before
[59], this indicates that RNA rich in AU could serve as a putative
ligand for RIG-I and MDA5, or in a secondary manner lead to a
specific structure that is recognized by both proteins. The slightly
weaker correlation of RIG-I associated sequences with their AU
content compared to MDA5 bound RNAs could be explained by
additional sequences or triphosphate RNAs recognized by RIG-I
that originate from regions less rich in AU.
Interestingly, ATP hydrolysis assays performed with recombi-
nant MDA5 and RNA transcripts indicate that the AU content of
RNA negatively correlates with the ATP hydrolysis rate of the
protein. This inverse correlation between the immunostimulatory
potential of RNAs and their capability to stimulate ATP hydrolysis
by MDA5 lets us speculate that the ATPase activity might not be
necessary for, or even interfere with, the immunoactivity of RNA
ligands. Although this observation disagrees with recent findings
about the role of ATP hydrolysis in RIG-I oligomerization on
59-triphosphate dsRNA [60], we assume that MDA5 and RIG-I
differ markedly in their mechanical activation and the role of ATP
hydrolysis. Our data is supported by results suggesting that MDA5
filament formation is abrogated in an ATP-sensitive manner. By
electron microscopy (EM) analysis it was shown that MDA5
filaments disassemble in the presence of ATP, indicating that
ATP hydrolysis triggers the translocation of the protein along
the dsRNA molecule or reduces the binding affinity, thereby
interfering with downstream signaling [26,27]. In light of the
available data in the literature we therefore hypothesize that the
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Figure 7. Analysis of in vitro transcribed RNA of the measles virus genome. Sequences were generated according to deep sequencing data.
The transcripts were either transfected into 293T ISRE-FF reporter cells in order to validate the immunostimulatory potential or ATPase hydrolysis
experiments were performed in presence of recombinant mMDA5. A: Comparison of relative luciferase activities (black) and relative ATPase activities
(grey) of in vitro transcribed RNAs (n = 3 and n = 2 respectively, values were normalized to the highest mean value of each replicate). B: Pearson
correlation between (+) RNA maximal coverage and relative luciferase activity. C: Pearson correlation between (+) RNA maximal coverage and relative
ATPase activity. D: Correlation analysis between AU content and luciferase or ATPase activity, and between ATPase and luciferase activity.
doi:10.1371/journal.ppat.1004081.g007
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ATPase activity of the MDA5 helicase domain contributes to
substrate specificity by detaching the protein from low affinity
substrates. To further test this hypothesis we generated RIG-
IE373Q and MDA5E444Q, which are mutated in the ‘‘Walker B’’
ATP hydrolysis motif [61], slowing down or abrogating the ATP
hydrolysis activity of the proteins, while preserving formation
of ATP complexes. Overexpression of these mutant proteins
from transfected plasmids showed a dramatic increase in their
immunostimulatory potential in the absence of any viral ligands
in comparison to expressed wild-type MDA5 (Figure S9).
Furthermore, pull-down studies with the RIG-I Walker B mutant
revealed an increase in the amount of recovered RNA while
their immunostimulatory potential decreased (data not shown).
The increased immunostimulation of ATPase deficient RLRs is
consistent with the model that RNAs that lead to a reduced ATP-
hydrolysis rate are more proficient in immunostimulation, possibly
by stabilizing RLR:RNA complexes. The negative correlation
between AU-rich sequences and the ATP hydrolysis rate suggests
that MDA5 binds AU-rich RNA in preference to GC-rich RNA.
This would lead to a stronger interaction between RNA and
MDA5 and result in a higher immunostimulatory signal. In order
to test this hypothesis, we performed binding assays with MDA5
and IVTs but we were not able to demonstrate differences in
the binding affinities between the different transcripts that might
support this theory (data not shown). Finally, we speculate that
RNA ligands for RLR proteins could be divided into two classes.
The first class would comprise RNA molecules originating from
the 59-triphosphate ends of the genome or antigenome. These
molecules could be generated in the course of read-through
transcription and abortive replication [45,46] and could therefore
represent preferred ligands of RIG-I, as shown previously [20].
The second class of RNA molecules could be recognized by both
receptor proteins. Our data suggest that recognition of these RNAs
might occur through the AU composition of sequences [34]. This
second class might also prominently include defective interfering (DI)
particles generated during MeV replication. For MDA5, however,
our deep sequencing data show that the (2) strand portion of the DIs
is either relatively short or the fraction of DIs binding to MDA5 is
magnitudes lower than the binding to L derived (+) sense RNAs and
therefore not easily detectable during sequencing. A more detailed
analysis of the deep sequencing data is currently ongoing in order to
shed more light on the complex nature of the DIs involved.
It will be interesting to see what types of RNA associate with
RIG-I and MDA5 during infections with different viruses and to
what extent the AU composition and DI generation contributes
to RNA recognition in these types of viruses. In particular, the
finding that both RIG-I and MDA5 localize to AU rich regions
suggests partially overlapping roles in detection of different viruses.
The specificity of RIG-I and MDA5 for certain viruses may lie not
only in the detection of 59-triphosphate by RIG-I, but also in the
heterogeneity of viral evasion strategies [62]. Our findings support
a model for the recognition of AU-rich sequences by RIG-I and
MDA5 from MeV-infected cells. Consistently, we find a similar
correlation for in vitro transcribed RNA from the Mengo virus
genome.
In general, the data support previous experiments indicating
that MeV is mainly recognized by RIG-I, while MDA5 seems to
play a minor role [4,5,13,63]. It could be possible that RIG-I
initially recognizes le-N read-through transcripts or abortive
replication products containing 59-triphosphate ends, leading to
the activation of the signaling cascade. In a second round of
recognition, RIG-I and MDA5 then recognize viral transcripts
that are rich in AU. To further test this hypothesis, time dependent
experiments need to be carried out.
One feature of the applied crosslinking technique is the
introduction of specific T to C transitions at the interaction sites
of 4SU-labeled RNA and the protein upon UV light exposure
[37]. By identifying these point mutations in the deep sequencing
data, one can exactly pinpoint the RNA sequences that interact
with the protein of interest. However, our bioinformatics analysis
did not reveal significant enrichment of T to C mutations, which
could be explained by the rather low incorporation efficiency of
the photoreactive nucleoside into viral RNA, consistent with the
low incorporation level of 4SU into host RNA. Nevertheless, by
increasing the incorporation efficiency in future studies, the
identification of point mutants could further narrow down the
precise binding sites of RLRs.
In summary, our approach provides a first insight into the
molecular basis of vRNA derived from MeV interaction with
MDA5 in living cells and reveals a preference for binding of AU-
rich regions originated from (+)-sense RNA of the L gene. In vitro,
these RNA molecules appear to be a poorer stimulator of the
ATPase activity of MDA5, and result in more stable MDA5
filaments and support better downstream signaling.
Materials and Methods
Cell lines, viruses and antibodies
Infection experiments were carried out in A459 human lung
carcinoma cells. HEK 293T ISRE-FF reporter cells (stable
expression of firefly luciferase under the control of an interferon
stimulated response element) were used for interferon stimulation
luciferase reporter gene assays. All cells were maintained in
Dulbecco’s Modified Eagle Medium supplemented with 2 mM L-
glutamine, 1% Penicillin-Streptomycin and 10% FBS (all purchased
from Invitrogen). Viruses used for infections were recombinant
measles virus with a sequence identical to the vaccine strain Schwarz
(AF266291.1.), Sendai virus, Sendai virus defective interfering
particles H4 (kindly provided by Dominique Garcin, Geneva,
Switzerland), Mengo virus strain pMC0 (kindly provided by Anne
Krug, TU Munich, Germany) and EMCV. Primary antibodies to
human MDA5 (AT113) and RIG-I (Alme-1) were purchased from
Enzo Life Science (Loerrach, Germany). Antibody to GFP (ab1218)
was obtained from Abcam (Cambridge, UK). Secondary antibodies
were supplied by GE Healthcare (Buckinghamshire, UK).
Crosslinking and immunoprecipitation of RLR-associated
RNA from virus-infected cells
A549 cells were infected with virus with an MOI of 1.0 in the
presence of 400 mM 4SU. Infection was allowed to proceed for
24 h and living cells were washed with PBS (10 mM phosphate,
137 mM NaCl, 2.7 mM KCl, pH 7.5) and exposed to 1 J/cm2
365 nm UV light using a photocrosslinker (Vilbert Lourmat). Cells
were harvested and incubated in Nonidet P-40 lysis buffer (50 mM
HEPES, 150 mM KCl, 1 mM NaF, 10 mM ZnCl2, 0.5% NP-40,
0.5 mM DTT, protease inhibitor, pH 7.5) for 10 min on ice. The
lysate was cleared by centrifugation and endogenous proteins were
immunoprecipitated for 4 h with the respective antibodies (1 mg/
mL) bound to protein G Dynabeads (Life Technologies). The beads
were washed five times with high-salt wash buffer (50 mM HEPES,
500 mM KCl, 0.05% NP-40, 0.5 mM DTT, protease inhibitor,
pH 7.5) and incubated with proteinase K (Thermo Scientific) for
30 min at 55uC. The RNA was isolated by phenol/chloroform/
isoamylalcohol extraction and subjected to further analysis.
Total RNA isolation from virus infected cells
A549 cells were infected with MeV with an MOI of 1. Cells
were harvested 24 hpi. Total RNA was isolated according to
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manufacturer’s protocol of the RNeasy Protect Mini Kit (Qiagen)
and subjected to Illumina deep sequencing.
Luciferase transfection assay
Immunoactivity experiments were carried out in 24-well plates.
2.56105 HEK 293T ISRE-FF reporter cells were transfected with
250 ng of recovered RNA, 500 ng in vitro transcripts or 500 ng
plasmid DNA using Lipofectamine 2000 (Invitrogen) according
to manufacturer’s protocol. After 24 h incubation, cells were
subjected to immunoactivity experiments using the Dual-Glo
luciferase assay system (Promega) according to manufacturer’s
instructions. The luciferase activity was determined in a 96-well
plate reader. Significance of differences in luciferase activity
between samples were determined via an unpaired t-test.
cDNA library preparation and deep sequencing analysis
Isolated RNA was prepared for Illumina sequencing using
the mRNA-Seq library preparation kit (Epicentre) according to
manufacturer’s protocol. To remove ribosomal RNA species from
the sequencing libraries a Ribo-Zero rRNA removal kit (Epicen-
tre) was used. Quality of RNA-Seq libraries was validated on a
DNA1500 chip for the Bioanalyzer 2100 (Agilent). Sequencing
was performed on the Illumina Genome Analyzer in the Gene
Center sequencing facility (LAFUGA). Obtained sequences were
processed with the FASTX toolkit (http://hannonlab.cshl.edu/
fastx_toolkit/) in order to remove adapter sequences and reads
with PHRED scores below 30. Remaining sequences were
mapped to human and viral genomes by utilization of the Bowtie
algorithm [64], allowing maximal one mismatch per unique read.
The Bowtie sequence alignments were converted with SAMtools
[65] to pileup format, which was subsequently used for further data
analysis. Relative sequence abundances were analyzed between
RLR pull-down samples and the GFP control. Specific read
enrichments were calculated by determining the relative sequence
abundance at each position on the genomic segment and calculating
the average of the RLR/GFP ratios over a dynamic window of 200
reads. Relative sequence abundances with log2 ratios above +1 were
defined as significantly enriched in the RLR library.
Analysis of RNA sequences
RNA secondary structure prediction from measles virus genome
or in vitro transcripts was performed by utilization of RNAfold from
the ViennaRNA package [53] using standard parameter settings.
For this purpose, the genome was divided into 201 nt fragments
with a shifting window size of 5 nt. The sequences were folded in
silico and the linear relationship between different data sets was
quantified with the Pearson correlation coefficient.
SYBR green quantitative PCR analysis
DNase treatment of the immunoprecipitated RNAs and qPCR
was performed as previously described [66]. The primer pairs
used for quantification were identical to those published [67]. For
cDNA synthesis a random hexanucleotide mix was used (Roche).
Full length MeV vac2 cDNA with a known concentration was
used for standard generation. Copy number values obtained for
MDA5 and RIG-I were normalized to the control GFP.
PCR for 59-copyback defective interfering genome
detection
Specific primers for reverse transcription (Roche transcriptor
transcriptase) and the subsequent PCR (Biozym Phusion Poly-
merase) were adapted from Calain et al [47]. PCR products were
analyzed on agarose gels and stained with ethidium bromide.
T7 RNA transcription
Templates were generated for in vitro transcription in a PCR
adding the T7 promoter sequence (TAATACGACTCACTATA
GGG) to the 59 end of the desired MeV or Mengo virus genomic
fragment, respectively (for oligonucleotides see Tables S2 und
S4 respectively). PCR products were subsequently purified on
agarose gels. RNA was transcribed using the Ambion Megashort-
script T7 Kit according to the manufacturer’s protocols. The
reaction was incubated overnight at 37uC and RNA was precipitated
using LiCl at 220uC for 30 minutes. Afterwards, RNA was
subjected to triphosphate digestion using FastAP (Fermentas)
according to the manufacturer’s instructions and purified on
denaturing 8 M urea/10% polyacrylamide gels at 25 mA constant
current. Gel slices containing RNA were incubated overnight with
450 mL probe elution buffer (0.5 M ammonium acetate, 1 mM
EDTA, 0.2% SDS). Eluted RNA was isolated by phenol/
chloroform/isoamylalcohol extraction and precipitated with ethanol.
ATPase hydrolysis assays
ATPase hydrolysis activity was determined using [c-P32] ATP.
Mouse MDA5 was purified as described previously [32] and
1.6 mM of protein was preincubated with 80 nM in vitro
transcribed RNA for 10 min at room temperature. The reaction
was initiated by addition of ATPase hydrolysis buffer (20 mM
HEPES, pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, and 2 mM
DTT) containing 2 mM ATP and 0.2 mCi [c-P32] ATP. The
hydrolysis rate was monitored over 1 h and analyzed by thin layer
chromatography (TLC).
Generation of RLR mutants
Sequences encoding full-length human RIG-I with N-terminal
FLAG-tag and full-length human MDA5 with N-terminal FLAG-
tag were cloned into pcDNA5 FRT/TO (Invitrogen). Mutants
(FLAG-RIG-I E373Q and FLAG-MDA5 E444Q) were generated
by site directed mutagenesis with PfuUltra (Agilent).
Supporting Information
Figure S1 Validation of immunostimulatory activity of
RNA from RIG-I, MDA5, and GFP immunoprecipitates
upon transfection into 293T ISRE-FF reporter cells (n = 3,
** P,0.01).
(TIF)
Figure S2 Deep sequencing analysis of total RNA from
MeV-infected cells 24 hpi. RNA was isolated according to
manufacturer’s protocol of the RNeasy Protect Mini Kit (Qiagen)
and total RNA was subjected to Illumina deep sequencing. The
data show an mRNA gradient declining in the 59 to 39 direction,
while RNA of negative polarity has no relevant copy numbers.
(TIF)
Figure S3 Qualitative PCR analysis of MeV copyback DI
RNA. Following a specific reverse transcription of RNA with a
primer binding at the 39-terminus of the antigenome, 59-copyback
DI genomes were specifically amplified using another primer in
the same direction 600 nt downstream. The PCR was afterwards
analyzed on agarose gels to separate the amplicons of specific
copyback DIs with different length and branching points. The
RNA used for these experiments is indicated on the lanes (RIG-I,
MDA5 and GFP immunoprecipitates).
(TIF)
Figure S4 Enrichments in RLR sequencing libraries.
Binary logarithms of RLR to GFP ratios of sequence reads
(log2([read number RLR/read number GFP] * [total read number
In Vivo Ligands of MDA5 and RIG-I
PLOS Pathogens | www.plospathogens.org 11 April 2014 | Volume 10 | Issue 4 | e1004081
1 In vivo ligands of MDA5 and RIG-I in measles virus-infected cells
45
GFP/total read number RLR])) were calculated in order to
determine specific accumulations within the RLR libraries. Data
points with log2 ratios above 1 represent sequencing reads that were
enriched in comparison to the control (GFP) library. A: Enrich-
ments within the whole RIG-I (+) or (2) stranded sequencing
library. B: Enrichments within the whole MDA5 (+) or (2) stranded
sequencing library. C: Similar to A and B, but zoomed in view of
the enrichments for positive polarity (le)N and L segments. Mean
values for RIG-I and MDA5 log2 ratios are shown in red and blue,
respectively. Standard deviations are represented in grey. The mean
coverage of (+) RNA sequences is shown for the RIG-I (red), MDA5
(blue), and GFP (black) libraries below each graph.
(TIF)
Figure S5 Secondary structure analysis of several
features from in silico folded 201 nucleotide MeV RNA
fragments and correlation to the fragment’s mean
coverage within the RIG-I sequencing library. In silico
folding was done with RNAfold using standard parameters. The
analysis is visualized in heatscatter plots and the linear correlation
is expressed via the Pearson coefficient. Every dot corresponds to
one fragment with its depicted feature and mean coverage. The
more yellow the plot, the more data points overlap. Analyzed
RNA features are: number of paired nucleotides, longest paired
stretch, number of stem-loops, mean size of stem-loops, number of
bulges, mean size of bulges and mean number of paired
nucleotides per branch. A: Correlation analysis of RNA secondary
structure features with the RIG-I associated RNA of positive
polarity. B: Correlation analysis of RNA secondary structure
features with the RIG-I associated RNA of negative polarity.
(TIF)
Figure S6 RNA secondary structure analysis of several
features from in silico folded 201 nucleotide MeV RNA
fragments and correlation to the fragment’s mean
coverage within the RIG-I sequencing library. Foldings
were performed with RNAfold using standard parameters. The
analysis is visualized in heatscatter plots and the linear correlation
is expressed via the Pearson coefficient. Every dot corresponds to
one fragment with its depicted feature and mean coverage. The
more yellow the plot, the more data points overlap. Analyzed
RNA features are: number of paired nucleotides, longest paired
stretch, number of stem-loops, mean size of stem-loops, number of
bulges, mean size of bulges and mean number of paired
nucleotides per branch. A: Correlation analysis of RNA secondary
structure features with the RIG-I associated RNA of positive
polarity. B: Correlation analysis of RNA secondary structure
features with the RIG-I associated RNA of negative polarity.
(TIF)
Figure S7 Analysis of in vitro transcribed RNA of the
Mengo virus genome. Six 201 nt fragments were chosen to
include low and high AU content. Transcripts were transfected
into 293T ISRE-FF reporter cells in order to validate the
immunostimulatory potential. A: Relative luciferase activity of
transfected RNA (n = 3). B: Pearson correlation between (+) RNA
maximal coverage and the relative luciferase activity.
(TIF)
Figure S8 MDA5 ATPase activity assay. Free phosphate
was separated by thin layer chromatography (TLC) and visualized
on a Storm PhosphorImager from Molecular Dynamics. The
ATPase hydrolysis rate was determined by quantifying free
phosphate in comparison to non-hydrolyzed ATP 15 min after
adding [c-P32] ATP to the reaction mixture.
(TIF)
Figure S9 Immunostimulatory activity of overex-
pressed Walker B mutants RIG-IE373Q and MDA5E444Q
compared to wildtype proteins in 293T ISRE-FF reporter
cells (n = 3, ** P,0.01, *** P,0.001).
(TIF)
Table S1 Sequences of in vitro transcribed MeV RNAs.
The gene annotation with the exact nucleotide position on the
MeV genome is shown in brackets.
(DOCX)
Table S2 Oligonucleotides used for generation of in
vitro transcribed MeV sequences.
(DOCX)
Table S3 Sequences of in vitro transcribed Mengo
RNAs. The gene annotation with the exact nucleotide position
on the Mengo virus genome is shown in brackets.
(DOCX)
Table S4 Oligonucleotides used for generation of in
vitro transcribed Mengo sequences.
(DOCX)
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Summary
In this publicationwe analyze the SF2 helicase domain of RIG-I like receptors. We engineered several
single amino acid point mutations in SF2 motifs or found in patients with the multi-system disease
Singleton-Merten syndrome (SMS) into RIG-I. We are thus able to dissected ATP binding and ATP
hydrolysis for the function of RIG-I as an innate immune sensor of non-self RNA.
By luciferase reporter gene assays in cells lacking endogenous RIG-I we show that, regardless of the
presence of an infection, ATP binding-deficient RIG-I is not able to induce any immune response at
all. ATP hydrolysis-deficient RIG-I on the other hand, as for instance found in SMS patients, con-
stitutively signals in an RNA binding-dependent manner. We exclude structural protein alterations
of the hydrolysis-deficient mutant by thermofluor assays and SAXS with purified proteins, and by
cellular competitions assays with wild type RIG-I. In addition, we were able to purify a physiological
ligand for ATP hydrolysis-deficient RIG-I, i.e. an expansion segment of the big ribosomal subunit,
by co-immunoprecipitation and visualize the interaction by cryo-electron microscopy. Similar co-
immunoprecipitation results were obtained for infected cells as well as for the respective MDA5
mutant. Subsequent biochemical studies with wild type RIG-I or the ATPase-dead mutant and ei-
ther purified human ribosomes or a derived hairpin-RNA verified binding of the mutated protein
and confirmed a loss of interaction of wild type RIG-I in presence of ATP. By EMSA and fluorescence
anisotropy we further show that, in contrast to the hairpin-RNA, dsRNA binding of wild type RIG-I is
enhanced under ATP hydrolyzing conditions.
Based on our studies and previous literature, we conclude that ATP hydrolysis of RIG-I confers a
proof-reading step in order to discriminate between self- and non-self RNA by testing the CTD affinity
towards the respective RNA. RNAs providing a high affinity CTD anchor, like a triphosphate motif,
bind very stable to RIG-I regardless of the presence of ATP. Endogenous RNAs lacking an anchor,
however, are removed from the protein through ATP hydrolysis.
Our results further provide themolecular basis of RLR signaling for the development of autoimmune
diseases like the Singleton-Merten syndrome and emphasize the importance of an intact RLR ATPase
domain in discrimination between self and non-self RNA.
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Abstract The cytosolic antiviral innate immune sensor RIG-I distinguishes 5¢ tri- or diphosphate
containing viral double-stranded (ds) RNA from self-RNA by an incompletely understood
mechanism that involves ATP hydrolysis by RIG-I’s RNA translocase domain. Recently discovered
mutations in ATPase motifs can lead to the multi-system disorder Singleton-Merten Syndrome
(SMS) and increased interferon levels, suggesting misregulated signaling by RIG-I. Here we report
that SMS mutations phenocopy a mutation that allows ATP binding but prevents hydrolysis.
ATPase deficient RIG-I constitutively signals through endogenous RNA and co-purifies with self-
RNA even from virus infected cells. Biochemical studies and cryo-electron microscopy identify a 60S
ribosomal expansion segment as a dominant self-RNA that is stably bound by ATPase deficient
RIG-I. ATP hydrolysis displaces wild-type RIG-I from this self-RNA but not from 5’ triphosphate
dsRNA. Our results indicate that ATP-hydrolysis prevents recognition of self-RNA and suggest that
SMS mutations lead to unintentional signaling through prolonged RNA binding.
DOI: 10.7554/eLife.10859.001
Introduction
The innate immune system provides a rapid initial reaction to invading pathogens and also stimu-
lates the adaptive immune system (Iwasaki and Medzhitov, 2015). Pattern recognition receptors
(PRRs) of the innate immune system sense pathogen- or danger-associated molecular patterns
(PAMPs or DAMPs) and trigger molecular cascades that together initiate and orchestrate the cellular
response through activation of e.g. interferon regulatory factors and nuclear factor kB
(Brubaker et al., 2015; Pandey et al., 2015; Wu and Chen, 2014).
Retinoic-acid inducible gene I (RIG-I), melanoma differentiation-associated gene 5 (MDA5) and
laboratory of physiology and genetics 2 (LGP2) are three structurally related PRRs – denoted RIG-I
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like receptors (RLRs) – that recognize cytosolic foreign RNA. RIG-I senses RNA from a broad range
of viruses including measles virus and Sendai virus (both paramyxoviridae), Influenza A virus, Japa-
nese encephalitis virus and Hepatitis C virus, whereas MDA5 is activated for example by picornavirus
RNA. LGP2 has augmenting and regulatory roles in MDA5 and RIG-I dependent signaling
(Bruns et al., 2014; Satoh et al., 2010; Sparrer and Gack, 2015).
RIG-I preferentially detects base-paired double-stranded RNA (dsRNA) ends containing either 50
triphosphate (ppp) or 50 diphosphate (pp) moieties (Goubau et al., 2014; Hornung et al., 2006;
Pichlmair et al., 2006; Schlee et al., 2009; Schmidt et al., 2009) and not 2’ OH methylated at the
first 5’ terminal nucleotide (Schuberth-Wagner et al., 2015). ppp-dsRNA arises, for example, at
panhandle structures of influenza virus nucleocapsids, or during measles or Sendai virus transcription
(Liu et al., 2015; Weber et al., 2013). 50 diphosphates are found on genomic RNA of reoviruses
(Banerjee and Shatkin, 1971). RIG-I can also detect poly-U/UC-rich dsRNA (Schnell et al., 2012).
Ligands of MDA5 are less well characterized but include dsRNA longer than 1000 bp (Kato et al.,
2008), higher-order dsRNA structures (Pichlmair et al., 2009), or AU-rich RNA (Runge et al., 2014).
RLRs are members of the superfamily II (SF2) of ATPases, helicases or nucleic acid translocases.
RIG-I and MDA5 consist of two N-terminal tandem caspase activation and recruitment domains
(2CARD), a central ATPase/translocase domain and a C-terminal regulatory domain (RD). LGP2 lacks
the 2CARD module but otherwise has a similar domain architecture. Binding of RNA induces a con-
formational change in RIG-I. If activated, the RD binds the ppp- or pp-dsRNA end, while the SF2
domain interacts with the adjacent RNA duplex and forms an active ATPase site (Civril et al., 2011).
In this conformation, the 2CARD module is sterically displaced from its auto-inhibited state
(Jiang et al., 2011; Kowalinski et al., 2011; Luo et al., 2011) and can be K63-linked poly-ubiquiti-
nated (Gack et al., 2007). Multiple Ub-2CARD complexes assemble to form a nucleation site for the
polymerization of mitochondrial antiviral-signaling adaptor protein (MAVS) into long helical filaments
(Hou et al., 2011; Wu et al., 2014; Xu et al., 2014). Instead of recognizing terminal structures like
eLife digest Living cells produce long, strand-like molecules of RNA that carry the instructions
needed to make proteins. Viruses also make use of RNA molecules to hijack an infected cell’s
protein-production machinery and create new copies of the virus. RNA molecules from viruses have
a number of features that distinguish them from a cell’s own RNAs, and human cells contain
receptors called RLRs that can start an immune response whenever they detect viral RNAs. All of
these receptors break down molecules of ATP, a process that releases useable energy. However, so
far it is not understood how this activity helps the receptors to distinguish viral RNA from the cell’s
own RNA molecules (called self-RNA).
Recently, some autoimmune diseases (including Singleton-Merten Syndrome) were linked to
mutations in the parts of RLRs that allow the receptors to break down ATP. Now, La€ssig et al. have
studied the effects of specific mutations in an RLR called RIG-I in human cells. The experiments
showed that mutations that disrupt RIG-I’s ability to bind to ATP also prevented the receptor from
becoming activated. However, mutations linked to Singleton-Merten Syndrome don’t stop ATP from
binding but instead slow its breakdown; this effectively locks the receptor in an ATP-bound state.
La€ssig et al. found that similar mutations in RIG-I caused human cells to trigger a constant immune
response against the self-RNAs.
Further experiments then suggested that the breakdown of ATP helps to remove RIG-I that has
bound to double-stranded sections of self-RNAs. This activity frees the receptor, making it more
able to detect double-stranded viral RNAs and preventing unintentional signaling. La€ssig et al. also
identified a specific double-stranded section of a human RNA that may be recognized by the
mutated version of RIG-I in people with Singleton-Merten Syndrome.
The next steps following on from this work are to extend the analysis to also include other RLRs
and further explore the underlying mutations within the three-dimensional structures of the
receptors and RNA molecules involved.
DOI: 10.7554/eLife.10859.002
Lässig et al. eLife 2015;4:e10859. DOI: 10.7554/eLife.10859 2 of 20
Research article Cell biology Immunology
Publications
52
RIG-I, MDA5 cooperatively polymerizes along dsRNA (Berke and Modis, 2012), which is suggested
to trigger MAVS polymerization.
The SF2 ATPase domain plays a critical part in RIG-I activation, although the role of the ATPase
activity is still debated. Mutation of the seven SF2 “helicase” motifs resulted in RLRs that are either
inactive or signal constitutively (Bamming and Horvath, 2009; Louber et al., 2015). On the other
hand, overexpression of the 2CARD module alone is sufficient for signaling (Yoneyama et al.,
2004). Further studies revealed that the SF2 domain is an ATP-dependent dsRNA translocase
(Myong et al., 2009) that can help enhance signaling by loading multiple RIG-I on dsRNA
(Patel et al., 2013) and may execute anti-viral “effector” functions through displacement of viral
proteins (Yao et al., 2015). Finally, RIG-I ATPase activity promotes recycling of RIG-I:dsRNA com-
plexes in vitro, suggesting a kinetic discrimination between self and non-self RNA (Anchisi et al.,
2015; Louber et al., 2015).
Several autoimmune diseases, including the Aicardi-Goutières and Singleton-Merten syndromes
(SMS), were linked to single amino acid mutations in the SF2 domains of MDA5 and RIG-I
(Funabiki et al., 2014; Jang et al., 2015; Rice et al., 2014; Rutsch et al., 2015). Two point muta-
tions within the Walker A (motif I) or Walker B (motif II) of RIG-I are linked to atypical SMS and func-
tional studies indicated constitutive RIG-I activation (Jang et al., 2015). Thus, these mutations have
been described as a gain of function, which is puzzling considering previous mutations in motif I led
to loss of RIG-I function, while mutations in motif II led to either gain or loss of function, depending
on the type of mutation (Bamming and Horvath, 2009; Louber et al., 2015).
In order to clarify the role of RIG-I’s ATPase in antiviral signaling and RLR associated human dis-
eases, we engineered structure-derived and patient-identified mutations into RIG-I and tested the
resulting proteins in different types of cell-based and in vitro analyses. Collectively, we find that SMS
mutations phenocopy the structure-derived E373Q mutation in motif II, which is designed to trap
RIG-I in an ATP-bound state. Freezing this state results in a dramatic autoimmune response because
the enzyme binds self-RNA and signals. An unexpected, strongly enriched self-RNA is the ribosomal
large subunit, which contains large, dsRNA expansion segments. Collectively, our results suggest
that a biomedical and functional critical role of RIG-I’s ATPase is to prevent spontaneous and unin-
tended activation by self-RNA. Thus, the SF2 translocase likely increases the sensitivity of the system
by reducing background signaling. Furthermore, our studies suggest that in SMS, RIG-I is trapped in
an ATP-bound state and signals through self-ligands.
Results
Prevention of ATP hydrolysis in RIG-I leads to a constitutive activation
of the interferon-b promoter by recognition of self-RNA
To address the roles of ATP binding and hydrolysis by the SF2 domain of RIG-I, we studied RIG-I var-
iants containing structure-based mutations designed to i) prevent ATP binding and formation of a
functional ATP-bound complex, ii) allow ATP binding and ATP-induced conformational changes but
prevent ATP hydrolysis, or iii) disable interaction of the RNA with either the 1A or 2A domain of SF2
(Figure 1A, B). The structure of RIG-I in complex with RNA and ADPBeFx served as guide for these
mutations ([Jiang et al., 2011], PDB code 3TMI, Figure 1B).
In order to dissect the influence of these mutations on the ability of RIG-I to elicit downstream
signaling, we used an interferon-b (IFNb) promoter activity assay carried out in HEK 293T RIG-I KO
cells (Figure 1—figure supplement 1A,B). Overexpressed wild-type RIG-I (wtRIG-I) is able to induce
a slight activation of the IFNb promoter, which can be further amplified by stimulation with Sendai
virus defective interfering particles (SeV DIs) (Figure 1C). The 2CARD module (RIG-I 1-229) induced
a strong activation in both non-infected and SeV DI-stimulated cells and is crucial since constructs
lacking these domains (D2CARD, RIG-I 230-925) cannot conduct any downstream signaling. RIG-I
K270I, carrying a mutation in the motif I lysine that reduces ATP binding (Rozen et al., 1989), sig-
naled in neither uninfected nor SeV DIs stimulated cells, consistent with previous studies. Remark-
ably, the E373Q substitution in motif II had a strikingly different effect. RIG E373Q, which has a
stabilized ATP-bound state by slowed-down ATP hydrolysis, strongly signaled in both non-infected
and SeV DIs stimulated cells. Western blots validated correct expression of all mutants (Figure 1—
figure supplement 1C).
Lässig et al. eLife 2015;4:e10859. DOI: 10.7554/eLife.10859 3 of 20
Research article Cell biology Immunology
2 ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA
53
Figure 1. Cellular studies of RIG-I ATPase mutants in infected or non-infected cells. (A) Location of amino acid substitutions of RIG-I SF2 domain
variants used in this study (orange lines) within different RLR helicase motifs (orange squares). (B) Single amino acid substitutions (orange) within the
RIG-I 3D structure (PDB: 3TMI). (C) Fold change of interferon-b (IFNb) promoter driven luciferase activity in uninfected HEK 293T RIG-I KO cells or in
cells challenged with Sendai virus defective interfering particles (SeV DIs). Cells were co-transfected with RIG-I expression vectors and p125-luc/ pCMV-
RL reporter plasmids, and infected with SeV DIs 6 hr post transfection. Firefly (FF) luciferase activities were determined in respect to Renilla (Ren)
luciferase activities 24 hpi. All ratios were normalized to the empty vector control. n=3–12, error bars represent mean values ± standard deviation.
Figure 1 continued on next page
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To rule out a “constitutive” active conformation of RIG-I E373Q due to an exposed 2CARD mod-
ule (e.g. from an unfolded SF2) we performed small angle X-ray scattering with purified wtRIG-I and
RIG-I E373Q demonstrating that both proteins have the same solution structure (Figure 1—figure
supplement 2A, B). In addition, thermal unfolding assays show that the E373Q mutation does not
destabilize RIG-I (Figure 1—figure supplement 2C). Finally, RIG-I D2CARD,E373Q has a dominant
negative effect on signaling by RIG-I E373Q (Figure 1, Figure 1—figure supplement 2D, E). Taken
together, these data show that RIG-I E373Q is neither destabilized nor constitutively active, suggest-
ing it needs productive RNA interactions.
To test whether E373Q signals in non-infected (and perhaps also infected cells) because of inter-
action with self-RNA, we additionally introduced mutations in various RNA binding sites, in particular
a DRD variant (RIG-I 1-798) and mutations in two RNA-interacting residues in domains 1A (T347A)
and 2A (V699A) of SF2. The single mutation RIG-I T347A did not signal in either infected or non-
infected cells, showing that the interaction of RNA with this specific amino acid is critical for signal-
ing (Figure 1C). Interestingly, we find that the single mutation V699A slightly increases the signaling
activity of RIG-I in non-infected cells (Figure 1C), which could be explained by a putative reduction
of translocation activity instead of a prevention of RNA binding to SF2 (see discussion). Finally, dele-
tion of the regulatory domain (DRD) inactivates signaling in both infected and non-infected cells as
previously observed (Cui et al., 2008). As expected, both combination mutants RIG-I E373Q,T347A
and RIG-I E373Q,DRD failed to signal in both SeV DIs infected and non-infected cells. These data
show that the increased immunostimulatory effect of E373Q requires a productive RNA interaction
of SF2 and RD.
Since RD is also required for the displacement of the 2CARD module from SF2, we
additionally analyzed a point mutation in RD. K888 mediates triphosphate binding in RD and muta-
tions in this residue inactivate recognition of viral RNA (Cui et al., 2008; Wang et al., 2010). Of
note RIG-I E373Q,K888T is still constitutively active in non-infected cells. This effect indicates that
the increased signaling capacity on endogenous RNA is independent from the ppp-dsRNA or pp-
dsRNA epitopes that RIG-I recognizes on viral RNA via the RD.
Finally, we addressed the effect of the Singleton-Merten mutations C268F and E373A. E373A is
at the same position as our structure-derived E373Q mutant. Consistent with this, we observed that
this substitution leads to a constitutive activation of the IFNb promoter (Jang et al., 2015)
(Figure 1C). Interestingly, although C268 is located in motif I, it also leads to constitutive signaling,
whereas motif I mutation of K270 (which coordinates the b-phosphate of ATP) blocks ATP binding
and renders RIG-I inactive. Thus, mutation of the non-ATP binding C268 in motif I appears to pheno-
copy a mutation that prevents ATP hydrolysis.
In summary, our studies show that signaling of RIG-I requires both ATP and RNA binding. ATP
hydrolysis, on the other hand, appears to be critical to dissolve the signaling state and to prevent
activation of RIG-I by self-RNA.
RIG-I ATP hydrolysis defective mutant E373Q shows increased
interaction with ribosomal RNA
We hypothesized that E373Q traps RIG-I in an ATP bound high affinity conformation that is activated
already by self-RNA. To test this idea, we immunoprecipitated RIG-I and its mutants from non-
infected HEK 293T RIG-I KO cells or cells infected with measles or Sendai virus and analyzed the co-
purified RNA molecules. Regardless of whether co-purified from infected or non-infected cells, the
amount of RNA recovered from RIG-I E373Q was about 3 times higher than that from RIG-I
(Figure 2A). Similarly increased amounts of RNA co-purified with the SMS mutants C268F and
E373A from uninfected cells, reflecting the same altered RNA binding properties as in RIG-I E373Q
(Figure 2—figure supplement 1A).
When analyzed on a Bioanalyzer RNA chip or on agarose gels, we found that the increased
amount of RNA is to a large extent due to the presence of 28S rRNA, while 18S rRNA remains unal-
tered (Figure 2B). Control analysis of the total RNA content ruled out an alteration of ribosome sub-
unit ratio in RIG-I E373Q transfected cells (Figure 2C). Both increased amount of RNA and specific
enrichment of 28S rRNA were also observed for the equivalent MDA5 E444Q Walker B mutant (Fig-
ure 2—figure supplement 1B, C).
In order to determine the immunostimulatory potential of the RNA co-purified from virus-infected
cells, we back-transfected the RNA into HEK 293T ISRE-FF/RFP reporter cells (which contain
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endogenous RIG-I, see Figure 2—figure supplement 2A). RNA co-purified with wtRIG-I and RIG-I
lacking the 2CARD module induced an immune response in these cells (Figure 2—figure supple-
ment 3A). RNA co-purified with RIG-I K270I (ATP binding deficient) and V699A (putative transloca-
tion deficient) was also able to stimulate the ISRE reporter in an amount comparable to wtRIG-I,
indicating no altered RNA binding properties in these mutants under virus infected conditions. In
Figure 2. RIG-I ATP hydrolysis defective mutant E373Q recognizes the 60S ribosomal subunit in vivo. (A) Relative RNA amount co-purified with
overexpressed RIG-I or RIG-I E373Q from virus infected or non-infected HEK 293T RIG-I KO cells. n=4 (infected) or n=10 (non-infected), error bars
represent mean values ± standard deviation. (B) Bioanalyzer evaluation and agarose gel separation of RNA co-purified with overexpressed RIG-I or RIG-
I E373Q from non-infected HEK 293T RIG-I KO cells. Curves are normalized in respect to 18S rRNA peaks. (C) Bioanalyzer evaluation and agarose gel
separation of total RNA content of non-infected HEK 293T RIG-I KO cells overexpressing RIG-I or RIG-I E373Q. Curves were normalized as in panel B.
(D) Immunostimulatory potential of co-purified RNA from RIG-I, RIG-I E373Q or GFP overexpressed in measles virus (MeV), MeV-Cko-ATU-Cs or Sendai
virus Cantell (SeV) infected HEK 293T RIG-I KO cells. RNA was back-transfected into HEK 293T ISRE-FF/RFP cells together with pTK-RL transfection
control. Firefly luciferase (FF) activities were determined 24 hr after transfection in respect to Renilla luciferase (Ren) activity and were normalized to the
immunostimulatory potential of RIG-I associated RNA. n=4, error bars represent mean values ± standard deviation. (E) Immunostimulatory potential of
endogenous RNA in cells overexpressing RIG-I E373Q. RNA was co-transfected into HEK 293T RIG-I KO cells together with a RIG-I E373Q expression
vector and p125-luc/ pCMV-RL reporter plasmids. FF luciferase activities were determined in respect to Ren luciferase activities 24 hr after transfection.
All ratios are normalized to the RIG-I E373Q control without RNA stimulation. Purified RNA was in addition analyzed on agarose gels. n=3, error bars
represent mean values ± standard deviation.
DOI: 10.7554/eLife.10859.006
The following figure supplements are available for figure 2:
Figure supplement 1. Analysis of RNA co-purified with RIG-I SMS or MDA5 variants.
DOI: 10.7554/eLife.10859.007
Figure supplement 2. Assay for defining the immunostimulatory potential of different RNAs.
DOI: 10.7554/eLife.10859.008
Figure supplement 3. Immunostimulatory potential of co-purified RNA from Sendai virus Cantell (SeV) infected cells.
DOI: 10.7554/eLife.10859.009
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contrast, RNA that co-purified with the RNA-binding deficient RIG-I T347A (mutation in SF2 domain),
RIG-I K858E (mutation in RD domain that reduces triphosphate recognition) or RIG-I DRD poorly
stimulated the ISRE promoter and probably represents background RNA (Figure 2—figure supple-
ment 3A). These data suggest that RIG-I recognizes immunostimulatory RNA via the SF2 and RD
domains, but does not require ATP binding for this process. ATP binding is necessary, however,
because RIG-I K270I expression alone does not stimulate the IFNb promoter (compare with
Figure 1C). Interestingly, RNA co-purified with RIG-I E373Q failed to induce reporter gene expres-
sion (Figure 2D, Figure 2—figure supplement 3A). Thus, despite the observation that RIG-I E373Q
co-purifies with approximately threefold more RNA than wtRIG-I from infected cells, the co-purified
RNA is not immunostimulatory in a wtRIG-I background. However, cells that transiently express RIG-I
E373Q can be further stimulated by transfection of total RNA extracts and purified ribosomal RNA
(Figure 2E), suggesting that ribosomal RNA can activate RIG-I E373Q. Cells lacking wtRIG-I or RIG-I
E373Q on the other hand do not respond to those RNAs. We conclude that host-RNA, which does
not activate wtRIG-I, can apparently compete with viral RNA for RIG-I E373Q.
In order to verify a higher affinity of the RIG-I ATP hydrolysis defective mutant towards ribosomal
RNA, we purified full-length human RIG-I and RIG-I E373Q, as well as human 80S ribosomes, and
tested for a direct interaction. We confirmed that while both RIG-I E373Q and the wild-type protein
are able to bind ATP, only wtRIG-I can hydrolyze ATP (Figure 3A, B). We subsequently conducted
sedimentation assays via ultra-centrifugation of sucrose cushions loaded with 80S ribosomes that
have been pre-incubated with wtRIG-I or RIG-I E373Q in presence or absence of ATP or the non-
hydrolysable ATP analogue ADPBeF3. In presence of ATP a minor binding of wtRIG-I to the ribo-
some could be observed, whereas RIG-I E373Q bound in a near stoichiometric manner. In absence
of ATP or in presence of ADPBeF3 binding of wtRIG-I was greatly enhanced and showed similar lev-
els compared to RIG-I E373Q (Figure 3C).
We next analyzed RIG-I E373Q:80S ribosome complexes by cryo-electron microscopy and single
particle 3D reconstruction (Figure 3D). The average resolution was estimated to be 17.7 Å based on
the Fourier shell correlation cut-off criterion at 0.5. When compared with the reconstruction of the
human 80S ribosome alone (Figure 3E), the ribosome:RIG-I E373Q complex revealed an additional
density located at rRNA expansion segment (ES) 7L, which is located at the back of the large ribo-
somal subunit. Calculation of a statistical difference map between the two reconstructions confirmed
that this distinct region contained significant additional density (Figure 3F). Human ribosomes con-
tain several long, G:C rich, base-paired RNA expansion segments forming large tentacle-like hairpin
structures of substantial double-stranded nature (Anger et al., 2013). A large part of the double-
stranded RNA in these segments is not covered by ribosomal proteins and accessible for cytosolic
proteins. The crystal structure of ADPBeFx-bound RIG-I 42CARD:RNA complex ((Jiang et al.,
2011), PDB code 3TMI) fits well into the density observed at ES7L and is located at the root of the
solvent exposed portion of helix A of ES7L that contains a contiguous stretch of seven G:C/C:G
base pairs (Figure 3G).
In summary, we conclude that stabilizing the ATP-bound state of RIG-I induces a conformation
where RIG-I binds to ribosomes, presumably at exposed dsRNA expansion segments.
Specificity of RIG-I towards double-stranded RNA is increased in
presence of ATP
To further evaluate the role of ATP binding and hydrolysis of RIG-I we performed electrophoretic
mobility shift assays (EMSAs), fluorescence anisotropy experiments and ATP hydrolysis assays in
presence and absence of ATP or ADPBeF3 with different RNAs. These RNAs mimic different types
of endogenous or viral RNAs and help dissecting contributions of RD’s binding to the RNA end and
SF2’s binding to the stem. In addition to a 24mer or 12mer blunt-ended dsRNA or ppp-dsRNA
(Goldeck et al., 2014), we also used a 60 nucleotide hairpin RNA (denoted as ES hairpin) derived
from the ribosomal expansion segment ES7L, which contains several bulges and a non-pairing end
(Figure 4—figure supplement 1A). The hairpin at one end and the added Y-structure at the other
end are used to minimize RNA end binding by RIG-I’s RD because RD has a high affinity for blunt
RNA ends.
RIG-I and RIG-I E373Q bound to the 24mer blunt ended dsRNA with a slightly higher affinity in
presence of ATP or ADPBeF3 than in its absence (Figure 4A), suggesting that ATP binding to the
SF2 domain positively contributes to the overall affinity in addition to RD. A similar result was
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Figure 3. RIG-I ATP hydrolysis defective mutant E373Q recognizes the 60S ribosomal subunit in vitro. (A) DRaCALA ATP binding assay of RIG-I or RIG-I
E373Q in presence or absence of RNA. (B) ATP hydrolysis assay of RIG-I or RIG-I E373Q in presence and absence of RNA. (C) Binding studies of human
80S ribosomes with RIG-I or RIG-I E373Q in presence or absence of ATP or ADPBeF3. Pre-formed complexes were separated on sucrose cushions via
ultracentrifugation and pellet (P) as well as supernatant (SN) fractions were analyzed by SDS-PAGE. (D) Side views of a cryo-EM reconstruction of RIG-I
E373Q (blue) bound to the human 80S ribosome (yellow: 40S subunit, gray: 60S subunit). Data was low pass-filtered at 15 Å. (E) Side views of a cryo-EM
reconstruction of the human 80S ribosome without prior RIG-I E373Q incubation. Data filtering and color coding as in panel D. (F) Statistical difference
map (left, s = 2) of cryo-EM reconstructions in panels D and E reveals a significant additional density at expansion segment 7L A (ES7L-A, pink) into
which RIG-I (PDB 3TMI) can be fitted (right, s = 1.51). (G) Secondary structure map of the 28S rRNA ES7L (derived from (Anger et al., 2013) and zoom
into RIG-I E373Q binding area. ES7L-A is indicated in pink (as in panel F).
DOI: 10.7554/eLife.10859.010
Lässig et al. eLife 2015;4:e10859. DOI: 10.7554/eLife.10859 8 of 20
Research article Cell biology Immunology
Publications
58
obtained when we used a 12mer dsRNA in fluorescence anisotropy experiments in order to further
dissect the influence of different RNA ends (Figure 4B). Interestingly, the positive effect of ATP was
not observed when we used the corresponding ppp-dsRNA 12mer (Figure 4C), most likely because
the RD dominates RNA binding under these conditions. Thus, it is plausible that RIG-I dissociates
from unphosphorylated RNA termini with an increased rate after ATP hydrolysis than from triphos-
phorylated termini.
We next tested the role of ATP on binding of wtRIG-I, RIG-I E373Q, RIG-I T347A,E373Q and the
SMS variant RIG-I C268F to the ES hairpin RNA mimicking the base of the ribosomal ES7L. In pres-
ence of ATP we observed moderately increased binding of RIG-I E373Q and of RIG-I C268F to this
hairpin, however wtRIG-I displayed a strikingly opposing effect (Figure 4D, Figure 4—figure supple-
ment 1C). For this RNA, ATP reduced rather than increased the affinity of wtRIG-I. The addition of
ADPBeF3 to RIG-I could reconstitute the high affinity state of RIG-I E373Q. The RIG-I T347A,E373Q
double mutant, on the other hand, showed binding affinities similar to RIG-I in presence of ATP,
probably caused by residual binding of RD (Figure 4D).
Consistent with this, the ES hairpin RNA could induce signaling in RIG-I E373Q transfected HEK
293T RIG-I KO cells (Figure 2F) and could also stimulate the ATPase activity of RIG-I 42CARD, and
to a lesser extent wtRIG-I (which is auto-inhibited by the 2CARD module) (Figure 5A, Figure 5—fig-
ure supplement 1A). A comparable stimulatory effect on the ATPase activity of RIG-I could also be
detected with whole human ribosomes (Figure 5A). Control assays with the ATP hydrolysis defective
mutants RIG-I E373Q and RIG-I T347A,E373Q confirmed the lacking ability of those proteins to
hydrolyze ATP even in the presence of triphosphorylated RNA (Figure 5A, Figure 5—figure supple-
ment 1B).
In summary, our results show that ATP hydrolysis leads to a moderately increased binding of RNA
containing base-paired ends, but decreased binding of RNA lacking base-paired ends. These in vitro
data are also consistent with our co-immunopurification studies of RNA from cells, where we
observed that the ATP hydrolysis deficient RIG-I E373Q mutant co-purified with increased amounts
of endogenous RNA.
Discussion
Here we show that mutations that slow down or inhibit RIG-I’s ATPase lead to an increased interac-
tion of RIG-I with endogenous RNA, including double-stranded RNA expansion segments of the
human large ribosomal subunit. Our results suggest that RIG-I’s ATPase confers specificity to viral
RNA by preventing signaling through the abundant background of self-RNA and provide a molecular
framework for understanding the pathology of atypical Singleton-Merton syndrome.
Recently, several autoimmune diseases, including the Aicardi-Goutières and Singleton-Merten
syndromes, have been linked to RLRs through whole exome sequencing, which discovered single
amino acid mutations that are mostly found within the ATPase domain of RLRs (Jang et al., 2015;
Rice et al., 2014; Rutsch et al., 2015). Increased interferon levels suggest that an increased activa-
tion of MDA5 or RIG-I underlies the molecular pathology of these diseases. Indeed we find that not
only E373Q, consistent with recent results, leads to an increased activation of RIG-I in non-infected
cells, but also the SMS mutations E373A and C268F (Jang et al., 2015) (Figure 1C). While this could
have been expected for E373A, because of its similarity to E373Q, the increased immunostimulatory
effect of C268F in motif I comes as a surprise. Prior mutations in motif I studied by others and us led
to an inactivation of RIG-I, rather than constitutive activation. The precise structural reason for the
increased signaling of C268F needs to be addressed in future studies, but our co-immunoprecipita-
tion and in vitro binding assay results suggest that this mutation may also lock RIG-I in an RNA-
bound, active conformation (Figure 2—figure supplement 1A, Figure 4—figure supplement 1C).
Mutational and biochemical analyses previously suggested a kinetic model for RIG-I’s specificity
towards viral RNA, where the ATP-dependent recycling helps to discriminate ppp-dsRNA from
endogenous RNA (Anchisi et al., 2015; Louber et al., 2015; Runge et al., 2014) (Figure 6A). Our
studies show that, in case of base-paired triphosphate containing RNA ends, the RIG-I RD dominates
binding. Although RIG-I’s ATPase is very active, we do not see a strong effect of ATP on the affinity
for the RNA (Figure 4C, Figure 5A). ATP hydrolysis may under the assayed conditions not efficiently
displace RIG-I from ppp-dsRNA because RD might prevent full dissociation even after ATP-hydrolysis
displaced SF2. Importantly, ATP reduces the affinity towards self-RNA containing a duplex region
Lässig et al. eLife 2015;4:e10859. DOI: 10.7554/eLife.10859 9 of 20
Research article Cell biology Immunology
2 ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA
59
Figure 4. RIG-I’s ATP hydrolysis enhances RNA end recognition and removes RIG-I from RNA stems. (A) Quantification of electrophoretic mobility shift
assays of RIG-I or RIG-I E373Q incubated with 24mer dsRNA in presence or absence of ATP, ADP or ADPBeF3 (compare with Figure 4—Figure
supplement 1B). (B) Fluorescence anisotropy changes measured by titrating RIG-I or RIG-I E373Q in presence or absence of ATP into solutions
containing fluorescently labeled 12mer dsRNA. (C) Fluorescence anisotropy changes measured by titrating RIG-I or RIG-I E373Q in presence or absence
of ATP into solutions containing fluorescently labeled 12mer ppp-dsRNA. (D) Quantification of electrophoretic mobility shift assays of RIG-I, RIG-I
E373Q or RIG-I T347A, E373Q incubated with an RNA hairpin derived from helix A of the human ribosome expansion segment 7L (ES hairpin) in
presence or absence of ATP, ADP or ADPBeF3 (compare with Figure 4—Figure supplement 1C). All binding curves were fitted using the LL.2 function
of the R drc package (Cedergreen et al., 2005). n=3-6, error bars represent mean values ± standard deviation.
DOI: 10.7554/eLife.10859.011
The following figure supplement is available for figure 4:
Figure supplement 1. Design of the ribosomal expansion segment derived hairpin RNA, EMSA raw figures and control experiments with RIG-I C268F
SMS mutant.
DOI: 10.7554/eLife.10859.012
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but not a “proper” ppp-dsRNA end (Figure 4D). Thus, if RD is unable to tether RIG-I to ppp-dsRNA
ends the ATPase could rapidly remove RIG-I from RNA duplex regions via its translocase and there-
fore prevents an autoimmune response towards self-RNA (Figure 6B). Our cellular studies are con-
sistent with this biochemical observation, because a point mutation in K888, a residue that is critical
for recognizing ppp-dsRNA ends, did not reduce the constitutive activation of ATP hydrolysis-defi-
cient RIG-I (Figure 1C). However, RD and ATP binding are clearly important for signaling, as shown
by 4RD and K270I mutations by us and others (Louber et al., 2015) (Figure 1C), suggesting that a
ring-like, ATP-bound structure is also involved in signaling caused by self-RNA (Figure 6C). In this
conformation, the RD likely helps to displace the 2CARD module from the SF2 domain but may not
have a high affinity for the RNA itself. Of note, the mutation in V699 of motif V also leads to
increased constitutive signaling (Figure 1C). A plausible explanation could be that this mutation in
RecA2 decouples RNA-binding induced ATP hydrolysis from translocation or displacement of RNA.
In summary, our results suggest a model where RIG-I’s translocase removes SF2 from dsRNA, per-
haps at nearby bulges, unless high-affinity binding by the RD on RNA ends containing di- or triphos-
phates tethers RIG-I despite ATP-hydrolysis and leads to repeated or prolonged exposure of the
2CARD module.
An unexpected finding was that trapping the ATP state of RIG-I leads to a particularly increased
interaction with the large ribosomal subunit via the expansion segment ES7L (Figure 3D, F). This
expansion segment is present in metazoan ribosomes, however its length is substantially increased
in human compared to drosophila ribosomes. The function of these expansion segments is not
understood, but since helix E (ES7L-E) was recently found to interact with the selenoprotein synthesis
factor SBP2, it is likely that the RNA in these elements is accessible to cytosolic proteins
(Kossinova et al., 2014). The specific enrichment of the large ribosomal subunit under conditions
where ribosomal subunits disengage argues for rather specific interactions of RIG-I E373Q with RNA
present on the large but not the small subunit. The dominant binding of ribosomes by RIG-I E373Q
can be explained by the high abundance of ribosomal RNA compared to other potential RIG-I
ligands in the cytosol. We could directly visualize RIG-I E373Q on the ribosome at the solvent
exposed root of ES7L-A (Figure 3F, G). This site contains a stretch of seven G:C/C:G base pairs,
which approximately matches the footprint of dsRNA across the two SF2 RecA domains in the crystal
structure of ADPBeFx-bound RIG-I (Jiang et al., 2011; Kohlway et al., 2013; Kowalinski et al.,
2011; Luo et al., 2011) and also meets the requirements for activation of RIG-I’s ATPase
Figure 5. RIG-I’s ATPase activity correlates with its RNA binding affinity. (A) Quantification of hydrolyzed [g-32P]ATP by RIG-I or RIG-I E373Q in presence
of different RNA substrates. Reactions were allowed to proceed for 20 min at 37 ˚C and free phosphate was separated from ATP via thin layer
chromatography. Spots corresponding to labeled ATP and labeled Pi were quantified using ImageJ. All curves were fitted using the LL.2 function of the
R drc package. n=3, error bars represent mean values ± standard deviation.
DOI: 10.7554/eLife.10859.013
The following figure supplement is available for figure 5:
Figure supplement 1. RIG-I’s 2CARD module reduces the ATP hydrolysis activity.
DOI: 10.7554/eLife.10859.014
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(Anchisi et al., 2015). Since 40% of the particles had this additional density, it is conceivable that
additional binding sites could contribute to the interaction with RIG-I E737Q as well. However, the
peripheral parts of the expansion segments are flexible and not visible in the 3D reconstructions,
preventing us from observing RIG-I at other regions.
The RNA corresponding to the observed binding region of ES7L-A is also bound by RIG-I in vitro
and can moderately stimulate RIG-I’s ATPase (Figure 4D, Figure 5A). The much more efficient stim-
ulation of RIG-I’s ATPase by ppp-dsRNA is likely due to the high affinity towards RD, which could
repeatedly “present” the RNA to SF2 (i.e. increasing the “local” concentration of RNA at SF2). Of
note, while the addition of ATP to RIG-I reduces the interaction with the ES hairpin RNA, consistent
with a role of the ATPase in preventing interaction with self-RNA, RIG-I E373Q binds with a moder-
ately increased affinity to the ES-hairpin RNA in presence of ATP. Because of the large number of
ribosomes in the cytosol it is therefore conceivable that RIG-I binds to double-stranded ribosomal
RNA, including ES7L-A, under conditions where the ATPase is not able to efficiently displace the
protein, such as those arising in patients with atypical SMS. In addition, the high local concentration
of ribosomes in polysomes as well as a potential binding of RIG-I to other expansion segments could
bring multiple RIG-I E373Q in contact, such that their exposed 2CARD module could interact for
downstream signaling (Peisley et al., 2014; Wu et al., 2014). We do not, however, want to rule out
contributions by other self-ligands as well. For instance, RIG-I can bind to endogenous mRNA
(Zhang et al., 2013) or RNase-L cleavage products (Malathi et al., 2007), while MDA5 was shown
to be activated by mRNA stem loop structures under conditions where reduction of A:T base-paired
RNA is not prevented by ADAR1 (Liddicoat et al., 2015).
In any case, there are two levels of control to limit RLR mediated signaling to viral RNA. On one
hand, RNA editing (Liddicoat et al., 2015) and methylation (Schuberth-Wagner et al., 2015) modi-
fies particular types of self-RNA that would otherwise form reasonable ligands for RIG-I or MDA5.
On the other hand, the intrinsic ATPase and translocase activity removes RLRs from short, but abun-
dant endogenous dsRNA stretches, thereby reducing background signaling and increasing the sensi-
tivity of the system.
Figure 6. Proposed model for impact of ATP on RIG-I signaling on different RNAs. (A) RIG-I recognizes tri- or diphosphorylated double-stranded RNA
and preferentially binds to the RNA end through its regulatory domain (RD, green). Binding of ATP-SF2 (purple) to the dsRNA releases the 2CARD
module (yellow) and activates the downstream signaling process. ATP hydrolysis displaces the SF2 domain from dsRNA leading to either rebinding at
the RNA end (tethered by RD) or to translocation along the RNA. (B) In healthy cells, sustained binding of RIG-I to self-RNA containing dsRNA stretches
is prevented by ATP hydrolysis. The SF2 domain can be sufficiently displaced because the RD does not provide a high affinity tether. (C) Mutations that
allow ATP promoted binding of dsRNA and displacement of the 2CARD module, but prevent ATP hydrolysis dependent dissociation of SF2 from
dsRNA, such as those underlying atypical Singleton-Merten Syndrome, will result in an unintended signaling through self-RNA.
DOI: 10.7554/eLife.10859.015
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Materials and methods
Cell lines, viruses and antibodies
Luciferase assays and RIG-I:RNA co-immunopurifications were carried out in HEK 293T cells (pur-
chased from ATCC, CRL-11268) or HEK 293T RIG-I KO cells (Zhu et al., 2014). HEK 293T ISRE-FF/
RFP reporter cells (stable expression of firefly luciferase and RFP under the control of an ISRE pro-
moter, kindly provided by Luis Martinez-Sorbid, University of Rochester, Rochester, NY) were used
for interferon stimulated luciferase reporter gene assays of recovered RNA. HEK cells were main-
tained in high glucose Dulbecco’s Modified Eagle Medium supplemented with GlutaMAX, pyruvate
and 10% FBS (all purchased from Gibco, UK). Human ribosomes were purified from HeLa S3 cells
cultured in SMEM (Sigma, Germany) supplemented with 10% FBS, Penicillin (100 U/mL)/ Streptamy-
cin (100 mg/mL) and 1x GlutaMAX (all purchased from Gibco, UK) using a spinner flask at 40 rpm. All
cell lines were routinely checked for Mycoplasms by PCR and were, except for the HEK 293T ISRE-
FF/RFP cell line, tested to be negative. Mycoplasm contaminations were suppressed using Plasmocin
(InvivoGen, France) according to the manufacturer’s protocol. Viruses used for infections were Sen-
dai virus Cantell, Sendai virus defective interfering particles H4 (kindly provided by Dominique Gar-
cin, Geneva, Switzerland), recombinant measles virus (MeV) with a sequence identical to the vaccine
strain Schwarz (AF266291.1.)(del Valle et al., 2007; Devaux et al., 2007) and recombinant MeV-
Cko-ATU-Cs. MeV-Cko-ATU-Cs expresses the C Schwarz protein from an additional transcription
unit (ATU) located between the M and the P gene, while expression of C from the P gene is abro-
gated. Specifically, three stop codons were introduced into the P gene for the C ORF while leaving
P and V protein expression intact. Cloning was done as described previously (Pfaller and Conzel-
mann, 2008; Sparrer et al., 2012). Additionally, an ATU was introduced between the P and M gene
by duplicating the gene borders of the P gene. The ORF of the C (Schwarz) protein was cloned into
that ATU and the virus rescued from cDNA using helper plasmids in 293-3-46 cells (Radecke et al.,
1995) and propagated on Vero cells as described previously (Parks et al., 1999; Pfaller et al.,
2014). Primary antibodies to human MDA5 (AT113) and RIG-I (Alme-1) were purchased from Enzo
Life Science (Loerrach, Germany). Antibodies to FLAG (M2), HA (HA-7) and b-tubulin (TUB 2.1) were
obtained from Sigma-Aldrich (Saint Luis, MO, USA). Secondary antibodies were supplied by GE
Healthcare (Buckinghamshire, UK).
Generation of RLR mutants
Sequences encoding full-length human RIG-I or MDA5 with N- or C-terminal FLAG/HA-tag were
cloned into pcDNA5 FRT/TO (Invitrogen, Carlsbad, CA, USA). Mutants were generated by site-
directed mutagenesis with PfuUltra polymerase (Agilent, Santa Clara, CA, USA).
Immunoprecipitation of RLR-associated RNA from infected or non-
infected cells
6x106 HEK 293T or HEK 293T RIG-I KO cells were transfected with 10 mg pcDNA5 vector coding for
different FLAG/HA tagged RLR proteins. Non-infected cells were harvested 24 h after transfection.
Infections were carried out 6h after transfection with an MOI of 0.05 for measles virus or high MOI
for Sendai virus and were allowed to proceed for 40 or 24 hr, respectively. Cells were harvested and
incubated in Nonidet P-40 lysis buffer (50 mM HEPES, 150 mM KCl, 1 mM NaF, 0.5% NP-40, 0.5
mM DTT, protease inhibitor (Sigma, Saint Luis, MO, USA), pH 7.5) for 10 min on ice. Lysates were
cleared by centrifugation and proteins were immunoprecipitated for 2.5 - –4 hr with anti-DDK mag-
netic beads (OriGene, Rockville, MD, USA) or anti-FLAG (M2) bound to magnetic protein G Dyna-
beads (Novex, Life Technologies, Carlsbad, CA, USA). Beads were washed five times with washing
buffer (50 mM HEPES, 300 mM KCl, 0.05% NP-40, 0.5 mM DTT, protease inhibitor, pH 7.5) and incu-
bated with proteinase K (Thermo Scientific, Vilnius, Lithuania) for 30 min at 50 ˚C. RNA was isolated
by phenol/ chloroform/ isoamyl alcohol extraction using Phase Lock Gel Heavy tubes (5
PRIME, Germany). The quality of the isolated RNA was validated on an Agilent RNA 6000 Nano
chip.
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Luciferase transfection assays
Immunoactivity experiments were carried out in 24-well plates seeded with 2.5105 HEK 293T RIG-I
KO or 2.5105 HEK 293T ISRE-FF/RFP reporter cells per well using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA, USA) as transfection reagent according to the manufacturer’s protocol. For down-
stream signaling assays HEK 293T RIG-I KO cells were co-transfected with 500 ng protein expression
vector, 100 ng p125-luc, 10 ng pCMV-RL and 50 ng empty expression vector. For RIG-I E373Q/RIG-I
D2CARD,E373Q competition assays HEK 293T RIG-I KO cells were co-transfected with 100 ng RIG-I
E373Q expression vector, varying concentrations of the RIG-I D2CARD,E373Q expression vector,
100 ng p125-luc and 10 ng pCMV-RL. DNA concentrations were held constant by adding empty
expression vector if necessary. For determination of the immunostimulatory potential of recovered
RNA from co-immunoprecipitations, HEK 293T ISRE-FF/RFP cells were transfected with 250 ng RNA
in Opti-MEM (Gibco, UK). For RNA stimulation of cells overexpressing RIG-I E373Q 2.5105 HEK
293T RIG-I KO cells were transfected with 100 ng RIG-I E373Q expression vector, 100 ng p125-luc,
10 ng pCMV-RL and 1000 ng total RNA/ rRNA or ES hairpin RNA in Opti-MEM. All cells were har-
vested 24 h after transfection using 200 mL PLB (Promega, Madison, WI, USA) and subjected to
immunoactivity experiments using the Dual-Glo luciferase assay system (Promega, Madison, WI,
USA) as previously described (Runge et al., 2014). The luciferase activity was determined with a
Berthold Luminometer in 96-well plates using 20 mL cell lysate.
Protein expression and purification
RIG-I and RIG-I E373Q were expressed and purified from insect cells as described previously
(Cui et al., 2008). Briefly, sequences encoding RIG-I were cloned into pFBDM vectors and trans-
formed into E. coli DH10MultiBac cells. Bacmids were extracted for transfection into SF9 insect cells
and propagated virus was used for protein expression in High Five insect cells. Seventy-two hours
after infection cells were harvested and flash frozen in liquid nitrogen. RIG-I D2CARD was expressed
in E. coli BL21 Rosetta (DE3), using pET expression vectors as described earlier (Cui et al., 2008). All
recombinant proteins were purified using metal affinity (QIAGEN, Germany), heparin affinity and gel
filtration chromatography (both GE Healthcare, Buckinghamshire, UK). Fractions containing RIG-I
were concentrated to 6 mg/mL and flash-frozen in liquid nitrogen.
Thermal unfolding assay
Thermal stability of RIG-I or RIG-I E373Q in presence or absence of ATP was analyzed by fluores-
cence thermal shift assays. Proteins (20 mM) were incubated in 25 mM HEPES pH 7, 150 mM NaCl,
10 mM MgCl2, 5 mM TCEP, 5% glycerol and 5 mM ATP. After addition of SYPRO orange (Invitro-
gen, Carlsbad, CA, USA, final concentration: 2.5x) the fluorescence signal was detected using a gra-
dient from 5 ˚C to 100 ˚C with 0.5 K/30 s and one scan each 0.5 K in a real-time thermal cycler
(Biorad, Germany, CFX96 touch) using the FRET mode.
Small-angle X-ray scattering
SAXS experiments were conducted at the PETRA3 P12 beamline of the European Molecular Biology
Laboratory/ Deutsches Elektronen-Synchrotron, Hamburg, Germany. Samples were measured in
absence or presence of 5 mM ATP in size exclusion buffer (25 mM HEPES pH 7, 150 mM NaCl, 5
mM MgCl2, 5 mM b-Mercaptoethanol, 5% glycerol). RIG-I samples were measured at protein con-
centrations of 1.28, 2.65 and 8.35 mg/mL and RIG-I E373Q samples with concentrations of 0.87,
2.13 and 6.84 mg/mL. The respective scattering of the corresponding buffer was used for buffer sub-
traction. The samples did not show signs of radiation damage, which was assessed by automatic and
manual comparison of consecutive exposure frames. The data was processed using PRIMUS from
the ATSAS package (Konarev et al., 2006) and the radius of gyration was determined by Guinier
plot [ln I(s) versus s2] analysis obeying the Guinier approximation for globular proteins (s x Rg < 1.3).
Human 80S ribosome preparation
HeLa S3 cells were harvested (2 min, 650 x g), washed with PBS (Invitrogen, Carlsbad, CA, USA) and
incubated with 1.5x vol Buffer 1 (10 mM HEPES/KOH, pH 7.2/4 ˚C, 10 mM KOAc, 1 mM Mg(OAc)2
and 1 mM DTT) for 15 min on ice, followed by disruption with nitrogen pressure (300 psi, 30 min, 4
˚C) in a cell disruption vessel (Parr Instrument, Moline, IL, USA). The cell lysate was cleared (10 min,
Lässig et al. eLife 2015;4:e10859. DOI: 10.7554/eLife.10859 14 of 20
Research article Cell biology Immunology
Publications
64
14,000 rpm, Eppendorf 5417R, 4 ˚C) and the resulting supernatant was loaded onto a sucrose cush-
ion (Buffer 1 supplemented with 35% sucrose). Subsequent spinning (98 min, 75.000 rpm, TLA
120.2, 4 ˚C) was performed. After resuspension of the ribosomal pellet, a high-salt purification by
centrifugation through a 500 mM sucrose cushion (50 mM Tris/HCl, pH 7.0/4 ˚C, 500 mM KOAc, 25
mM Mg(OAc)2, 5 mM b-mercaptoethanol, 1 M sucrose, 1 mg/mL cycloheximide and 0.1% Nikkol)
was conducted (45 min, 100,000 rpm, TLA120.2, 4 ˚C). The ribosomal pellet was resuspended in
Ribosome Buffer (50 mM Tris/HCl, pH 7.0/4 ˚C, 100 mM KOAc, 6 mM Mg(OAc)2, 1 mM DTT, 1/200
EDTA-free Complete protease inhibitor (Roche, Germany), 0.2 U/mL RNasin (Promega, Madison, WI,
USA)), quickly centrifuged, frozen in liquid nitrogen and stored at -80 ˚C.
Total RNA and ribosomal RNA isolation
For total RNA isolation 2.5 x 105 HEK 293T were seeded per well of 24 well plates. After 24 h cells
were harvested in PBS, collected by centrifugation and lysed in Nonidet P-40 lysis buffer for 10 min
on ice. Supernatant was cleared by centrifugation and DNA was digested with TURBO DNase
(Ambion, Life Technologies, Carlsbad, CA, USA) for 3 min at 37 ˚C. Proteins were digested and RNA
was extracted as described above. For ribosomal RNA isolation purified human ribosomes were pro-
teinase K digested and RNA was extracted accordingly.
Ribosomal binding studies
Human 80S ribosomes were incubated with or without 2.5x molar excess of RIG-I or RIG-I E373Q in
binding buffer (50 mM HEPES/KOH, pH 7.5/ 4 ˚C, 100 mM KCl, 2.5 mM Mg(OAc)2, 2 mM DTT, 1
mM ATP, 0.1% DDM, 10% Glycerol) for 15 min at room temperature and then for 15 min at 4 ˚C.
The mixture was loaded onto a sucrose cushion (binding buffer with 750 mM sucrose) and spun (3 h,
40,000 rpm, SW55Ti, 4 ˚C). Supernatant and pellet fractions were separated and TCA precipitated.
The resulting samples were analyzed by SDS-PAGE and visualized using SYPRO Orange
Staining (Molecular Probes, Eugene, OR, USA).
Cryo-grid preparation
5 OD/mL human 80S ribosomes were incubated with or without 2.5x molar excess of RIG-I E373Q.
Each sample (50 mM HEPES / KOH, pH 7.5 / 4 ˚C, 100 mM KCl, 2.5 mM Mg(OAc)2, 2 mM DTT, 1
mM ATP, 0.1% DDM, 5% glycerol) was applied to 2 nm pre-coated Quantifoil R3/3 holey carbon
supported grids and vitrified using a Vitrobot Mark IV (FEI Company , Germany).
Cryo-electron microscopy and single particle reconstruction
Data were collected on a 120 keV TECNAI SPIRIT cryo-electron microscope with a pixel size of 2.85
Å/pixel at a defocus range between 1.4 mm and 4.6 mm (with RIG-I E373Q ligand) or between 1.8
mm and 5.3 mm (without ligand) under low dose conditions. Particles were detected with SIGNATUR-
E (Chen and Grigorieff, 2007). Initial alignment resulted in 61,067 particles (with ligand) and 29,959
particles (without ligand). Subsequent data processing and single particle analysis was performed
using the SPIDER software package (Frank et al., 1996). Non-ribosomal particles (19,080 particles,
31% (with ligand) and 10,663 particles, 35% (without ligand)) were removed from each data set by
unsupervised 3D sorting (Loerke et al., 2010). The remaining particles were further sorted, resulting
in a volume with additional density (with ligand: 23,715 particles, 39% ). The identical sorting scheme
was applied to the control 80S ribosome without ligand, resulting in final 11,727 particles (39% ).
The final 80S structures with and without ligand were refined to an overall resolution (FCS0.5) of 17.7
Å and 21.9 Å, respectively. For comparison of the two final volumes, a statistical difference map
between the two reconstructions was calculated.
Figure preparations and model docking
We used the crystal structure of the human RIG-I protein (PDB code 3TMI) (Jiang et al., 2011) and
the human ribosome (PDB 4V6X) (Anger, et al., 2013) for rigid-body fitting into the additional den-
sity. Figures depicting atomic models with and without density were prepared using UCSF Chimera
(Pettersen et al., 2004).
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Differential radial capillary action of ligand assay
ATP binding was determined by DRaCALA using [a-32P]ATP (Hartmann Analytik, Germany). 12 mM
RIG-I or RIG-I E373Q were incubated in 50 mM HEPES, pH 7.5, 150 mM KCl, 5 mM MgCl2, 2.5 mM
TCEP, 0.1 mg/mL BSA supplemented with 2.5 nM [a-32P]ATP for 10 min at room temperature in
presence or absence of 100 nM RNA. 2.5 mL of reaction mixture was spotted on nitrocellulose mem-
branes (0.22 mM pores, GE Healthcare, Buckinghamshire, UK), air-dried and [a-32P]ATP was detected
using a phosphor-imaging system (GE Healthcare, Germany).
Electrophoretic mobility shift assay
Proteins at different concentrations were pre-incubated with ATP, ADP or ADPBeF3 (all 3 mM end
concentration, ADPBeF3 was generated using ADP, NaF and BeCl2 in a 1:1:5 molar ratio) and added
to 0.5 mM ES hairpin RNA or 0.2 mM 24mer RNA in EMSA buffer (50 mM Tris pH 7.5, 50 mM KCl, 5
mM MgCl2, 5 mM TCEP, 7.5 mM ZnCl2, 3 mM ATP, 5% glycerol). Reactions were incubated for 20
min at 37 ˚C. Samples were separated on TB agarose gels (89 mM Tris, 89 mM boric acid, 0.8% aga-
rose) and stained with Gel-Red (Biotium, Hayward, CA, USA). Unbound RNA bands were quantified
with ImageJ.
Fluorescence anisotropy assays
Different RIG-I or RIG-I E373Q protein concentrations were titrated into EMSA buffer without ATP
and glycerol. Reactions were started by addition of 5 mM ATP and 20 nM Cy3- or Cy5-labeled RNA
and fluorescence anisotropy was measured with a TECAN M1000 plate reader after incubation at
room temperature for 20 min.
ATPase hydrolysis assays
ATPase hydrolysis activity was determined using [g-32P]ATP (Hartmann Analytik, Germany). Proteins
at different concentrations were pre-incubated with 100 nM RNA or purified ribosomes for 10 min at
room temperature in EMSA buffer without ATP. The reaction was initiated by addition of 1.5 mM
unlabeled and 10 nM [g-32P]ATP and incubated for 20 min at 37 ˚C. Free phosphate was separated
from ATP by thin layer chromatography in TLC running buffer (1 M formic acid, 0.5 M LiCl) on polye-
thyleneimine cellulose TLC plates (Sigma-Aldrich, Germany). [g-32P]Pi and [g-
32P]ATP were detected
using a phosphor-imaging system (GE Healthcare, Germany) and quantified using ImageJ.
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1 Discrimination of self vs non-self by RIG-I and MDA5
1.1 What are physiological ligands of RIG-I and MDA5?
One of the main unsolved questions within the field of RIG-I like receptors is still addressing in vivo
occurring ligands of RIG-I and MDA5. Even though several in vitro experiments successfully defined
optimal RNA substrates for both proteins, data under infectious conditions are so far only sparse and
often raise more questions than they answer. Regarding the present knowledge, how do RIG-I and
MDA5 ligands look like? When, if ever, do they occur in vivo? And how does the cell protect itself
from generating these ligands?
Optimal RIG-I ligands are described as short blunt-ended dsRNA containing 5′ tri- or diphos-
phates265,266. Naturally such RNAs could occur within the nucleus, but are typically masked be-
fore they are transported to the cytosol. mRNAs modifications that are believed to abolish cytosolic
immune activation include capping of the 5′ end with a guanosine residue methylated at N7, and
methylation of the first 5′ nucleotide ribose267. Methylation of the 5′ cap is mainly important for
translation initiation and was recently shown to only partly suppress RIG-I activation105. This is due
to the flexible incorporation of the cap within RIG-I‘s CTD where contacts to the RNA were demon-
strated to be limited to theα and β-phosphates105,109. In this regard, capped but unmethylated RNA
have been shown to fully activate RIG-I similar to non-capped triphosphorylated RNA105 (compare
to Figure 4). Methylation of the first 5′ nucleotide however, effectively inactivates RIG-I-dependent
signaling by introducing a steric clash with the CTD105. This efficiently prevents binding of RIG-I to
folded mRNA 5′ ends or even capturing of mRNAs by the RIG-I CTD. Other potential endogenous
ligands like tRNAs are cleaved to produce 5′ monophosphate ends268 and ribosomal RNA is mainly
masked by ribonucleoprotein complexes and modified ribonucleotides. Furthermore, miRNAs and
siRNAs generated by Dicer have a characteristic 2 nucleotide 3′ overhang which is unfavorable for
RIG-I end recognition269.
During viral infections however, viruses often fail to entirely mask their own RNA and thereby pro-
duce species that can be detected by RLRs. Potential RIG-I ligands are the incoming viral genome in
the first place105,117, but as well replication intermediates or defective interfering genomes harbor-
ing 5′ triphosphates119,135. Nevertheless, more and more evidence, including our own study, also
points towards 5′ triphosphate independent recognition of viral RNA like internal mRNAs regions
and parts of the 3′ UTRs114,122,123,135. In this regard, also short RNAs generated by RNase L through
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cleavage of U-rich cytosolic RNA have been described as RIG-I ligands115,116.
Sensing of these ligands happens primarily via a basic surface on the RIG-I CTD and its RNA end-
capping loop that provides a strong specificity towards the di- or triphosphate. However, also other
RIG-I domains help ensure specificity: The CARDs:domain 2b interface aids in discriminationof blunt-
ended and non blunt-ended dsRNA or ssRNA, since it prevents the generation of productive pro-
tein:RNA complexes that do not have a high affinity tether towards the CTD108,109. In addition, the
SF2 helicase domain lowers the general affinity towards dsRNA stems, thereby raising the specificity
towards RNA ends as well (discussed in detail in discussion section 2).
The optimal MDA5 ligand, on the other hand, is long dsRNA without bulges and regardless of the
presence of a tri- or diphosphate end270. The more general appearance of MDA5 ligands without a
characteristic feature like phosphate-containing ends, as for instance RIG-I ligands have, renders this
RLR more prone to the recognition of endogenous RNA. Most cellular RNAs, however, only contain
short dsRNA regions and even if longer parts occur, base pairing is effectively destabilized by con-
verting adenosine ribonucleotides to inosine by ADAR1234. This is further supported by the fact that
loss of A-to-I editing results in embryonic death through the induction of an autoimmune response
against self-RNA by MDA5235. Other potential endogenous MDA5 ligands could arise from short
interspersed nucleotide elements (SINEs) like repetitive Alu elements that constitute up to 10% of
the human genome and that can occur within introns or other non-coding regions of transcripts271.
Alu elements are approximately 300 bases long, contain an A-rich region and are, if present within
inverted repeats, ideal MDA5, but also ADAR, substrates272. A-to-I editing and the subsequent loss
of base pairing might therefore prevent MDA5-dependent signaling.
Consistent with the preference for long dsRNA stems, viral MDA5 agonists have been found to be for
instance the replicative form of viruses273. Furthermore, and similar to RIG-I, several sense or anti-
sense transcripts were found to be recognized in virus-infected cells by deep sequencing of MDA5
associated RNA95,123,135. However, since MDA5 does not signal on ssRNA, the identified transcripts
might harbor yet unrecognized double-stranded regions. With conventional RNA folding software,
nevertheless, so far no connection between length of potential dsRNA parts and sequencing reads
could be established, leaving room for speculations about non-cooperative MDA5 binding and sig-
naling.
In addition, besides RNA length, also AU composition of viral RNA was suggested to have an influ-
ence onMDA5 recognition135. In the same context, also an decreased ATPase activity ofMDA5 upon
recognition of AU-rich transcript was found. Since so far no base-specific recognition ofMDA5 could
be detected within any structural protein analysis, one could speculate, that less stable AU-rich se-
quencesmightmore likely partiallymelt, leading to a slow-down ofMDA5 translocation. Hereof, any
RNA structure that disfavors ATP hydrolysis by at the same time preserving RNA binding might lead
to prolonged protein:RNA interactions and therefore to increased immune signaling. Nevertheless,
the exact mechanism of MDA5 signaling on shorter dsRNA stems still remains to be analyzed.
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1.2 Is RIG-I’s CTD able to bind dsRNA stems?
A still controversial question within RIG-I in vivo-functioning concerns the ability of the protein to
bind dsRNA stems similar to MDA5. This, however, is a prerequisite for translocation or binding at
internal dsRNA parts without proper end. Whereas different crystal structures of RLRs show interac-
tions of the SF2 domain exclusively with the RNA backbone, the relative CTD position
varies60–62,109,144,145. All so far published RIG-I:RNA complexes show an RNA end-capping mode
of RIG-I’s CTD via a positively charged loop that encloses the phosphate groups and stacks to the
terminal base pair61,109. For MDA5, on the other hand, data showing both RNA end-binding as well
as recognition of the dsRNA stem are available144,145. In all MDA5:RNA crystal structures, however,
the end-capping loop, is found to be disordered. This might be convincing since, the end-capping
loop of MDA5, contrary to RIG-I, lacks the aromatic amino acids required for base stacking of the
RNA end as well as the lysines contacting the phosphates. This suggests, that when MDA5 accom-
modates dsRNA stems, this loop has an increased flexibility compared to the end-capping loop of
RIG-I.
NMR titration experiments of dsRNA to isolated RIG-I and MDA5 CTDs further report different bind-
ing modes of these domains146,274: Whereas in solution, the RIG-I CTD was found to bind RNA ends
via the end-capping loop as well, the MDA5 CTD was shown to sequester the dsRNA stem via its flat
surface. Further, biochemical assays and electron microscopy confirm MDA5 stem binding on long
double-stranded RNA130,149 and the preference of RIG-I for (phosphorylated) dsRNA ends102,103.
However, all isolated CTDs are found to adopt similar conformations in solution if no RNA is bound
(Figure 17)146,274, arguing for an intrinsic flexibility of the CTDs that might allow different confor-
mations according to the appropriate RNA substrate. More and more recent data also point to the
ability of RIG-I to translocate and oligomerize on dsRNA stems110,198,199. Co-immunoprecipitation
studies of RIG-I from different virus-infected or uninfected cells further identified binding sites dis-
tant from dsRNA-ends indicating that RIG-I might indeed be able to bind dsRNA stems123,135,275. A
RNA end 
capping loop
Figure 17: Comparison of RIG-I (cyan, RCSB PDB code 2rmj, human) and MDA5 (gray, RCSB PDB code 2rqb,
human) CTD NMR structures in solution without presence of RNA. Each 4 out of 20 NMR structures
are depicted. The overall root mean square deviation of all RIG-I structures compared to all MDA5
structures equals 2.5 Å as calculated with pymol.
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binding mode of the RIG-I CTD similar to the MDA5 CTD might thus be conceivable, but would need
to shift the whole domain towards the dsRNA stem followed by an enforced alteration within the
RNA capping loop. Nevertheless, structural data supporting the RIG-I stem binding hypothesis are
mostly lacking.
In the same regard, also the RIG-I footprint is currently not exactly known and ranges from 8 to 10
nucleotides depending on the crystal structure61,113. Otherwise, RIG-I‘s footprint was suggested
to be as small as 6 to 7 nucleotides as known for other SF2 helicases276. In vitro studies further
showed, that even though an 8mer ppp-dsRNA is stably bound by RIG-I via the SF2 helicase domain
and CTD, the CARD2:domain 2b interface is not allosterically disrupted106. Since those experiments
where done in absence of ATP, however, one cannot exclude that ATP binding-dependent structural
changes might reduce a potential footprint below 8 nucleotides. The structural integrity of such an
RNA under in vivo temperature conditions however remains questionable.
Nevertheless, knowledge of the precise minimal binding unit of RIG-I on RNA might help design
dsRNA oligos suitable to address questions concerning a RIG-I RNA-stem binding mode.
2 What role has ATP in RIG-I-like receptor signaling?
Another question in the field of RLRs addresses the SF2 domain and its ATPase function upon binding
to double-stranded RNA.Why do RLRs hydrolyze ATP?Would it not be easier to just release the CARD
domains as soon as a suitable ligand is found? Already with the discovery of RIG-I it became clear,
that blocking of the ATPase function impedes signaling of the protein72. But how is an immune
response triggered by RIG-I connected to the ability to hydrolyze ATP? And is it the same for MDA5?
Nevertheless, despite intense biochemical and cellular studies over the last years, the exact function
of the RLR ATPase domain remained puzzling and only recently it started to be understood.
Several RIG-I constructs co-crystallizedwith different ATP analogues or ADP and RNA captured differ-
ent protein conformations during the ATP hydrolysis cycle (Figure 18). Thereby, the main difference
in all RIG-I structures is due to different orientations of both domain 1a and 2a to each other depend-
ing on the usedATP analogue. This apparentmovement of the SF2 domain is further accompanied by
changes of the orientation of the insertion domain 2b. The RIG-I CTD however, is so far only caught
in one distinct orientation relative to the dsRNA, independent of the presence of a triphosphate or
other dsRNA termini.
Recently, three independent groups, including us, dissected the role of ATP binding vs. ATP hydrolysis
for the RIG-I immune response by mutating different key amino acids in the Walker A and B motifs,
respectively275,277,278. Thereby, theWalker Amotif lysine (RIG-I K270) was exchanged to a neutral or
even acidic amino acid (e.g. alanine, isoleucine or glutamic acid) in order to decrease ATP binding.
The ATP bound state, in contrast, was assessed by disturbing the activation of the catalytic water
through conversion of a glutamic acid residue of the Walker B motif to glutamine. Thus magnesium
binding by neighboring Walker B residues as well as ATP binding stays intact, but ATP hydrolysis is
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Figure 18: Residues involved in coordination of ATP during different states of hydrolysis in RIG-I. ADP·BeF3
(RCSB PDB code 3tmi, human) resembles the ATP bound state, ADP·AlF3 (RCSB PDB code 4a36,
duck) corresponds to the ATP hydrolysis transition state and ADP (RCSB PDB code 3zd7, human)
resembles the reaction product state.
slowed down. This is in contrast to the earlier used aspartate mutation within Walker B motifs that
mainly disturbs magnesium ion coordination: Loss of magnesium within the ATP binding pocket,
however, disturbs ATP binding as well and therefore is indistinguishable to a Walker A mutation.
Interestingly through different experiments all three studies showed, that ATP binding and hydrolysis
for RIG-I and MDA5 have opposing cellular effects: Recognition of both RNA and ATP by RIG-I, or
RNA only by MDA5, are sufficient to induce signaling. ATP hydrolysis, in contrast, destabilizes the
RLR:RNA complexes and leads to RNA disengagement of the SF2 helicase domain, thereby testing
the substrate interactions with the CTD106,275,277.
2.1 RNA and ATP binding liberate the RIG-I CARDs, whereas MDA5 activation needs
RNA only
Blocking of ATP binding in RIG-I through a Walker A lysine mutation in cellular studies with over-
expressed proteins resulted in reduced or abrogated signaling even in presence of stimulating RNA
or Sendai virus defective interfering genomes275,277,278. Interestingly, ATP binding assays of RIG-I
K270A/R mutants showed an only two-fold reduced affinity of the protein towards ATP, whereas
hydrolysis activity was abolished as expected278. RNA binding properties, in contrast, are not al-
tered73,279. Immune response signaling on the other hand, as monitored by IRF3 dimerization as
well as binding of free ubiquitin chains was shown to be prevented in cell-free systems mimicking
viral infections168. Thus abrogation or impeding of ATP binding leads to loss of immune signaling,
probably though disrupted CARDs release, even in presence of bound RNA. In accordance with this,
published crystal structures of RIG-I:RNA complexes bound to ADP with an open helicase state280
as well as RIG-I with sequestered CARDs to domain 2b61 can be superimposed without introducing
any clash between different domains192.
Contrary to RIG-I, the MDA5 CARDs do not entirely fold back to domain 2b and are already partially
released even without binding to RNA and ATP as shown in SAXS and deuterium exchange measure-
ments106,149. Further, overexpression of MDA5 in cells is already sufficient to induce signaling73.
75
Discussion
Full activation of an immune response by MDA5 is nevertheless dependent on cooperative MDA5
oligomerization on long dsRNA stretches130.
The function of ATP binding in MDA5 signaling might thus differ from RIG-I. In accordance with this
and contrary to RIG-I, mutations that disrupt ATP binding are shown to result in constitutive signal-
ing200,277. This can be reversed, similar to RIG-I, by additionally disrupting RNA binding sites within
the MDA5 SF2 like helicase domain or by abrogating the RNA driven self-assembly of MDA5277. In-
terestingly, a doublemutation of theWalker Amotif aswell as an RNAbinding residuewithin the CTD
cannot impede signaling, emphasizing a comparably smaller contribution of theMDA5 CTD towards
RNA binding.
2.2 ATP hydrolysis by RIG-I and MDA5 impedes signaling on endogenous RNA
Recently, the ATP hydrolysis activity of MDA5’s and RIG-I’s SF2 helicase domains was found to be
required to avoid activation by self-RNA275,277,278. In this regard, RIG-I shows enhanced dissociation
kinetics for varying RNA substrates already in presence of ADP or the non-hydrolyzable ATP analogue
ATPγS in vitro278.
RIG-I trapped in the ATP bound state, in contrast, constitutive signaled in cellular overexpression
studies regardless if cells are stimulated with RIG-I ligands or not275,277. Signaling is dependent on
RNA binding, since the additional insertion of RNA binding mutations in both helicase or CTD results
in loss of signaling275,277. Structural changes of the protein that could result in constant CARDs-
release without RNA stimulus were ruled-out by SAXS and thermofluor experiments as well as by
cellular competition assays with a CARD-less RIG-I construct. Furthermore, co-immunoprecipitation
studies revealed an expansion segment of the large ribosomal subunit as a possible abundant en-
dogenous ligand, that might be responsible for the immune response275. The relevance of this
ligand was further highlighted by transfection into ATPase-deficient RIG-I-expressing cells. Simi-
lar to triphosphorylated dsRNA, this endogenous ligand further enhanced the cell´s immune re-
sponse275,277. Nevertheless, the idea that RIG-I could not signal from internal duplexes, since they
would not efficiently displace the CTD in order to induce a clash with the CARDs278, cannot entirely
be rejected: Even though in vitro and cellular studies confirm binding of RIG-I in absence of ATP or in
presence of an ATP analogue to the dsRNA stem, there is still the possibility, that signaling in cellular
assays in fact relies on other endogenous ligands that are recognized as well. Further, increased sig-
naling upon transfection of this RNA into RIG-I Walker B mutant-stimulated cells could be induced
due to any other upregulated ISG.
Nevertheless, even though nucleotide binding lowers the RIG-I affinity for RNA substrates, it seems
not to be enough to restrict activation of an immune response in cells. Therefore, ATP hydrolysis
provides the important mechanisms to avoid signaling on endogenous RNA.
An explanation might be, that ATP hydrolysis contributes a proof reading mechanism, that recycles
RIG-I on triphosphorylated RNA ends or promotes its dissociation from supposedly non-pathogenic
RNA111,275,277,278. The CTD of RIG-I might thus serve as an anchor towards tri- or diphosphorylated
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dsRNAs, whose binding strength to the protein is constantly challenged by the SF2 helicase domain
which in turn weakens the interactions with the RNA stem111. By that, ATP hydrolysis of RIG-I en-
hances specificity towards viral dsRNA and reduces background binding to endogenous RNA. Ac-
cordingly, loss of this feature, like e.g. observed in atypical SMS patients, results in the development
of autoimmune diseases against cytosolic self-RNA247.
MDA5 signaling in contrast is independent of ATP binding, since both ATP binding and ATP hydrolysis-
deficient mutants were found to induce a constitutive immune response277. Nevertheless, in vitro
filament formation of MDA5 was shown by electron microscopy to be stabilized in presence of the
ATP analogue ADP·AlFx 281 and in addition ATPase-deficient MDA5 co-purifies with the big riboso-
mal subunit275. Similar to RIG-I, ATP hydrolysis of MDA5 thus seems to be important to disengage
MDA5:RNA complexes and to prevent a continuous response149. Thereby contrary to RIG-I, not the
MDA5 CTD provides the RNA anchor but rather oligomerization on long RNA stems provides the
stability needed for signaling.
2.3 ATP influences LGP2’s regulatory function
In contrast to MDA5 and RIG-I, only limited data concerning the ATP dependency of LGP2 is avail-
able. LGP2 is thought to possess regulatory functions in RLR signaling in general170. Cellular over-
expression assays showed, that low amounts of LGP2 enhance MDA5-dependent signaling, while
higher levels of LGP2 inhibit an immune response of both RIG-I and MDA594,281. The increase of
MDA5-dependent signaling through LGP2 is realized by attenuating the length ofMDA5filaments281.
These shorter, but more numerous polymers seem to have higher signal-transducing abilities than
longer filaments. Interestingly, LGP2’s positive regulatory role depends on the availability of ATP,
since ATP binding-deficient LGP2 (Walker A mutant) only retains the ability to inhibit signaling at
higher concentrations97,281. In addition, the LGP2 Walker A mutant severely suppresses RIG-I sig-
naling even upon transfection with RIG-I ligands281.
Since LGP2 lacks the CARDs for immune response signaling, an ATP binding-dependent molecular
switch, similar to RIG-I, upon RNA binding might not be necessary. Rather ATP hydrolysis could be
important to destabilize the protein:RNA interactions, as in the case of RIG-I and MDA5. This might
allow either translocation on long dsRNA and thereby aid in MDA5 cooperative binding, or enhance
RNA end recognition in order to turn off an RIG-I mediated immune response282. Further, LGP2 was
found to have increased RNA recognition abilities in presence of ATP in vitro98. This could have a
broad effect on different cellular RNAs as well, thereby affecting both RIG-I and MDA5 during later
stages of infection and in the presence of higher cellular levels of LGP2.
In addition, ATP hydrolysis might drive effector like functions of LGP2 similar to those suggested for
RIG-I and MDA5200 in order to release dsRNA-bound viral factors or even other RLRs and to stop an
immune response.
Nevertheless, the effect of ATP onto LGP2’s regulatory function is so far less understood and requires
further analysis.
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3 Translocation of RLRs: a model based on the Hepatitis C virus NS3
protein
Related to the ability of RLRs to hydrolyze ATP and due to their assignment to Superfamily 2 helicases,
another question concerning their ability to move on RNA emerged. Are RLRs able to translocate
on dsRNA? Biochemical studies, mainly conducted on RIG-I, suggested that it binds via the CTD to
the 5′ triphosphate end of dsRNA and then subsequently moves into the RNA interior in an ATP-
dependent manner110,198,199. This process might be required to achieve oligomerization of several
RLRs on one RNA molecule in order to induce the spatial proximity of the RLR CARDs that is needed
for their tetramerization and the subsequent signal transfer. Further, as mentioned, translocation-
dependent effector-like functions of RIG-I andMDA5have been described, proposing a displacement
of bound proteins or a remodeling of RNA structures200.
Nevertheless, the structural basis for an ATP-dependent translocation of RLRs is still lacking. In order
to overcome these limitations, a comparison to other SF2 proteins can be done. In this context, one
of the best studied SF2 helicases is the viral non-structural protein 3 (NS3) of which structural data on
proteins of different viruses, including Dengue virus, Yellow fever virus, Murray Valley encephalitis
virus and Hepatitis C virus (HCV), are available283–289. Especially in case of the HCV NS3 protein,
a precise model can be established based on several biochemical assays combined with structural
data of the protein bound to nucleic acids and varying nucleotide analogues representing different
ATP hydrolysis states.
The HCV NS3 protein consists of an N-terminal serine protease as well as a C-terminal helicase do-
main290. The helicase domain contains, similar to the corresponding domain of RLRs, two RecA-like
domains (domains 1 and 2, corresponding to domains 1a and 2a of RLRs, see Figure 19), between
whose interfaces a nucleotide binding pocket is formed, as well as anα-helical domain 3. In contrast
to RLRs, the NS3 helicase domain can hydrolyze any nucleotide upon nucleic acid binding and further
has no preference for DNA or RNA substrates291–293.
Based on biochemical and structural studies, a canonical translocation and unwinding mechanism
has been proposed. According to the model, NS3 binds to single-stranded regions of nucleic acids
and then translocates in anATP-dependentmanner nucleotide-wise in 3′ to 5′ until it reaches double-
stranded regions. Duplexes are subsequently unwound by a ”spring-loaded” mechanism after each
3 cycles of ATP hydrolysis via the α-helical domain of NS3294. Mechanistically, domains 1 and 2 step
from 3′ to5 ′direction into the duplex interior, whereas the α-helical domain 3 lacks behind, stays
placed at the double-stranded end and accumulates tension towards the protein:nucleic acid com-
plex. After three nucleotide steps, i.e. three cycles of ATP hydrolysis, the created tension reliefs in a
burst of 3 base pairs unwinding.
Themovement of NS3 on the nucleic acid backbone can be linked to different ATP hydrolysis states of
the protein288: In the ATP-unbound state, the NS3 domains 1 and 2 form an open nucleotide binding
cleft. Domain 1 contacts the nucleic acid backbone phosphates (p) 1 and p2 (counted from 3′ direc-
tion), wheres domain 2 captures p3 to p5. Upon binding of ATP to NS3 (which is resembled by the
ADP·BeF3-bound state) domain 1 moves one nucleotide towards domain 2, now interacting with p2
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Figure 19: Structure and sequence alignment of the SF2 domains of human RLRs and the Hepatitis C virus NS3
protein. (A) Comparison of the RIG-I RecA-like domains 1a and 2a (RCSB PDB code 4a36, duck RIG-I
helicase domain) to the NS3 domains 1 and 2 (RCSB PDB code 3kql, HCV NS3). Accessory domains
as well as the second RNA strand within the RIG-I structure are hidden for comparison purposes.
(B) Sequence alignment of RLRs and HCV NS3 based on a structure alignment of RIG-I and NS3
using pymol. Conserved motifs involved in ATP binding and hydrolysis are marked in red, motifs
involved in RNA binding are depicted in green and motifs involved in coupling of ATP hydrolysis to
RNA binding are shown in orange (compare with Figure 13).
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and p3, whereas domain 2 looses the contact to p3. During the ATP transition state (ADP·AlF3-bound
state), the distances between domain 1 and the nucleic acid are rearranged, stabilizing the inter-
actions to p2 and p3 via new hydrogen bonds. ATP hydrolysis leads to re-opening of the helicase
domain cleft and thereby shifts domain 2 into 5′ direction to phosphates p4 to p6.
Since key residues involved in nucleotide hydrolysis, nucleic acid binding and translocation are con-
served in SF2 proteins, a similar translocation mechanism might occur in RLRs. In addition, even
though RLRs signal only upon binding to double-stranded nucleic acids, domains 1a and 2a almost
exclusively contact the bottom RNA strand and could therefore perform a similar movement like
NS3. Concerning RIG-I, several binary and ternary structures co-crystallized with RNA and different
ATP analogues are available as well. Alignment of these structures based on domain 1 as well identi-
fies movements within the SF2 domain (Figure 20). Interestingly and opposed to NS3, regardless of
the co-crystallized nucleotide, no shift of domain 1 relative to the RNA strand is visible. The reason
for this could be the high affinity anchor of the CTD, which might relocate the SF2 domain towards
the RNA end. The lack of translocation by domain 1a upon ATP binding, however, is compensated
by a shift within domain 2a motif V (Figure 20 residues V699 and T697). Yet, in accordance with
NS3, nucleotide binding seems to destabilize RIG-I:RNA interactions as well, as emphasized by an
reduced affinity of the protein towards RNA278. Nevertheless, if the ATP-bound state (ADP·BeF3) is
compared to the ATP hydrolysis transition state (ADP·AlF3) a clear compaction of the whole helicase
domain is visible, bringing domain 2a into close contact to domain 1a and decreasing the footprint
of both domains on RNA from 5 nucleotides to 4 (Figure 20A). Compared to NS3, translocation of
RIG-I in presence of an RNA endmight thus be prevented by the CTD leading to stumbling of domain
1a and a subsequent 5′ to 3′shift of domain 2a rather than a translocation into 3′ to 5′direction.
In order to avoid RNA end binding, further studies with hairpin RNAs or RLR constructs lacking the
CTD in the presence of different ATP analogues would therefore give important evidence whether
domain 1a of RIG-I is able to move or not.
After ATP hydrolysis, i.e. in the ADP bound state, the RIG-I SF2 domain is open again, leading to a loss
of RNA contacts within domain 2a, while domain 1a still stays bound (Figure 20B). Repeated cycles
of ATP hydrolysis, however, might due to the intramolecular movements facilitate the disruption of
the CTD:RNA end interface and could thus help establish a translocation competent binding state.
Contrary to that and as discussed earlier, ATP hydrolysis by RIG-I and MDA5 was shown to lead to
disengagement of the SF2 domain from RNA, and thereby helps restore the open helicase state and
enables rebinding of the CARDs to domain 2b106,275,280. All those scenarios, however, are not mu-
tually exclusive and could happen during different states of infection.
Moreover ATP-dependent translocation of RIG-I andMDA5 could even help dissociate both proteins
from endogenous RNA275. In that regard, translocation and subsequent running into bulges on en-
dogenous dsRNA could help release protein:RNA complexes. Evidence for this is provided by studies
of amino acid residues contacting the RNA backbone. A prominent amino acid pair are e.g. two
conserved threonine residues within domain 1a and 2a which are shown to reduce RNA binding and
unwinding in NS3295 (compare to RIG-I in Figure 20C). According to that finding, mutation of the
corresponding threonine T347 in RIG-I results in loss of signaling due to decreased RNA binding275.
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Figure 20: RIG-I domain movements. For comparison reasons only domains 1a and 2a are shown. (A) Com-
parison of the ATP bound state (ADP·BeF3, light gray: domain 1a, green: domain 2a) with the ATP
hydrolysis transition state (ADP·AlF3, dark gray: domain 1a and 2a). (B) Comparison of the ATP hy-
drolysis transition state (ADP·AlF3, dark gray: domain 1a and 2a) with reaction product state (ADP,
light gray: domain 1a, light blue: domain 2a). (C) RNA coordination of domain 1a motif Ic and
domain 2a motif V (upper panels) and domain 1a motif Ib and domain 2a motif IVa (lower panels)
during different states of ATP hydrolysis.
RCSB PDB codes for the depicted structures are: 5f9f (RIG-I ∆CARDs without nucleotide, hu-
man), 3tmi (RIG-I ∆CARDs, ADP·BeF3, human), 4a36 (RIG-I helicase, ADP·AlF3, duck), 3zd7 (RIG-I
∆CARDs, ADP, human).
Interestingly, if a valine residue (V699) near the domain 2a-located threonine (T697) is mutated, sig-
naling is not prevented but rather slightly enhanced even under non-infected conditions. V699 does
not initially bind to the RNA backbone, but is later relocated and helps coordinating the RNA during
the ATP reaction cycle. An explanation for increased signaling might be, that not RNA binding, but
translocation is affected. This might result in a slipping of domain 2a on the RNA backbone rather
than a distinct one-nucleotide translocation step and could lead to prolonged binding of domain 1a.
If the theory holds, this finding would emphasize the importance of translocation on non-perfect
dsRNA stems in non-infected cells for protein dissociation and prevention of signaling on endoge-
nous RNA.
81
Discussion
4 The current model of RNA- and ATP-dependent activation of RIG-I and
MDA5
The current view on regulation of signaling by RIG-I and MDA5 in uninfected and virus-infected cells
can be updated, based on the presented literature. Thereby, crucial structural differences between
both RLRs lead to distinct activation and signaling suppression mechanisms.
In healthy and uninfected cells several instances ensure inactivation of RIG-I but allow surveillance
of the cytoplasm in order to detect optimal ligands. In this regard, the RIG-I CARDs are folded back
to the insertion domain 2b in order to prevent a stochastic communication with the MAVS CARDs
in absence of an RNA stimulus61. Thereby, especially CARD2 is shielded from the cytosol since this
is the domain to provide the template surface for MAVS activation152,153. The RIG-I CTD, however,
is flexibly linked to the rest of the protein and free to interact with RNA61,62. In addition, several
post-translational modifications impede signaling in uninfected cells: examples are phosphorylation
of the CARDs that prevents ubiquitination and therefore tetramer stabilization in case of a release
of the CARD domains, and acetylation of the CTD that decreases RNA binding69,178. Furthermore,
unspecific binding to endogenous RNA is decreased through ATP hydrolysis, which leads to either im-
mediate dissociation or to translocation and subsequent disengagement on nearby bulges275 (Figure
21A). On the other hand compartmentalization of eukaryotic cells shields triphosphate containing
unmethylated mRNAs from the cytosol which also helps to avoid the immune activation by those
RNAs.
Upon viral infection, the RIG-I CTD captures 5′ phosphorylated ends of double-stranded RNA and
presents it to the helicase domain102–104 (Figure 21B). Thereby, even a capped 5′ end is tolerated,
but not methylation of the first nucleotide105,109. RNA-binding again stimulates the ATPase function
of the SF2 domain. Since the phosphorylated RNA end now provides a strong anchor to the CTD,
ATP hydrolysis still leads to a widening of both domain 1a and 2a of the SF2 helicase domain, there-
fore decreasing RNA stem recognition, while CTD-mediated binding is not disturbed. Subsequently,
the SF2 helicase domain could rebind as before, or might bind with a slightly different orientation,
helping to reposition the CTD in order to start translocation on the duplex. Translocation itself might
function to dislocate bound viral proteins or to load several RIG-I molecules onto the RNA double-
strand in order to enhance downstream signaling198–200.
Release of the CARDs is, besides being dependent on dsRNA binding, coupled to ATP and is trig-
gered by a molecular switch upon ATP binding that compacts the SF2 helicase domain. This induces
a clash between CARDs and RNA bound to the CTD, and either liberates the CARDs or leads, in case
of non tri- or diphosphorylated dsRNA, to dissociation61. Successfully freed CARDs, in turn, inter-
act with adjacent CARDs to form tetramers and build a scaffold for the recruitment of MAVS CARDs
in order to start an immune response152,153. Released RIG-I CARDs or CARDs-tetramers are fur-
ther dephosphorylated and either bind polyubiquitin chains, ubiquitin-like proteins or domains, or
are covalently polyubiquitinated69,70,166,296. Ubiquitination, itself is not strictly required for an im-
mune response199, but it stabilizes the RIG-I signaling competent complex, especially if no oligomers
can be formed on an RNA double-strand, and thus impedes CARDs complex dissociation. In ad-
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Figure 21: RIG-I ATP- and RNA-dependent signaling. (A) RNA binding alone is not sufficient to induce signaling
and needs subsequent ATP. ATP hydrolysis and translocation, however, result in rapid dissociation,
prevent prolonged protein binding and therefore enable refolding of the CARDs. (B) RIG-I binds
phosphorylated dsRNA ends via its CTD. Subsequent ATP binding releases the CARDs and allows
immune response signaling. ATP hydrolysis displaces the SF2 domain from the RNA strand, but
leads to either rebinding on the RNA end caused by the CTD anchor, or to translocation on the
stem.
RIG-I SF2 domain: gray, CTD: cyan, CARDs: orange, phosphates: red dots. Figure adopted from
Lässig et al. 275 .
dition, deacetylation of the RIG-I CTD further stimulates RNA binding and enhances the immune
response178. Activation of the downstream signaling cascade ultimately leads to expression of hun-
dreds of ISGs including RLRs themselves in order to boost or fine-tune the immune response.
MDA5 is like RIG-I autoinhibited by phosphorylation of its CARDs166. Nevertheless, the CARDs them-
selves do not as tightly associate with domain 2b as in RIG-I, which leads to partially exposed CARDs
and higher background activity of MDA5106 (Figure 22A). Phosphorylation and its suppressive role
in immune response activation through decreased binding of free ubiquitin chains might thus even
play a more crucial role for MDA5 compared with RIG-I. The MDA5 CTD is as well flexible, but pref-
erentially captures dsRNA stems144. In addition and contrary to RIG-I, also the MDA5 SF2 domain
alone is able to bind dsRNA277. TheMDA5 CTDmight therefore have an especially crucial role in sta-
bilizing the MDA5 ring-like structure on dsRNA by docking onto domain 2b via the convex zinc-ion
containing surface144.
If bound to dsRNA,MDA5 cooperatively forms large filaments and thus scans the RNA length130 (Fig-
ure 22B). Thereby, MDA5 preferentially nucleates within the RNA interior. In contrast to RIG-I and
because of the higher flexibility of the MDA5 CARDs, ATP binding is not as essential in order to start
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binding alone is sufficient to induce signaling. ATP hydrolysis and translocation, however, prevent
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background signaling. (B) MDA5 binds to viral dsRNA stems. Subsequent ATP binding entirely re-
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an immune response277. Nevertheless, RNA binding induces ATP hydrolysis similar to RIG-I, which
leads to disassembly of the filaments and therefore displays immunosuppressive effects as well130.
Since MDA5 lacks the high affinity anchor of the CTD towards phosphorylated RNA ends, transloca-
tion might happen easier compared with RIG-I and might lead to faster loading of several molecules
onto the dsRNA strand, thereby filling gaps. Cooperative protein binding provides filament stabil-
ity, whereas ATP hydrolysis-driven disassembly might primary happen at RNA ends199. In addition
MDA5 might have a preference for U or A/U-rich dsRNA, which show lower ATP hydrolysis rates and
thus could result in more stable filaments through decreased translocation or dissociation. Spatial
proximity of several MDA5 molecules on longer dsRNA further induces CARD oligomerization and
immune response activation via MAVS.
Importantly, the ATPase function of both RIG-I and MDA5 indirectly prevents immune signaling by
disturbing the CARDs-tetramer formation needed for MAVS activation until post-translational mod-
ifications are exchanged or the CARDs are ubiquitinated. In that regard, RNA dissociation from non-
phosphorylated dsRNA of RIG-I allows CARDs rebinding to domain 2b. Translocation or dissociation
on short RNA stems by MDA5 disturbs the spatial proximity. Further, ATP hydrolysis of both RIG-I
and MDA5 reduces signaling on short internal dsRNA stems by challenging the helicase:RNA back-
bone interactions and highlighting additional RNA features but themere double-stranded nature: In
case of RIG-I the SF2 domain tests for the presence of a tri- or diphosphate and for MDA5 it restricts
signaling to long dsRNAs.
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List of abbreviations
ADAR1 adenosine deaminase acting on RNA 1, A-to-I RNA editing enzyme
aa amino acids
CARDs caspase activation and recruitment domains, tandem domain of RLRs involved
in signal transmission
CTD C-terminal domain, domain of RLRs that confers substrate specificity
dsRNA double-stranded RNA
HBV/ HCV hepatitis B/ C virus
IFN interferon
IKK IκB kinase, kinase that phosphorylates IκB
IRF interferon regulatory factor, transcription factor
ISG interferon regulated gene
LGP2 laboratory of genetics and physiology 2, RIG-I paralogue involved in viral RNA
sensing
MAVS mitochondrial antiviral signaling protein, adapter protein of RLRs
MDA5 melanoma differentiation-associated gene 5, RIG-I paralogue involved in viral
RNA sensing
MeV measles virus, single-stranded, negative-sense RNA virus
NF-κB nuclear factor κ-light-chain-enhancer of activated B cells, transcription factor
NS3 non-structural protein 3, viral enzyme
PAMP pathogen-associated molecular pattern
PP1 phosphoprotein phosphatase 1, RIG-I and MDA5 dephosphorylating enzyme
PRR pathogen recognition receptor
RIG-I retinoic acid-inducible gene I
RLRs RIG-I-like receptors
RNase L ribonuclease L, enzyme that cleaves ssRNA
SF2 Superfamily 2, domain that characterizes Superfamily 2 helicases/ translocases
SMS Singleton-Merten syndrome, multi-system disease
SNP single-nucleotide polymorphism
ssRNA single-stranded RNA
TBK1 TANK-binding kinase 1
TLRs Toll-like receptors
TRAF tumor necrosis factor (TNF) receptor-associated factor
TRIM25 tripartite motif 25, a RIG-I ubiquitinating enzyme
UTR untranslated region, non-coding part of mRNA
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